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Abstract 
 
Background: Coronary heart disease can have a long lasting impact on affected 
individuals in terms of both physical and psychological adjustment and quality of life. It 
is, therefore, important to investigate determinants of outcome in these patients. The 
thesis has four main aims; (i) to investigate predictors of outcome (adherence, quality of 
life, functional impairment, psychological distress and benefit finding) post-myocardial 
infarction (MI); (ii) to determine the prevalence and stability of Type D personality in the 
UK; (iii) to determine if personality predicts outcome after controlling for mood, 
demographic and clinical factors, and (iv) to investigate potential mechanisms which may 
explain the link between personality and poor prognosis in cardiac patients. Method: Five 
studies were conducted. In Studies 1-3, participants completed measures of Type D 
personality, health-related behaviour, social support and neuroticism. In Study 4, 
participants completed an experimental stressor with cardiovascular monitoring. Study 5 
was a prospective study in which 131 MI patients completed measures of personality, 
illness cognitions and outcome at two time points, 3-5 days post-MI, then again 3 months 
later. Results: The prevalence of Type D personality in the UK is 39% in the healthy 
population, and 34% in the cardiac population. In addition, Type D is predictive of 
adherence, quality of life, and functional impairment in post-MI patients after controlling 
for mood, demographics, and clinical factors. Five possible mechanisms (health-related 
behaviour, adherence, social support, cardiovascular reactivity, and illness perceptions) 
by which Type D may lead to adverse outcome in cardiac patients were identified. Mood 
predicted quality of life and functional impairment post-MI, illness perceptions predicted 
quality of life post-MI, and future thinking predicted quality of life, functional 
impairment and depression post-MI. Discussion: These findings have important 
therapeutic and theoretical implications for understanding the role of personality and 
illness cognitions in the short-term recovery of post-MI patients.  
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 1 
Chapter 1: Introduction 
 
Cardiac Disease: Prevalence Rates and Established Risk Factors 
 
 
1.0 Overview 
The current chapter introduces the topic of cardiac disease. It describes the prevalence 
of cardiac disease in the UK, including the economic implications. Section 1.2 
outlines the established risk factors for coronary heart disease (CHD) including, 
smoking, unhealthy diet, alcohol consumption, diabetes, and elevated blood pressure 
and blood cholesterol. The development of CHD is then described, followed by 
treatments for myocardial infarction (MI), and recovery following an MI. The 
concluding sections relate specifically to the aims and structure of the thesis. 
 
1.1 Prevalence of Coronary Heart Disease 
CHD is the most common cause of premature death in the UK, causing 21% of 
premature deaths in men and 12% of premature deaths in women. It is estimated that 
one in five men and one in six women die from the disease (British Heart Foundation, 
2007). In 2006, CHD caused just over 100, 000 deaths in the UK. Although there has 
been improvement in the death rate from coronary heart disease in the UK in recent 
years (Fox et al, 2007), it remains one of the highest in the world. In addition, a large 
number of people in the UK are now estimated to be living with heart disease, 
estimated at just under 2.7 million people (British Heart Foundation, 2007). 
 
 The majority of deaths from CHD are because of a heart attack (also known as 
myocardial infarction or MI). 270, 000 people suffer a heart attack in the UK each 
year, resulting in 117, 000 deaths. It is estimated that almost 1.3 million people are 
living in the UK who have had a heart attack (British Heart Foundation, 2007). 
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Furthermore, the World Health Organisation MONICA Project which monitored the 
trends and determinants of cardiovascular disease (CVD) found that the incidence 
rates of heart attack in the two UK populations in the study, Belfast and Glasgow, 
were among the highest in the world (Tunstall-Pedoe et al, 1999). 
 
The economic costs of CHD to the health service are considerable, costing an 
estimated £1,750 million each year. In addition, CHD costs the UK economy around 
£5,300 million each year because of days lost to death, illness and informal care of 
people with the disease (British Heart Foundation, 2007). 
 
Due to advancements in the treatment of CHD more people are now surviving heart 
attacks and other cardiac events (Fox et al, 2007), meaning that there are large 
numbers of people in the UK now living with CHD. This presents a new problem as 
CHD can have a long lasting impact on affected individuals and their families in 
terms of both physical and psychological adjustment and quality of life (e.g. Frasure-
Smith & Lesperance, 2003). It is, therefore, important to investigate the aetiological 
factors and determinants of psychological outcome in cardiac patients, which are the 
central aims of this thesis. 
 
1.2 Established Risk Factors for Coronary Heart Disease 
There are a number of well-known and well established medical risk factors for CHD, 
it is these factors which guide current prevention efforts for CHD. Smoking is an 
important risk factor and it is estimated that smoking causes more than 30,000 deaths 
per year from CVD. Additionally, second-hand smoke is also harmful, with regular 
exposure increasing the risk of CHD by 25% (British Heart Foundation, 2007). 
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Unhealthy diet, consisting of high fat and salt intake combined with low fruit and 
vegetable consumption represents a further reason why CHD rates are high in the UK 
(British Heart Foundation, 2007). Lack of physical activity is also important as 
physical activity lowers the risk of CHD. In recent years the levels of physical activity 
have declined in the UK, with only 37% of men and 25% of women doing enough 
exercise to meet the current recommendations of 30 minutes of activity five times a 
week (British Heart Foundation, 2007). 
 
It is estimated that about 43% of men, and 34% of women are overweight in the UK, 
and a further 22% of men, and 23% of women are obese. Being overweight (a BMI of 
25-30kg/m²) or obese (a BMI of more than 30kg/m²) increases the risk of CHD as it is 
associated with raised blood pressure and the development of diabetes (British Heart 
Foundation, 2007). With regards to alcohol, although moderate alcohol consumption 
is claimed to be associated with a reduced risk of CHD (e.g. Rimm et al, 1999), high 
levels of intake, particularly in ‘binges’ are associated with increased risk of CHD. It 
is estimated that 38% of men and 23% of women in the UK drink more that the daily 
recommended limits of no more than four units of alcohol in men, and three in women 
(British Heart Foundation, 2007). Diabetes also substantially increases the risk of 
CHD, currently around 3% of adult men and women are thought to have diabetes, this 
figure has been rising rapidly in recent years (British Heart Foundation, 2007). 
Elevated blood pressure and blood cholesterol are also directly related to CHD. 
Thirty-seven per cent of men and 34% of women have raised blood pressure, and 
about 60% of people have blood cholesterol levels above the recommended level 
(British Heart Foundation, 2007). There is also a strong genetic component of CHD, 
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with many heart conditions being influenced by hereditary factors (e.g. Freidlander, 
Kark & Stein, 1985). 
 
Although these are all important risk factors for CHD, they provide an incomplete 
account of the causes of CHD. Therefore, it is important to also consider 
psychological factors, such as, personality, social support and depression, which have 
an important role in the development of CHD. These factors will be described in 
further detail in Chapter 2. 
 
1.3 The Development of Coronary Heart Disease 
This thesis focuses on one manifestation of coronary heart disease, myocardial 
infarction (MI). An MI is caused by atherosclerosis of the blood vessels, the process 
through which deposits of fatty substances, cholesterol, cellular waste products, 
calcium and other substances build up in the inner lining of an artery. This develops 
into an atherosclerotic plaque (Weissberg, 2000). Atherosclerosis can remain 
clinically silent due to positive remodelling of the vessel, during this time the vessel 
will expand as the plaque grows, this expansion preserves both the lumen diameter 
and blood flow. Therefore, it is possible for large atherosclerotic lesions to 
accumulate without a resulting effect on blood flow or symptoms (Davies et al, 2004). 
 
Atherosclerosis will remain clinically silent until one of two events occurs; (1) the 
lesion expands to the point at which it limits blood flow, resulting in symptoms of 
reversible ischaemia during exertion, known as angina, or (2) the fibrous plaque 
ruptures causing the exposure of sub-endothelial collagen and lipid. The latter event 
can lead to a condition in which platelets are prone to activation, the coagulation 
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system is in a prothrombotic state, and high levels of circulating inflammatory factors 
are present (Naghavi et al, 2003). This may result in the formation of a thrombus that 
blocks the artery, stopping it from supplying blood to the region of the heart that it 
supplies, resulting in an MI (Davies et al, 2004). 
 
Reported symptoms at the time of an MI often include, central crushing chest pain, a 
feeling of heaviness or discomfort in the left arm, and collapse. Other patient reported 
symptoms include; shortness of breath, nausea and vomiting, palpitations, feeling 
faint, dizzy or weak, stomach upset, indigestion-like abdominal discomfort, flu-like 
symptoms, pain in the jaw/head/shoulder/back, or feelings of panic (American Heart 
Association, 2007). However, there are problems with delayed presentation in MI 
patients, with only 15% of patients coming to hospital within 1 hour of experiencing 
symptoms (Norris, 1998), due to a mismatch between expected and experienced 
symptoms (O’Carroll et al, 2001). 
 
1.4 Treatment for MI 
Recent advances in treatment have significantly improved survival rates in MI 
patients (Fox et al, 2007). Specifically, the advent of thrombolytic therapy (the 
injection of clot dissolving medication into the artery) has greatly improved survival 
rates by enabling blood flow to be restored to the myocardium (van Domburg, 
Boersma & Simoons, 2000). Patients who receive thrombolytic therapy within the 
first hour after symptoms begin were shown to be 50% more likely to survive the first 
year following an acute MI (AMI) (GISSI, 1986). An alternative procedure also used 
to relieve obstruction or reduce narrowing in coronary arteries is coronary angioplasty. 
The procedure involves a small balloon catheter being inserted into the artery and 
 6 
advanced to the narrowing; here the balloon is inflated and removed, leaving in place 
a rigid support (stent) to keep the blood vessel open. Angioplasty has been shown to 
be a very effective treatment in MI patients, indeed some research has found it to be 
superior to treatment by thrombolysis in patients with AMI (e.g. Andersen et al, 2003). 
A further treatment used in some MI patients is coronary artery bypass graft (CABG), 
this procedure creates a bypass around the blocked part of the coronary artery to 
restore the blood supply to the heart muscle. Again, this treatment has high rates of 
clinical effectiveness (Serruys et al, 2001). 
 
1.5 Recovery and Quality of Life Following MI 
Advancements in the treatment of cardiovascular disease has led to a shift from hard 
endpoints (such as mortaility or repeat MI), to include the patient’s perspective; 
prolonged survival is no longer the ‘be all and end all’ but also the quality of life of 
the patient has become important (Pedersen et al, 2007). As stated by Lesperance & 
Frasure-Smith (1999) ‘When we begin to see improved survival as the gold standard 
for judging the value of psychological and psychiatric treatments, we have missed the 
point both practically and philosophically’. With this shift in outcomes, it is important 
to identify patients at risk of impaired functioning and quality of life. As stated earlier, 
it is estimated that there are currently 1.3 million people living in the UK who have 
experienced an MI (British Heart Foundation, 2007) Therefore, prospective studies 
are required which aim to identify important predictors of outcome (including both 
hard and soft endpoints) in MI patients. The simple outcome measure of mortality is 
insufficient in assessing the real and full picture of the effect of experiencing an MI 
on patients overall well-being.  
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There is little evidence linking key medical variables, such as left ventricle ejection 
fraction, to quality of life (e.g. Gorkin et al, 1993). It is therefore important to focus 
on the role of psychological factors, such as negative emotions, personality and 
health-related cognitions. These factors will be described in more detail in Chapter 2. 
Indeed, studies have shown that cardiac patients may suffer from a wide-range of 
psychological sequelae following a cardiac event, including poor perceived health, 
anxiety, depression, and posttraumatic stress disorder (PTSD) (Ladwig et al, 1991; 
Kutz et al, 1994; Frasure-Smith, Lesperance & Talajic, 1995; Duits et al, 1997). 
Moreover, these sequelae have been shown to have a negative prognostic impact 
independent of disease severity (Berkman, Leo-Summers & Horwitz, 1992; 
Hemingway & Marmot, 1999). 
 
1.6 Aims of the Thesis 
The primary aim of this thesis is to investigate patient outcome following an MI by 
identifying predictors of psychological wellbeing and quality of life in a prospective 
cohort of patients who have been admitted to hospital following an MI. It will 
investigate the role of Type D personality, future thinking, and role and goal 
investment in predicting psychological distress, quality of life, and functional 
outcome post-MI. In addition, the role of Type D personality and patients’ beliefs will 
be examined in relation to medication adherence. The thesis will also examine the 
association between several key psychological variables; locus of control, illness 
perceptions, and optimism, and whether they are predictive of outcome post-MI. 
Within the context of identifying predictors of outcome, a particular focus is placed 
on the role of personality. The concept of Type D personality (the joint effects of 
social inhibition and negative affectivity), an emerging risk factor in CHD, is 
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investigated. It is of importance to determine if it is an important predictor of outcome 
in the current sample of MI patients. Specifically, studies will be conducted to 
investigate the prevalence and stability of the Type D construct in both healthy and 
cardiac populations in the UK. In addition, these studies seek to investigate potential 
mechanisms by which Type D may lead to adverse prognosis in cardiac patients. 
 
Therefore, the aims of the thesis are: 
(i) To investigate predictors of psychological outcome post-MI. 
(ii) To determine the prevalence and stability of Type D Personality in the UK. 
(iii) To determine if personality is predictive of psychological outcome after 
controlling for mood, and demographic and clinical factors. 
(iv) To investigate potential mechanisms which may explain the link between 
personality and adverse outcome in cardiac patients. 
 
1.7 Thesis Structure 
The literature review in Chapter 2 focuses on the psychological variables which are 
utilised in the thesis in order to predict outcome post-MI. This focuses on established 
cardiovascular psychological risk factors, such as depression and anxiety, ‘newer’ 
cardiovascular risk factors such as Type D personality and variables which have been 
shown to be important in other patient groups, which are utilised in a cardiovascular 
setting for the first time, for example, prospective thinking and role and goal 
investment. Chapter 3 describes the psychological model underpinning the thesis, 
Leventhal’s Self Regulation model, and how the variables described in Chapter 2 are 
operationalised in this model. Chapter 4 provides an overview of the methodology of 
the thesis. Specifically, this provides a detailed summary of each of the measures 
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being used in each of the five studies that are described. Chapters 5, 6 and 7 are 
experimental chapters and report the findings from studies focussing on one particular 
emerging risk factor for cardiovascular disease, Type D personality. These studies 
aimed to identify possible mechanisms through which Type D may lead to poor 
outcome in cardiac patients. Chapter 8 presents the results of the clinical study, 
presenting the baseline measures, and the results of the follow-up assessment at 3 
months in a prospective cohort of MI patients. A flow diagram of the studies is 
presented in Figure 1.1. Chapter 9 provides a general discussion of the findings of the 
thesis and their implications for research and clinical practices. It also reviews the 
strengths and limitations of the research, and suggests possible areas that may be 
developed in future research. 
 
 
 
 
 
 
 
 
 
 
 10 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Flow diagram depicting the experimental studies which make up the thesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study 1 
Prevalence of Type D personality in the UK and Ireland: 
Associations with health behaviour and social support 
Study 2 and 3 
Type D personality, health behaviour and social support: 
Further evidence 
Study 4 
Type D personality and cardiovascular reactivity to stress 
Study 5 
Predictors of psychological outcome post myocardial 
infarction: A prospective study 
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Chapter 2: Literature Review 
 
Psychosocial Risk Factors in Coronary Heart Disease 
 
 
2.1 Psychosocial Risk Factors in CHD 
 
As outlined in Chapter 1, there are a number of established medical risk factors for 
CHD. However, medical risk factors alone are not sufficient to explain all the cases of 
CHD. Therefore, it is important to outline the main established psycho-social risk 
factors in CHD, these are, socio-economic status, job strain, social isolation, 
depression and anger and hostility. Each of these is described in more detail in the 
following sections. 
 
2.1.1 Socio-economic Status 
 
Socio-economic status (SES) indicators, including income, occupation and education 
have been associated with CHD, in terms of both morbidity and mortality. Morrison 
et al (1997) investigated the effect of socioeconomic group on incidence of, 
management of, and survival after MI in a Scottish sample. They found that event 
rates increased 1.7-fold in men, and 2.4-fold in women from the least to the most 
deprived SES group. These findings were replicated 4 years later by Macintyre et al 
(2001) who investigated the relationship between SES and death from an MI in 
Scotland. They found that socioeconomic deprivation had an effect on the risk of 
having a first MI, the chance of reaching hospital alive, and the probability of 
surviving the first month. For example, those experiencing the most deprivation had 
twice the risk of having a first MI, and of dying before reaching hospital.  
 
More recently, a study undertaken in Finland reported similar results. Manderbacka et 
al (2006) again reported that the lower the SES group the higher the risk of death from 
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MI. Recent research has also investigated the influence of SES on quality of life in 
cardiac patients who have undergone percutaneous coronary intervention. Results 
demonstrated that patients with low SES had lower quality of life at baseline and 12 
months (Denvir et al, 2006). 
 
 With regards to education, studies have demonstrated an inverse relationship between 
education and long term risk of CHD. For example, Mayer et al (2004) investigated 
the relationship between educational level and the risk profile of 5556 patients. They 
reported that significantly more patients with ischaemia had only primary education. 
In addition, men with the highest education were found to have significantly lower 
systolic blood pressure and cholesterol compared to those with a lower education 
level.  
 
A similar pattern is observed for income. Salomaa et al (2000) investigated the 
relationship between SES and the mortality rates of MI patients. They reported that 
among men with their first MI, the adjusted incidence ratios were 1.67 and 1.84 in the 
low and middle income categories compared to the high income categories. More 
recently, Ljung & Hallqvist (2006) sought to examine the impact of SES position over 
the lifetime and the risk of MI. The relative risk of having an MI was 2.36 for men, 
and 2.54 for women who had been in an adverse SES position throughout their life, 
compared to those who had never been.  
 
SES is thought to have this effect through a number of mechanisms. For example, 
those in better off social positions have better access to care and to knowledge and 
resources relating to health (Kirby & Kaneda, 2005). Indeed, studies have 
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demonstrated that underprivileged groups are less likely to receive invasive and 
diagnostic procedures and are more likely to experience delays in these types of care 
(e.g. Alter et al, 1999). Furthermore, people from lower socioeconomic groups are 
also known to be more likely to smoke, exercise less, and be obese, all of which are 
important risk factors for CHD (Erkkila et al, 1999).  
 
Importantly, recent studies have reported that socioeconomic differences seem to be 
increasing (e.g. Valkonen et al., 2000). Therefore, it is important for studies to 
continue to investigate SES, and to consider psychosocial factors which explain why 
these differences seem to be increasing. 
 
2.1.2 Job Strain 
The job-strain model postulates that a combination of high psychosocial demand (the 
need to work quickly and hard) and low control (lack of control over skill use, time 
allocation and organisational decisions) (Karasek, 1979) is related to cardiovascular 
risk (Schnall, 1994). Research has demonstrated job strain to be associated with CHD 
and hypertensive risk in a number of occupations (Bosma et al., 1997; Goldstein et al., 
1999; Steptoe et al., 1996).  
 
Research has shown that occupations characterised by low control have increased 
CHD mortality (Marmot & Theorell, 1988). Evidence from the Whitehall II study 
demonstrates that low decision latitude is associated with increased incidence of CHD 
over 5 years, independently of measures of socioeconomic status (Bosma et al, 1997). 
A more recent study of the same sample by Kuper and Marmot (2003) sought to 
extend the earlier work by Bosma and colleagues by investigating the full job strain 
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model in relation to CHD events. They reported that those individuals who were 
simultaneously low on decision latitude and experienced high demands were at the 
highest risk of CHD. In addition, the separate components of the model, job demands, 
and to a lesser extent decision latitude also predicted incidence of CHD. 
 
Further evidence for the association between job strain and CHD risk comes from a 
prospective cohort study of industrial employees (Kivimaki et al, 2002). They found 
that high job strain was associated with a two-fold increased risk of cardiovascular 
death compared to individuals with low job strain at 25-year follow-up. In addition, 
this finding remained significant after controlling for biological and behavioural risk 
factors at baseline. Furthermore, in one study of work related stressors, upcoming 
deadlines were associated with a six fold increase in myocardial infarction (Johansen 
et al, 2002).  
 
Research has also been carried out to examine the effects of job strain on blood 
pressure in difference occupational groups. For example, O’Connor, O’Connor, White 
and Bundred (2000) found that general practitioners who experienced high job strain 
had elevated blood pressure levels, compared to their low strain counterparts. More 
recently, Guimot et al (2006) reported that cumulative exposure to job strain led to 
significant increases in systolic blood pressure among male white-collar workers. 
Research has also demonstrated that job strain is associated with increased 
atherosclerosis in young males (Hintsanen et al, 2005). 
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2.1.3 Social Support 
Lack of social support is a leading psychosocial risk factor for CHD. Social support 
can refer both to the number and quality of a person’s social contacts (including 
emotional and confiding support). Initial reports of the role of social support in health 
came from the investigators of the Alameda County Study (Berkman & Breslow, 
1983). Since then, studies have been carried out to investigate the relationship 
between the lack of social support and cardiovascular disease incidence. Orth-Gomer, 
Rosengren & Wilhelmsson (1993) found that lack of social support was associated 
with an increased future risk of an acute myocardial infarction and death from CHD at 
6 year follow-up in a population of healthy middle-aged Swedish men. More recently, 
a 15 year follow-up investigation of this same sample of healthy middle-aged Swedish 
men was published. Again, social support was predictive of coronary morbidity 
(Rosengren, Wilhelmsson & Orth-Gomer, 2003). The concept of social support is 
described in more detail in Section 2.2.2. 
 
2.1.4 Depression 
Depression has been linked with the development and progression of CHD, For 
example, depression has been associated with a 3-4 fold increase in cardiac mortality 
over the first 18 months following an MI (Frasure-Smith, Lesperance & Talajic, 
1995a). Several substantial literature reviews (e.g. Kuper, Marmot & Hemingway, 
2002; Frasure-Smith & Lesperance, 2005; Frasure-Smith & Lesperance, 2006) have 
considered the evidence for the link between depression and the development of CHD 
in initially disease-free individuals. These reviews have concluded, that despite some 
variability in outcomes, depression is a consistent risk factor for both the aetiology 
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and prognosis following CHD. The role of depression as a prognostic risk factor in 
CHD is described in more detail in 2.2.1. 
 
2.1.5 Anger and Hostility  
The deleterious effects of anger and hostility on cardiovascular health have also been 
investigated. For example, trait anger has been positively associated with blood 
pressure and cardiovascular reactivity (Durel et al, 1989; Siegman et al, 1992). 
Prospective studies have also demonstrated a relationship between anger and the 
development of CHD (Williams et al., 2000; 2001). Investigators from the 
Framingham Heart Study reported that suppressed anger independently predicted the 
8-year incidence of CHD among both men and women (Haynes, Feinleid & Kannel, 
1980). In addition, Kawachi et al (1996) report findings from the Normative Aging 
Study of a 3-fold increase in CHD risk among individuals with the greatest difficulty 
controlling their anger. More recently, Williams et al (2000) demonstrated that 
proneness to anger in normotensive middle-aged men and women predicted CHD 
morbidity and death independent of established biological risk factors. In a further 
study, Williams et al (2001) demonstrated that a strong, angry temperament puts 
normotensive, middle-aged persons at increased risk for cardiac events and may 
confer a CHD risk similar to that of hypertension. 
 
Hostility has also been implicated in the development of CHD. For example, an early 
study from Williams et al (1980) established an association between hostility and the 
severity of coronary atherosclerosis in patients undergoing coronary arteriography. A 
further study by Barefoot, Dahlstrom & Williams (1983) found an association 
between the hostility scores of healthy young men and the incidence of CHD over the 
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subsequent 15-year interval. More recently, Niaura and colleagues reported findings 
from the Normative Aging Study which demonstrated that healthy individuals with 
high levels of hostility were at the greatest risk for the development of CHD, 
independent of the effects of traditional CHD risk factors, such as body mass index 
(BMI) and blood pressure (Niaura et al, 2002). 
 
The above section serves to highlight the potential importance of psychological 
factors (in addition to the medical factors described in Chapter 1, Section 1.2) to the 
development of CHD. As the purpose of this thesis is to examine predictors of 
outcome post-MI, the following section outlines the psychological factors that will be 
examined during the thesis. Many of these factors are established prognostic risk 
factors in CHD, such as depression, social support and adherence. Others are 
emerging risk factors, for example Type D Personality, and others are factors which 
are important in other health domains and may have utility as predictors of outcome in 
the area of CHD. 
 
2.2 Established Psychological Predictors of Outcome Post-MI 
The following section describes established psychological predictors of outcome post-
MI; these factors are investigated in the main clinical study described in Chapter 8.  
 
2.2.1 Depression and Anxiety 
Symptoms of depression and anxiety are prevalent in patients with MI (e.g. Crowe et 
al, 1996). Several studies have demonstrated that depression and anxiety predict 
subsequent mortality in MI patients (e.g. Frasure-Smith, Lesperance & Talajic, 1993; 
Moser & Dracup, 1996). A study conducted among MI patients in Canada, published 
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in a series of articles by Frasure-Smith, Lesperance and Talajic (1993, 1995a, 1995b, 
1996) has examined the role of anxiety and depression on cardiac events. At 6-month 
follow-up after acute MI, major depression and elevated Beck Depression Inventory 
(BDI) scores predicted cardiac mortality. At 18-month follow-up, again both major 
depression and elevated BDI scores were related to cardiac mortality, although only 
the BDI prediction remained significant after controlling for other clinical variables. 
In the same study, anxiety emerged as a predictor of recurrent cardiac events, 
independent of depression. 
 
Research has also examined the effects of depression and anxiety on quality of life of 
patients after MI. Patients who are depressed after a MI are less likely to return to 
work (Schleifer et al, 1989), or to resume sexual activity (Stern, Pascale & Ackerman, 
1977). Conn, Taylor & Wiman (1991) specifically examined the quality of life in MI 
survivors, they found depression to be the single best predictor of quality of life, 
accounting for 49% of the variance. In addition, further studies have found that both 
anxiety and depression predicted quality of life at 4 months (Lane et al, 2000) and 1 
year in MI patients (Mayou et al, 2000). In addition, Lane et al (2002) have 
demonstrated that symptoms of depression and anxiety are a persistent problem 
during the first year following MI, with prevalence rates of 37.2% for depressive 
symptoms and 40% for symptoms of anxiety. The role of depression and anxiety after 
MI is described in further detail in Section 8.1.1. 
 
2.2.2 Social Support 
As described in section 3.1.3, lack of social support has also been associated with 
adverse prognosis in cardiac patients. Indeed, systematic reviews and meta-analyses 
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have consistently concluded that social support is among the most robust risk factors 
for CHD (e.g. Berkman, 1995; Kuper, Marmot & Hemingway, 2002). For example, a 
review from Hemingway & Marmot (1999) found the magnitude of the risk for lack 
of social support on all cause mortality ranges from 1.33 to 5.62 after adjusting for 
cardiac disease severity. In addition, a more recent review by Lett et al (2005) 
concluded that low social support confers a risk of 1.5 to 2.0 in both healthy 
populations and in patients with CHD. 
 
The beneficial effect of social support on CHD is thought to be the result of either 
healthier lifestyles among those who have a supportive network, or social support acts 
as a buffer against the deleterious effects of life events and stress (Hemingway & 
Marmot, 1999). 
 
A series of prospective studies carried out with initially healthy individuals have 
provided evidence in support of social support as a predictor of the onset and 
progression of CHD. Studies have demonstrated a relationship between low perceived 
emotional support and increased CHD incidence (Orth-Gomer, Rosengren & 
Wilhelmson, 1993; Rosengren, Wilhelmson & Orth-Gomer, 2004). Research has also 
highlighted the relationship between structural support (e.g. the number of social 
contacts, marital status, living arrangements) and initial cardiac events, and mortality 
due to CHD (Eng et al, 2002; Kaplan et al, 1988; Vogt et al, 1992). 
 
Prospective studies have also been carried out with CHD patients to determine the 
impact of social support on health outcomes. For example, Berkman, Leo-Summers 
and Horwitz (1992) found that perceived emotional support was a predictor of 
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mortality in a sample of 194 MI patients. Similarly, Gorkin et al (1993) found that 
perceived availability of needed support was associated with a hazard ratio of 1.46 for 
subsequent mortality in nearly 700 MI patients. However, Frasure-Smith et al (2000) 
did not find a main effect of perceived social support in their sample of 887 MI 
patients, but instead found an interaction with depression. Specifically, depressed 
patients with low perceived social support were at the greatest risk for mortality 
during the first year post-MI.  
 
Research has also been carried out with CHD patients to determine the effect of 
structural support on outcome. Williams et al (1992) demonstrated that individuals 
with CHD who were unmarried, or without a confidant had a relative risk of 3.34 
compared to those who were married or had a confidant. The same pattern of results 
was also found in MI patients (Case et al, 1992). Furthermore, Brummett et al (2001) 
found that low network size was associated with a hazard ratio of 2.43 for cardiac 
mortality in a 4-year follow-up study of CHD patients.  
 
A number of studies have found that patients with a lack of social support report more 
cardiac symptoms compared to those with high levels of social support (Fontana et al, 
1989; Lindsay et al, 2001, Pedersen, Van Domburg & Larsen, 2004). MI patients with 
low social support also have more difficulty in changing maladaptive health-related 
behaviours (Conn, Taylor & Hayes, 1992).  
 
More recently, low levels of social support have been associated with CHD in a 
number of studies. For example, Pedersen, Van Domburg & Larsen (2004) 
investigated the effect of social support on the short-term prognosis in MI patients. 
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They reported that lower social support at baseline was associated with a 10% 
increased risk of cardiac events at follow-up 9 months later. In addition, Petersson et 
al (2007) reported that low social support at work was an independent predictor of MI 
and stroke in women. 
 
However, inconsistency regarding how social support has been defined and measured 
has restricted efforts aimed at fully understanding the relationship between social 
support and CHD, and consequently has impacted the design of effective 
interventions. For example, few studies have simultaneously compared different types 
of social support, therefore it is difficult to pinpoint which types of support are most 
associated with CHD (Lett et al, 2005). 
 
2.3 Health-Related Cognitions 
The following section outlines each of the cognitive variables that are examined in the 
thesis. Patients’ beliefs and perceptions concerning their illness have shown to be 
important predictors of outcome in a number of patients groups (Petrie & Weinman, 
1998). This thesis investigates established health-related cognitions, including illness 
perceptions, locus of control, and medication beliefs. These factors have been shown 
to be important determinants of outcome in a variety of health contexts (e.g. Johnston 
et al., 2004; Petrie et al, 1996). However few studies have examined their impact on 
outcome prospectively in MI patients. This thesis will therefore address this gap in the 
literature. In addition, this thesis examines the role of future thinking and role and 
goal investment in predicting psychological outcome post-MI. These variables have 
been shown to be important predictors of psychological distress and adverse mental 
health in several patient groups, including patients with physical illness. Therefore, it 
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is of interest to investigate future thinking and role and goal investment in MI patients, 
to determine if these cognitions play a role in predicting outcome in MI patients. 
 
2.3.1 Illness Perceptions 
The common-sense model of self-regulation (Leventhal et al, 1980) has been utilised 
extensively within health psychology to predict health and illness behaviour (see 
Chapter 3, Section 3.4.2). The central component of this model is concerned with the 
individual’s illness perceptions which are thought to be organised in terms of five 
components. These components are; beliefs about (a) the causes of the illness; (b) 
identity (i.e. symptoms that the patient associated with the illness); (c) the 
consequences of the illness; (d) time line (i.e. whether the patient believes the illness 
will be acute, chronic or cyclical); and (e) ways to control or cure the illness. 
 
Petrie et al (1996) identified that patients’ perceptions of illness, assessed shortly after 
their MI, had important effects on recovery. For example, patients who believed that 
their MI would have more serious long-lasting consequences were found to have 
higher levels of illness-related disability and were slower to return to work. 
Additionally, patients who had weaker beliefs in the control or cure of their heart 
condition were less likely to attend cardiac rehabilitation (Petrie et al, 1996; Cooper et 
al, 1999; Whitmarsh, Koutanjti & Sidell, 2003).  
 
Further research demonstrates that illness perceptions measured within 24 hours of an 
acute MI were predictive of quality of life at 6 month follow-up (French et al, 2005). 
While the majority of studies investigating illness perceptions have relied on 
completion of the Illness Perception Questionnaire (IPQ; Weinman et al, 1996), or the 
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IPQ-R (Moss-Morris et al, 2002), a study conducted by Broadbent et al (2004) asked 
MI patients to draw pictures of their heart in order to assess the patients’ ideas of the 
extent of damage to their heart. They found that the patients drawing of damage to 
their heart was a better predictor of recovery at 3 months than medical indicators of 
damage. In addition, a large amount of research has focussed specifically on patients’ 
beliefs concerning the causes of their MI. The evidence suggests that causal beliefs 
are predictive of outcomes up to eight years later (Affleck et al, 1987; Low et al, 1993; 
Weinman et al, 2000). 
 
More recently, French, Cooper and Weinman (2006) carried out a systematic review 
and meta-analysis of research which has examined the relationship between illness 
perceptions and attendance at cardiac rehabilitation following MI. They reviewed a 
total of eight studies (N=906 patients). It was found that four illness perception 
constructs were significant predictors of attendance at cardiac rehabilitation. They 
were; patients with more positive identity, cure/control, consequences and coherence. 
However, it was also concluded that effect sizes are often small. Therefore, this 
review did provide some support for the role of illness perceptions in predicting 
attendance at cardiac rehabilitation.  
 
In addition, Petrie et al (2002) have demonstrated that it is possible to alter the illness 
perceptions of MI patients, thus offering a potential route for interventions. They 
carried out a randomised control and found that a brief hospital intervention with 
patients aimed at altering their perceptions about their MI was successful in changing 
patients’ view of their MI. This change meant that these patients returned to work 
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more quickly and experienced fewer angina symptoms compared to those patients in 
the control condition.  
 
Given these promising findings linking illness perceptions to recovery in cardiac 
patients, including those who have experienced an MI, the clinical study described in 
Chapter 8 will utilise a measure of illness perceptions. It is of interest to determine 
which illness perceptions have utility in predicting short-term outcome following MI. 
 
2.3.2 Locus of Control 
Linked to the idea of patients’ perceptions of their illness is the concept of locus of 
control. Individuals differ as to whether they tend to regard events as controllable by 
them (an internal locus of control) or uncontrollable by them (external locus of 
control). Wallston & Wallston (1982) have developed this concept for use within 
health domains. Health locus of control refers to whether individuals believe their 
health is controllable by them, not controllable by them and in the hands of fate, or 
whether they regard their health as being under the control of powerful others (e.g. 
doctors).  
 
A number of studies have indicated the positive affect of patients’ perceptions of 
control in cardiac disease (e.g. Affleck et al., 1987). The concept of locus of control 
has also been investigated in relation to attendance at cardiac rehabilitation, Cooper et 
al (1999) found that patients with a stronger belief that their condition is controllable 
were more likely to attend cardiac rehabilitation compared to those who believed less 
strongly that their condition was controllable. In addition, Sturmer, Hasselbach and 
Amelang (2006) demonstrated that a high internal locus of control was associated 
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with a decreased risk of MI in a large population based cohort at eight year follow-up. 
Furthermore, in a study designed to examine factors which were implicated in delayed 
presentation in MI patients, O’Carroll et al (2001) demonstrated that the belief that 
health is due to chance factors was the best predictor of delayed attendance.  
 
In addition, there is some evidence to suggest that locus of control is related to 
specific health-related behaviours which are relevant to CVD. Steptoe and Wardle 
(2001) investigated the relationship between locus of control and ten health-related 
behaviours in young adults from 18 countries. They found that the odds of carrying 
out healthy activities were 40-70% greater in those with high locus of control. 
However, the findings linking locus of control and health behaviours have been 
inconsistent (Norman & Bennett, 1995).  
 
A series of studies by Johnston and colleagues have examined the impact that 
patients’ recovery locus of control have on outcome. For example, Johnston et al 
(1999) found that stroke patients who held internal recovery locus of control beliefs, 
that is beliefs that their recovery was attributable to themselves, were less disabled six 
months following stroke. An earlier study by Partridge and Johnston (1989) which 
introduced the Recovery Locus of Control scale found that greater internality was 
associated with faster recovery in stroke patients, and patients who had a fractured 
wrist. Orbell et al (1998) also found a similar pattern of results in joint replacement 
patients. More recently, Johnston et al (2004) found that perceptions of control 6 
months after discharge predicted recovery from stroke at 3 years. 
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There is a relative lack of studies which have utilised locus of control as a predictor of 
outcome after a cardiac event prospectively. This thesis will therefore address this gap 
in the literature and examine the association between locus of control and illness 
perceptions in a prospective cohort of MI patients. 
 
2.3.3 Medication Adherence and Beliefs 
Medications such as beta-blockers, and cholesterol lowering medication are known to 
reduce mortality and morbidity rates in MI patients. Adherence to prescribed 
medication is therefore very important for MI patients in aiding their recovery. For 
example, Horwitz et al (1990) found that MI patients who took >75% of prescribed 
medication were more than three times as likely to have survived after one year 
compared to patients who took <75%. However, adherence to medication has been 
found to be quite poor across a range of patient groups and time periods. DiMatteo et 
al (1992) demonstrated that 20% to 30% of patients are non-adherent to short-term 
medication. In addition, for long term medication, the rate of non-adherence is higher, 
with about 50% of patients failing to follow the prescribed regime (Benner et al, 
2002). Osterberg & Blaschke (2005) have reported six general patterns of medication 
taking among patients with a chronic illness. They report that approximately one sixth 
come close to perfect adherence; one sixth take nearly all doses but with some timing 
irregularity; one sixth miss an occasional single day’s dose; one sixth take drugs 
holidays (when they take no medication) three to four times a year, with occasional 
omission of doses; one sixth have a drugs holiday monthly or more often, with 
frequent omissions of doses; and one sixth take few or no doses while giving the 
impression of good adherence. 
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It should also be noted that measuring adherence to medication is problematic (Gordis, 
1979). Indeed, adherence to medication has been measured in a number of different 
ways. A direct measurement of concentrations of a drug, its metabolite or a biologic 
measure in the blood or urine is the most accurate way of assessing adherence. 
However, it is expensive and impractical in many situations. There are problems 
associated with all methods of measurement of adherence. For example, performing 
pill counts does not take into account patients discarding of pills to give the 
impression of compliance. Rates of refilling prescriptions or electronic medication 
monitors can be used, but they do not prove the medication has been used correctly. 
The method that is most commonly used is that of self-report measures, these can be 
subject to social desirability bias as the patient wants to please the researcher, 
resulting in over-estimations of compliance. However, if a supportive and non-
punitive atmosphere is created then this can help to gain a more accurate picture of 
patient adherence (Horne, 2000). For example, the Medication Adherence Response 
Scale (MARS; Horne, 2000), attempts to diminish the social pressure on patients to 
under report non-adherence by framing adherence questions in a non-threatening 
manner, ‘Many people find a way of using their medicines which suits them. This 
may differ from the instructions on the label of from what their doctor has said. We 
would like to ask you a few questions about how you use your medicines’. 
 
A number of predictors of poor adherence have been identified. These can generally 
be related to either intentional or unintentional non-adherence. Unintentional non-
adherence is usually due to capacity and resource limitations that prevent patients 
from following treatment recommendations. For example, individual constraints such 
as, memory or dexterity and environmental constraints such as problems accessing 
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prescriptions and cost could prevent patients taking their medication. Intentional non-
adherence arises from beliefs, attitudes and expectations that influence the patients 
motivation to take their medication in a particular manner.   
 
A number of qualitative studies have shown that people possess beliefs about 
medicines in general (e.g. Britten, 1994), as well as beliefs about medicines 
prescribed for a specific illness (e.g. Morgan & Watkins, 1988). Horne, Weinman & 
Hankins (1999) have developed the Beliefs About Medicines Questionnaire to assess 
both the general and specific beliefs that patients have about medicines. Two major 
themes emerged for beliefs about medicines in general (Horne, 2000). The first is 
‘General-Harm’, patients hold a variety of beliefs about the dangers of prescribed 
medications. For example, fears of experiencing harmful side-effects and concerns 
about addiction and dependence. These concerns are relevant across a range of 
disease states and are typically endorsed by over a third of participants (Horne & 
Weinman, 1999). The second theme is ‘General-Overuse’ and refers to beliefs about 
the way in which medicines are used and the extent to which the patient believes that 
medicines are over-prescribed by doctors. Two themes also emerged for beliefs about 
specific prescribed medication. The first is necessity beliefs, the patients’ views about 
the necessity of the medication for maintaining and improving health. The second is 
concerns, and comprises beliefs about the potential adverse effects of taking 
medication. 
 
Beliefs about medications are therefore assessed in the patient study to investigate 
their role as predictors of medication adherence in MI patients. In addition, the study 
will determine how beliefs about medicines and adherence is associated with illness 
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perceptions, locus of control and Type D personality. More information on adherence 
in cardiac patients is given in Section 8.1.3. 
 
2.3.4 Future Thinking 
An individual’s negative view of the future as characterised by their ability to 
generate positive and negative thoughts about the future has been widely assessed 
within the area of psychological distress, including depression and suicidality 
(MacLeod et al, 1997; O’Connor et al, 2007). A series of studies by MacLeod and 
colleagues have demonstrated that a lack of positive future thinking, rather than 
increased negative future thinking, is an important risk factor for psychological 
distress, hopelessness and suicide risk (MacLeod et al, 1997; MacLeod & Moore, 
2000). They investigated samples of suicidal patients and compared them to matched 
control groups. Suicidal patients were found to be impaired in the number of positive 
events they were looking forward to, but did not show an increase with regards to 
future negative events. Given that it is normally the role of negative experiences in 
mental health which are investigated, these findings suggest that positive, as well as 
negative aspects of experience should be taken into account when attempting to 
understand psychological disorders (MacLeod & Moore, 2000). 
 
MacLeod and colleagues have investigated future cognitions using a task based on the 
verbal fluency paradigm. The future-directed thinking task (FTT; MacLeod et al, 
1997) measures the mental accessibility of future positive and negative events. In this 
procedure, participants are presented with three future time periods and are asked to 
generate things that they are looking forward to and things that they are not looking 
forward to during these periods. Results from studies using this task has shown that 
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depressed patients showed reduced anticipation of future positive experiences, but not 
increased anticipation of future negative experiences, compared to healthy controls 
(e.g. Conaghan & Davidson, 2002) 
 
More recently, future thinking has been investigated in other patient groups. Godley et 
al (2001) investigated the role of future-directed thinking in individuals with eating 
disorders. They found that bulimics had significantly fewer positive future cognition 
and significantly more negative future cognitions compared to controls. The role of 
prospective thinking has also been investigated in women suffering recurrent 
miscarriage. Magee et al (2003) found that having more negative child-related 
thoughts and fewer non-child related positive thoughts about the future. 
 
There are few studies which have investigated future thinking within people with 
physical illness. Therefore, it is not known if the biases in cognitive processing that 
have been demonstrated in depressed patients are the same or the different in the 
context of physical health problems. One study that has investigated future thinking in 
the context of physical illness was undertaken by Moore et al (2006). They 
investigated future thinking in patients with multiple sclerosis (MS). The aim of the 
study was to investigate how patients with MS anticipate their future in terms of 
positive and negative events. They found that MS patients with depression anticipated 
significantly fewer future positive events than the healthy control group and MS 
patients without depression. In addition, the three groups did not differ in the total 
numbers of anticipated future negative events. The results from this study therefore 
provide evidence that similar to depressed but physically healthy individuals, MS 
patients are characterised by a lack of positive thoughts about the future, rather than 
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an increased number of negative events. Conversely, a study by Andersson et al (2007) 
which investigated future thinking in a population of tinnitus patients found that 
tinnitus patients generated a greater number of negative future events compared to the 
controls, and there was no difference between the groups on positive future events. 
 
The results described above link future thinking to psychological distress and adverse 
mental health in several patient groups, including patients with physical illness. 
Therefore, it is of interest to investigate future thinking in the context of an MI. One 
aim of this thesis is to establish if these prospective cognitions also play a role in 
predicting psychological distress in MI patients, and to determine if future thinking in 
an MI population follows a similar pattern to that found in previous studies with 
physically healthy individuals. 
 
2.3.5 Role and Goal Investment 
There is also a growing literature which suggests that role and goal investment may be 
important risk factors for psychological distress, particularly following a significant 
life event. For example, the central idea of Carver and Scheier’s model of self-
regulation (1998) is that people live life by identifying goals and behaving in ways 
aimed at attaining these goals. Oatley & Bolton, (1985) propose a social-cognitive 
model of depression, in this model, over-investment in one aspect of one’s life roles 
and goals can lead to distress. Specifically, depression will occur when an event 
disrupts a role that has been primary in providing the basis for a person’s self-worth. 
Crucially, the impact of the specific event will depend on the range of alternative or 
potential roles available to the individual. The more flexible a person can be in 
deriving a sense of self-worth in a range of domains (i.e. the compensatory roles and 
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goals they have available to them) the lower vulnerability to distress they will have 
(Champion & Power, 1995). Lam and Power (1991) developed the Roles and Goals 
Questionnaire (RAG) to assess the degree to which individuals are invested in a range 
of life roles and goals. The key variable from the measure is the extent to which a 
person is invested in one goal to the exclusion of all others. 
 
To-date, role and goal investment, as described by Lam and Power (1991), has not 
been studied in MI patients. However, it would seem a particularly appropriate factor 
to investigate given that experiencing an MI can significantly affect the patient’s life 
in many ways; patients may be unable to return to work, or be able to take part in their 
normal social activities. Therefore, it will be important for them to have compensatory 
roles and goals to use in the absence of their normal activities. Moreover, if 
individuals are over-invested in roles that they are now unable to fulfil they may be 
more vulnerable to distress. 
 
To my knowledge only one study has operationalised Lam and Power’s (1991) theory 
within a study of at-risk individuals. In addition to studying the role of prospective 
cognitions in women with recurrent miscarriage, Magee et al (2003), also investigated 
the impact of role and goal investment in psychological distress. They found that 
distress was associated with being over-invested in the goal of becoming a parent, 
relative to other life roles and goals. 
 
More generally, the importance of achieving one’s goals has been investigated in 
relation to patient well-being and quality of life. For example, Carver and Scheier’s 
self-regulation model (see Chapter 3, Section 3.4.1) proposes that that people live life 
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by identifying goals and behaving in ways aimed at attaining these goals. A 
disturbance in the attainment of higher-order or life goals has been shown to be 
related to quality of life outcomes in cardiac patients on waiting list for angioplasty 
(Echteld, van Elderen & van der Kamp, 2001) and to be predictive of quality of life 
and depression four months after MI (Boersma, Maes & van Elderen, 2005). In 
addition, Oldridge et al (1999) identified that attainment of a self-chosen goal was 
associated with higher levels of well-being 12 months after MI. Similar research has 
been carried out by Boersma, Maes & van Elderen (2006) who found that goal 
disturbance predicted both health-related quality of life, and depression, 4 months 
after MI.   
 
Therefore, given the promising findings linking goal attainment to outcome in MI 
patients, investigating role and goal investment, as outlined by Oatley and Bolton 
(1985) may prove to be a particularly fruitful avenue for research, in identifying 
predictors of psychological distress post-MI. Moreover, the RAG has not been 
utlilised previously in MI patients, therefore, the current study will use the RAG in 
order to determine the importance of role and goal investment in predicting 
psychological outcome in a prospective cohort of MI patients. 
 
2.4 Personality 
The following section outlines the personality variables (optimism and Type D) that 
are investigated in the thesis. As described earlier (see section 2.2.1), a number of 
studies have demonstrated that psychological distress is associated with the 
pathogenesis of CVD, However, few studies examine the contribution of personality 
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in CVD prognosis. Therefore a key aim of this thesis is to examine the role of 
optimism and Type D personality in predicting patient outcome post-MI.  
 
2.4.1 Optimism 
Optimism refers to the tendency to believe that present or future events will have 
personally favourable outcomes (Carver & Scheier, 1992). It has been strongly 
associated with emotional well-being in people with chronic and severe health 
problems (e.g. Carver et al., 2005). Specifically, in the area of CHD, optimism 
predicts better physical recovery following coronary artery bypass graft surgery 
(CABG) (e.g. Scheier et al., 1989; Helgeson, 1999). Scheier et al (1989) demonstrated 
that CABG patients with higher levels of positive expectancies preoperatively 
demonstrated a faster rate of recovery after surgery. Similarly, a further study from 
Scheier et al (1999) CABG patients with more positive expectancies were half as 
likely to be rehospitalized 6 months later for problems including wound infection, 
angina and MI.  King et al (1998) also found that optimism was related to positive 
mood status in patients undergoing coronary artery surgery. 
 
Optimism has also been associated with superior emotional well-being after a 
coronary event (Desharnis et al., 1990; Scheier., et al 1989; Scheier., et al, 1999). 
Desharnais and colleagues (1990) investigated the relationship between optimism and 
health-relevant cognitions in patients following an MI. They found that patients high 
on optimism scored significantly lower on perceived susceptibility, perceived severity 
and experienced less fear compared to pessimists. Other research has found Optimism 
to be associated with more successful modification of coronary risk behaviours 
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(Sheppard, Maroto & Pbert, 1996). More recently, optimism was found to be 
inversely related to fatigue in patients after MI (Brink & Grankvist, 2006). 
 
The most compelling evidence for a relationship between optimism and CHD comes 
from a prospective study carried out by Kubzansky et al (2001). They examined the 
effects of an optimistic versus a pessimistic explanatory style on CHD incidence in 
the Veteran Normative Aging Study over a 10 year follow-up period. They found that 
individuals with high levels of optimism had a lower risk of developing coronary 
heart disease (nonfatal MI and cardiac death) relative to those with high levels of 
pessimism. Their evidence suggests that an optimistic explanatory style may protect 
against risk of coronary heart disease. 
 
Relatively few prospective studies have been carried out examining the effect of 
optimism on psychological outcome and quality of life in MI patients. Therefore, a 
measure of dispositional optimism will be utilised in the current study in order to 
uncover further information about the predictive power of optimism in CHD. 
Specifically, whether optimism is predictive of psychological well-being 3 months 
post-MI and how optimism is associated with other predictors, particularly future 
thinking and role and goal investment (which are described in sections 3.4.1 and 
3.4.2). 
 
2.4.2 Type D Personality 
In part, the paucity of studies which have examined the role of personality in the 
pathogenesis of CVD is due to inconsistent findings on the Type A behaviour pattern. 
The Type A behaviour pattern describes individuals who are impatient, excessively 
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time-conscious, insecure about one's status, highly competitive, hostile and aggressive, 
and incapable of relaxation (Friedman & Rosenman, 1974). Initial studies on Type A, 
such as the Western Collaborative Group Study (WCGS; Rosenman et al, 1975) 
established a correlation between Type A behaviour and the development of CHD in 
healthy middle-aged men. However, a 22- year follow-up of results from the WCGS 
study found that Type A behaviour was not predictive of disease progression 
(Ragland & Brand, 1988). In addition, contradictory findings from other studies (e.g. 
Shekelle et al, 1985) have led to scepticism towards the Type A construct.  
 
The Type A behaviour pattern is often referred to as a personality type; yet this 
construct was specifically designed to avoid association with global personality traits. 
As a result Type A reflects a ‘heterogeneous hodgepodge’ of behavioural symptoms 
and signs (Dimsdale, 1988). By contrast, the Type D construct was specifically 
designed to refer to a homogenous subgroup that is defined by the combination of two 
broad and stable personality traits that have a clear conceptual basis in psychological 
theory (Denollet & Van Heck, 2001). 
 
The lack of knowledge surrounding the role of personality in the pathogenesis of 
CVD led Denollet et al (1995) to propose the idea of the ‘distressed’ personality type 
or ‘Type D’. The Type D construct describes individuals who simultaneously 
experience high levels of negative affectivity (NA) and high levels of social inhibition 
(SI). Type D individuals are, therefore, thought to experience negative emotions (such 
as anxiety, sadness, anger etc.) across time and situations and inhibit the expression of 
these emotions in social interactions due to fears of how others may react. Crucially, it 
is the synergistic effect of high scores on both stable personality traits, negative 
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affectivity and social inhibition, which is important, suggesting that it is not merely 
the presence of negative emotions that should be considered as a risk factor but also 
how an individual copes with these negative emotions. Denollet derived this model 
from previous research which suggested that social alienation and depression are 
associated with poor outcome in cardiac patients, social inhibition and negative 
affectivity were therefore chosen as these personality traits may promote social 
alienation and depression (Denollet et al, 1996). 
 
Type D personality is currently assessed using the DS14: Type D Personality Scale 
(Denollet, 2005). The scale consists of two sub-scales, one which measures negative 
affectivity, and one measuring social inhibition. In order to be classified as Type D, 
an individual must score highly (≥ 10) on both sub-scales. Accumulating evidence 
indicates that Type D can be considered a risk on par with established biomedical risk 
factors, with Type D patients experiencing a four-fold increased risk of adverse 
clinical outcome (Denollet et al, 1996; Denollet & Brutsaert, 1998; Denollet, Vaes & 
Brutsaert, 2000). 
 
2.4.2.1 Type D Personality: More Than Just a Measure of Depression 
Some critics have argued that Type D personality is nothing more than another 
measure of negative affect, labelling it as ‘old wine in new bottles’ (Lesperance & 
Frasure-Smith, 1996). However, the inclusion of the social inhibition component 
means that the Type D construct is more than a measure of negative affect or 
depression, as it also assesses how patients cope with this affect. Indeed, Denollet et 
al (2006) demonstrated, in a study of over 800 cardiac patients, that it was the 
interaction between high social inhibition and high negative affectivity, rather than 
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negative emotions alone which predicted death, MI, and repeat revascularization at 9-
month follow-up. Furthermore, studies have demonstrated that Type D predicts 
adverse clinical outcome, even after controlling for measures of negative affect, such 
as anxiety and depression (Denollet & Brutsaert, 1998; Denollet, Vaes & Brutsaert, 
2000). In addition, Denollet argues that Type D represents a normal personality 
construct, whereas, depression reflects psychopathology. Table 2.1 gives an overview 
of the studies published on Type D personality to date (adapted from Pedersen & 
Denollet, 2006). 
 
2.4.2.2 Type D Personality and Psychological Distress 
Type D personality is associated with increased psychological distress in CHD 
patients, including symptoms of depression and social alienation (Denollet et al, 1995; 
Schiffer et al, 2005), anger and anxiety (Denollet & Brutsaert, 1998) and pessimism 
(Denollet, 1998). In addition, in a study of almost 200 cardiac patients, Type D was 
associated with a six-fold increased risk of vital exhaustion at baseline and more than 
a four-fold risk at 6 weeks following treatment (Pedersen & Middel, 2001). Pedersen 
& Denollet (2004) also demonstrated that Type D individuals were at more than a 
fourfold risk of qualifying for a diagnosis of PTSD compared with non-Type D’s. 
 
2.4.2.3 Type D Personality and Cardiovascular Mortality and Morbidity 
Type D personality has also been shown to have an adverse effect on mortality and 
morbidity across a number of patient groups (including patients with chronic heart 
failure, peripheral arterial disease, arrhythmia, sudden cardiac arrest, hypertension and 
heart transplantation recipients).  
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The first study to suggest that Type D personality has an adverse effect on health was 
conducted by Denollet et al (1995). They reported that the rate of death among 
patients following a Myocardial Infarction (MI) was significantly higher for those 
patients who were classified as Type D (39%) than those with other personality types 
(5%). These results were extended in a six-to-ten year follow-up study which revealed 
that CHD patients who were initially classified as Type D had a four-fold mortality 
risk compared with non-Type D patients (Denollet et al, 1996). In a 5-year 
prospective study in a new sample of over 300 patients with CHD, patients were 
classified as Type D or non-Type D. At follow-up, three factors emerged as 
significant predictors of cardiac death or nonfatal myocardial infarction, these were: 
left ventricle ejection fraction <50% (odds ratio = 3.9), age <55 years, (odds ratio=2.6) 
and Type D (odds ratio=8.9). Crucially, Type D remained a significant predictor even 
after controlling for medical variables (Denollet & Brutsaert, 1998). Type D 
personality was also associated with a 7-fold increased risk of developing cancer in a 
sample of 246 cardiac patients (Denollet, 1998). More recently, a 5-year follow-up 
study of over 300 CHD patients identified that those with a Type D personality had an 
increased risk of cardiac death (OR:4.8) and adverse cardiac event (OR: 2.9) at 
follow-up (Denollet et al, 2006). 
 
It is also important to examine the role of Type D across other patient groups. Several 
studies have examined Type D in patients being treated with percutaneous coronary 
intervention (PCI; describes a range of procedures that treat narrowing or blockages in 
coronary arteries) or coronary artery bypass graft surgery (CABG). Pedersen et al 
(2004) in a sample of 875 PCI patients, found that Type D was an independent 
predictor of a composite of death and MI at nine months compared to non-Type D’s, 
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5.6% versus 1.3% (OR=4.73). Further studies with PCI patients have found Type D to 
be associated with impaired health status (Pedersen et al, 2007a) and vital exhaustion 
(Pedersen et al, 2007b), and to predict the onset of depressive symptoms (Pedersen et 
al, 2006). In a study of patients undergoing CABG for multivessel disease, Type D 
was a predictor of both physical and mental quality of life one year after the 
procedure. Specifically, Type D patients were more than twice as likely to have poor 
physical quality of life, and more than five times as likely to have poor mental quality 
of life, after controlling for all other pre and postoperative variables (Al-Ruzzeh et al, 
2005). 
 
Results from other patient groups also point towards an important role for Type D. 
For example, Type D was a predictor of impaired quality of life, mood status and 
increased depressive symptoms in patients with chronic heart failure (Schiffer et al, 
2005). In addition, Type D was also associated with poorer quality of life (and higher 
perceived stress) in patients with peripheral arterial disease (Aquarius et al, 2005). 
Furthermore, in patients with an implantable cardioveter defibrillator, symptoms of 
anxiety and depression were more prevalent in Type D patients compared to non-
Type D patients (Pedersen et al, 2004) However, this is not surprising given that Type 
D is, in part, a measure of negative emotions. A study from Appels et al (2000), found 
that the prevalence of Type D personality is significantly higher in hypertensive 
patients (53%) compared to controls (20%) suggesting a role for Type D in 
hypertension (Denollet, 2005). More recently, evidence from heart transplantation 
recipients, indicates that Type D personality is associated with a three to six fold 
increased risk of impaired quality of life, even after controlling for demographic and 
clinical factors (Pedersen et al, 2006). Moreover, in a further study of heart transplant 
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recipients, Type D independently predicted mortality and acute rejection 5-years post-
transplantation (Denollet et al, 2007). 
 
Taken together, the findings from the studies described above (as outlined in Table 
3.1), demonstrate that the Type D personality construct has important predictive 
utility across a wide range of CVD patient groups. These studies suggest that Type D 
personality is predictive of adverse clinical prognosis, increased distress and impaired 
quality of life. Importantly, the findings show that the impact of Type D personality 
on outcome remains significant even after controlling for disease characteristics, 
including disease severity. Given the accumulating evidence on Type D, it will be a 
key psychological factor within the thesis and will be utilised as a possible predictor 
of outcome post-MI in Chapter 8. 
 
2.4.2.4 Criticisms of the Type D Personality Construct 
Although the results described above on Type D are promising, it is important to 
acknowledge possible problems with the construct. First, the importance of negative 
emotions in heart disease is widely recognised, therefore it may be that the Type D 
construct is merely adding a further concept to a field which is already congested with 
related terms (e.g. anger and hostility, vital exhaustion, depressive symptoms). Indeed, 
the Type D construct has been criticised by Lesperance and Frasure-Smith (1996) as 
representing ‘old wine in new bottles’, highlighting the possibility that the Type D 
construct may not tell us anything new about risk factors for CHD. Second, as Type D 
personality is considered to be a stable trait, it may be difficult to develop successful 
treatments based on this concept. The overall aim of any Type D based intervention 
would be to reduce patients’ risk of ill-health, however, personality features are 
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difficult to change with affordable and rapid treatment. Third, at present it is unclear if 
Type D is an aetiological risk factor for the development of CHD. At the moment all 
Type D research has been carried out with patients who have existing CHD, thus 
limiting Type D to be nothing more than a prognostic risk factor at present. It is 
therefore important for future research to be carried out to determine whether Type D 
is predictive of cardiac events in previously healthy individuals. 
 
 
Table 2.1. Overview of Studies Published on Type D Personality (adapted from 
Pedersen & Denollet, 2006) 
 
Authors Participants Study design Follow-up Main 
endpoint 
Risk* 
Denollet et al. 
(1996) 
303 CHD 
patients 
Prospective 6-10 yrs All cause 
mortality 
OR: 4.1 
Denollet et al. 
(1998) 
87 MI patients Prospective 6-10 yrs Cardiac death, 
non-fatal MI 
RR: 4.7 
Denollet 
(1998) 
246 CHD 
patients 
Prospective 6-10 yrs Cancer OR: 7.2 
Denollet et al. 
(2000) 
319 CHD 
patients 
Prospective 5 yrs Cardiac death, 
non-fatal MI 
OR: 8.9 
Pedersen et 
al. (2001) 
171 CHD 
patients 
Intervention 
study 
6 weeks Symptoms of 
exhaustion 
OR: 4.7-
6.4 
Pedersen et 
al. (2004) 
112 first MI 
patients, 115 
healthy controls 
Case-control          -  PTSD OR: 4.5 
Denollet et al 
(2006) 
337 CHD 
patients 
Prospective 5 years Cardiac death OR: 4.8 
Pedersen et 
al. (2004) 
875 PCI 
patients 
Prospective 9 months Composite of 
death and MI 
OR: 4.5 
Denollet et al. 
(2006) 
875 PCI 
patients 
Prospective 9 months Major adverse 
cardiac event 
HR: 1.92 
Pedersen et 
al. (2006) 
542 PCI 
patients without 
depression 
Prospective 6 months Depression OR: 3.0 
Pedersen et 
al. (2007a) 
692 PCI 
patients 
Prospective 12 months Health status OR: 4.0 
Pedersen et al 
(2007b) 
419 PCI 
patients 
Prospective 12 months Symptoms of 
exhaustion 
OR: 3.5 
Al-Ruzzeh et 
al. (2005) 
437 CABG Cross-sectional          - Quality of Life OR: 2.3-
5.5 
Schiffer et al. 
(2005) 
84 CHF patients Cross-sectional          -  Quality of life, 
depression 
OR: 3.3-
7.1 
Aquarius et 150 PAD Case-control          - Perceived stress, OR: 6.5-
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al. (2005) patients, 150 
healthy controls 
quality of life 7.4 
Pedersen et 
al. (2004) 
182 CHD 
patients, 144 
partners 
Cross-sectional          - Anxiety, 
depression 
OR: 4.4-
8.7 
Appels et al. 
(2000) 
99 SCA 
patients, 119 
CHD patients 
Case-control          - Sudden cardiac 
arrest 
OR: 9.4 
Denollet 
(2005) 
2508 general 
population, 573 
CHD patients, 
732 
hypertensives 
Cross-sectional           - Hypertension OR: 5.5 
Pedersen et 
al. (2006) 
186 heart 
transplantation 
patients 
Cross-sectional           -   Quality of life OR: 3.6-
6.1 
Denollet et al. 
(2007) 
51 heart 
transplantation 
patients 
Prospective 5 years Mortality, acute 
rejection 
OR: 6.7 
* Risk associated with Type D personality (adjusted analyses) 
CABG = coronary artery bypass graft surgery; CHD = coronary heart disease; CHF = chronic heart 
failure; HR = hazard ratio; ICD = implantable cardioveter defibrillator; MI = myocardial infarction; OR 
= odds ration; PAD = peripheral arterial disease; PCI = percutaneous coronary intervention; RR = 
relative risk; SCA = sudden cardiac arrest 
 
Research investigating possible mechanisms to explain the link between Type D 
personality and adverse prognosis is very much in its infancy. Therefore, a further aim 
of this thesis is to identify mechanisms which may help to explain the link between 
Type D and poor prognosis. The studies described in Chapters 5-7 aimed to test 
potential psychosocial and psychophysiological mechanisms linking Type D and ill-
health.  
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Chapter 3: Theoretical Model 
 
3.1 Theoretical Models in Health Psychology 
The development of theoretical models to explain why people engage in health and 
illness behaviours has been a key priority for health psychology. It has been 
recognised for a number of years that patients’ beliefs and cognitions about their 
health and illness affect both their responses to symptoms and their decisions about 
treatment. A number of models of health behaviour have been proposed to explain the 
ways in which individuals attempt to make sense of the problems that arise following 
illness onset or in response to symptoms. Much of this work has focussed on social-
cognitive approaches. For example, the theory of planned behaviour (Ajzen, 1985; 
Ajzen & Madden, 1986; Ajzen, 1988) and self-regulatory frameworks, such as, 
Carver and Scheier’s self-regulation model (Carver & Scheier (1998) and Leventhal’s 
common sense model (Leventhal et al, 1980). These models have been used to try to 
understand the health-related behaviour of MI patients, including medication 
adherence, attendance at cardiac rehabilitation and predicting pre-hospital delay. 
 
3.1.1 The Health Belief Model 
As shown in Figure 3.1 the Health Belief Model (HBM) is a model that attempts to 
explain and predict health behaviours by focusing on the attitudes and beliefs of the 
individual. The HBM was developed in the 1950s as part of an effort by psychologists 
in the United States Public Health Service to explain the lack of public participation in 
health screening and prevention programmes. Since then, the HBM has been adapted 
to explore a variety of long and short-term health behaviours, including sexual risk 
behaviours and the transmission of HIV/AIDS.  
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Figure 3.1 Basics of the Health Belief Model  
 
Initially developed by Rosenstock (1966), and developed further by Becker and 
colleagues (e.g. Becker, Radius & Rosenstock, 1978), the Health Belief Model (HBM) 
has been utilised extensively to predict health behaviours. Specifically, it has been 
used in relation to the behaviour of MI patients, particularly in relation to adherence 
(Becker, Drachman & Kirscht, 1972). The HBM predicts that behaviour is a result of 
certain core beliefs. For example, in the case of adherence to medication in MI 
patients, the decision would be made based on two variables: 
 
1) The amount of threat perceived by the patient in relation to the symptoms. This will 
determine how vulnerable s/he feels to cardiac disease and general illness, and is 
confirmed by the presence of symptoms, previous experience of symptoms, degree of 
disruption to social roles etc. 
2) The attractiveness or value of the action in question, i.e. taking medication. This is 
based on the probability that, in the patients’ view, the decision to take medication 
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will reduce the threat and will not be too costly in terms of time, money or emotional 
energy. 
 
The HBM was defined in terms of four constructs representing perceived threat and 
net benefits: perceived susceptibility (one's subjective perception of the risk of 
contracting a health condition), perceived severity (feelings concerning the 
seriousness of contracting an illness or of leaving it untreated, including evaluations 
of both medical and clinical consequences and possible social consequences), 
perceived benefits (the believed effectiveness of strategies designed to reduce the 
threat of illness), and perceived barriers (the potential negative consequences that 
may result from taking particular health actions, including physical, psychological, 
and financial demands). These concepts were proposed as accounting for people's 
‘readiness to act.’ An added concept, cues to action, would activate that readiness and 
stimulate overt behaviour. A more recent addition to the HBM is the concept of self-
efficacy, or one’s confidence in the ability to successfully perform an action. This 
concept was added to help the HBM better fit the challenges of changing habitual 
unhealthy behaviours. 
 
Although the HBM has met with some success in explaining behaviours such as 
having vaccinations, attending screening, and adherence (e.g. Harrison, Mullen & 
Green, 1992; McClenahan et al, 2007; Turner et al, 2007), it may not be the best 
model to use when predicting the behaviour of MI patients. First, the model seems to 
be more accurate at describing preventative health behaviours compared to behaviours 
that may need to be initiated once an illness has occurred, e.g. medication adherence 
(Haynes, 1976). Second, it emphasises the individual without taking into 
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consideration the role of others in the patients’ adherence decisions. Third, there is an 
absence of a role for emotional factors, it is known that emotional factors are 
important in determining a patients’ perception of their symptoms and subsequent 
action (Bunde & Martin, 2006). 
 
3.1.2 The Theory of Planned Behaviour 
The theory of planned behaviour (TPB; Ajzen, 1985) has also been used to predict the 
behaviour of MI patients. It was developed from the earlier, theory of reasoned action 
(Ajzen & Fishbein, 1980). As demonstrated in Figure 3.2, TPB suggests that a 
person's behaviour is determined by his/her intention to perform the behaviour and 
that this intention is, in turn, a function of his/her attitude toward the behaviour and 
his/her subjective norm. The best predictor of behaviour is intention. Intention is the 
cognitive representation of a person's readiness to perform a given behaviour, and it is 
considered to be the immediate antecedent of behaviour. This intention is determined 
by three things: their attitude toward the specific behaviour, their subjective norms 
and their perceived behavioural control. The TPB holds that only specific attitudes 
toward the behaviour in question can be expected to predict that behaviour. In 
addition to measuring attitudes toward the behaviour, the model proposes that it is 
also important to measure people’s subjective norms – their beliefs about how people 
they care about will view the behaviour in question. To predict someone’s intentions, 
knowing these beliefs can be as important as knowing the person’s attitudes. Finally, 
perceived behavioural control influences intentions. Perceived behavioural control 
refers to people's perceptions of their ability to perform a given behaviour. These 
predictors lead to intention.  
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Figure 3.2 Basics of the Theory of Planned Behaviour 
 
 The TPB therefore suggests that behavioural intentions are the result of three factors: 
1) Attitude towards a behaviour, which is a judgement of whether or not the 
behaviour is a good thing to do and comprises both positive and negative evaluations 
of the behaviour and possible outcome. 
2) Subjective norm, reflecting the impact of social pressure or influence on the 
behaviours acceptability and appropriateness 
3) Perceived behavioural control, which is the belief that the individual can carry out 
a particular behaviour, based on internal and external control factors. 
 
The theory has met with some success across a wide range of behaviours (Armitage & 
Conner, 2001; Conner & Sparks, 1996) such as exercise (Hausenblas, Carron & Mack, 
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1997) and condom use (Sheeran, Abraham & Orbell, 1999). In addition, Johnston et 
al (2004) tested if the intention and perceived behavioural control components of TPB 
would predict behavioural risk factors one year post-MI. They found that only the 
perceived behavioural control component, and not intention, predicted behaviour 
(exercise, distance walked, and smoking cessation). The TPB has been criticised on 
the basis that intentions and behaviour are only moderately correlated, therefore 
people do not always perform the behaviour that they intend to. Indeed, although 
some people may develop an intention to change their health behaviour, they might 
not take any action. This discrepancy has been labelled the ‘intention-behaviour gap’ 
(Sheeran, 2002). In addition, the TPB fails to take into account the role of past 
behaviour, which is often the best predictor of future behaviour (e.g. Mullen et al, 
1987). 
 
3.2 Self-Regulation Models 
In recent years there has been an increased interest in self-regulation within health 
psychology. All models of self-regulation describe self-regulation as a ‘systematic 
process involving conscious efforts to modulate thoughts, emotions, and behaviours in 
order to achieve goals within a changing environment’ (Cameron & Leventhal, 2003). 
It is a ‘dynamic motivational system of setting goals, developing and enacting 
strategies to achieve those goals, appraising progress, and revising goals and 
strategies’ (Cameron & Leventhal, 2003). As such, feedback loops play a critical role 
in these models, wherein goals serve as a reference point for appraising the relative 
success of efforts.  
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There are two main models of self-regulation which have been applied to health and 
illness behaviour. They are Carver & Scheier’s (1998) self-regulation model and 
Leventhal’s Common-Sense Model (CSM; Leventhal et al, 1980). The CSM was 
developed primarily to explain health and illness behaviour, and focuses on schematic 
contents, whereas, Scheier and Carver’s model was developed as a more general 
theory of behaviour. Both models are described in greater details in the subsequent 
sections. 
 
3.2.1 Carver and Scheier’s Self-Regulation Model 
Carver and Scheier’s model of self-regulation (1998) has been developed as a general 
theory of behaviour, which can be applied to health. The central idea in this model is 
that people live life by identifying goals and behaving in ways aimed at attaining 
these goals. The model posits that there is hierarchical organisation among goals. For 
example, a higher level goal may be to be healthy, whereas, a lower level goal may be 
going to the gym on a daily basis. The model also makes the distinction between 
approach goals, such as those described above, and avoidance goals (e.g. avoid 
visiting the doctor) (Elliot & Sheldon, 1997).  
 
An individual will regulate their actions in relation to these goals through feedback 
loops which guide behaviour. A second feedback process is related to affect, it checks 
on how effectively the behaviour system is operating with regards to specific goals 
(Carver & Scheier, 1999). The result of this feedback process is thought to lead to 
feelings of confidence or doubt and a sense of positivity or negativity. These feedback 
processes will allow an individual to determine if the expectation of achieving their 
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goal is favourable or not, which will lead the individual to either renew their efforts or 
to disengage from the goal (see Figure 3.1; Carver & Scheier, 1998). 
 
 
 
Figure 3.3 A flow-chart depiction of self-regulatory possibilities when obstacles to 
goal attainment are encountered (adapted from Carver and Scheier, 1981) 
 
The model can be applied to health in a number of ways (Scheier & Carver, 2003). 
For example, illness episodes may undermine people’s confidence in achieving their 
goals. Furthermore, the onset of illness would directly threaten the goal of being 
healthy. With regards to health-related behaviours, these can be viewed as lower-level 
goals which are required to meet the higher-order goal of maintaining health. Many of 
the studies which have used Carver & Scheier’s model in the area of cardiac disease 
have focussed on the role of optimism on adjustment to heart disease and its treatment 
(see section 3.2.4). More recently, research has focussed on goal disengagement from 
unattainable goals (Rasmussen, Wrosch, Scheier & Carver, 2006). Findings suggest 
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that disengaging from unattainable goals should be adaptive because it removes the 
person from the negative emotional consequences of repeated failure. Indeed, 
abandoning unattainable goals has been found to preserve a person’s subjective well-
being (e.g. Heckhausen, Wrosch & Fleeson, 2001). The process of goal re-
engagement, the ability to adopt a new goal, or to take a new path towards an existing 
goal, is also an important part of being goal-engaged. 
 
3.2.2 Leventhal’s Self-Regulation Model 
The common sense model (CSM) is based on the idea that individuals are 
active problem solvers who make sense of a threat to their health, such as symptoms 
or illness diagnosis, by developing their own cognitive representation of the threat, 
which, in turn determines how they respond. The CSM covers three important stages 
(as shown in Figure 3.4). Stage 1 describes a process of interpretation, at this time 
patients have been confronted with a health threat either in the form of symptom 
perception (e.g. chest pain) or from social messages (e.g. receiving a diagnosis of 
angina). Early research by Leventhal and colleagues led to the development of the 
parallel processing approach (Leventhal, 1970) which suggested that both cognitive 
and emotional processing is activated in the presence of this health threat. In terms of 
emotional processing, the health threat will change the emotional state of the 
individual and often lead to feelings of fear, anxiety and depression. However, most 
research has focussed on the cognitive processing and the development of illness 
cognitions. 
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Figure 3.4: Adaptation of Leventhal’s Common Sense Model to include Type D 
personality. 
 
Illness cognitions stand for an individual’s common-sense definition of health threats 
(Leventhal, Leventhal & Contrada, 1998). Evidence suggests that these 
representations consist of five components that serve to define the nature of the health 
threat for the individual. Allowing them to make sense of their symptoms, assess 
health risk and ways of coping with this risk. These illness representations are 
activated when a health threat becomes apparent, usually this occurs in the form of 
symptoms or a disease label when asymptomatic. The five main illness cognitions as 
identified by Leventhal are identity, cause, time-line, consequences and cure or 
control.  
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The identity component refers to the label given to the health threat (e.g. heart attack) 
and the symptoms experienced from it (e.g. chest pain, breathlessness). Linked to this 
is the individual’s beliefs of the causes of their condition (e.g. stress) and their 
expectations about its time-line i.e. the time for the development of the disease, its 
duration, and time for recovery; the individual will also have beliefs relating to the 
consequences of the illness (e.g. time off work); and control, or the degree to which 
the disease can be cured or controlled. These five components will determine the way 
in which the patient copes with the health threat, for example it will impact on their 
health-related behaviour such as medication adherence (Petrie et al, 2002). 
 
The next stage in the CSM is the development and identification of suitable coping 
strategies, generally this refers to the individual engaging either in approach coping 
(e.g. adhering to medication) or avoidance coping (e.g. denial). The third stage in the 
model involves individuals evaluating the success of their coping strategy and the 
reassessment of their cognitive representations.  
 
3.2.2.1 The Common Sense Model and Recovery Following MI 
It is known that patients’ beliefs and perceptions of their illness are important during 
recovery from MI. For example, Byrne (1982) showed that MI patients who had more 
negative expectations about their illness and future work capacity were less likely to 
return to work and to have lower levels of functioning independent of the severity of 
their MI. ‘Cardiac invalidism’ refers to patients who adopt an extremely passive, 
dependent and helpless role believing that any form of vigorous activity will bring on 
another MI. Indeed, accumulating evidence suggests that psychological variables are 
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more important than medical ones in influencing recovery following MI (e.g. 
Diedricks et al, 1991; Garrity, 1973).  
 
The CSM has therefore been applied to predict recovery from illness. More 
specifically, research in this area has primarily focussed on the utility of illness 
cognitions in predicting recovery following myocardial infarction (MI). For example, 
Petrie et al (1996) examined whether patients’ perceptions of their MI assessed at the 
time of hospital admission predicted subsequent attendance at cardiac rehabilitation, 
return to work, disability, and sexual dysfunction at three and six months later. One 
hundred and forty three MI patients completed measures of illness perceptions, 
anxiety and distress, and sexual functioning. It was found that patients’ illness 
perceptions were associated with attendance at rehabilitation programmes, speed of 
return to work, later sexual difficulty, and recovery of domestic and social functioning. 
Specifically, patients who believed that their illness was amenable to cure or control 
were more likely to attend cardiac rehabilitation. In addition, those who anticipated 
that their illness would have major consequences on their life were slower to return to 
work and regain social and domestic duties. Furthermore, patients’ initial perception 
of illness identity was related to later sexual problems.  
 
Further research carried out by Cooper et al (1999) also found that patients who had 
weaker beliefs in the control or cure of their heart condition were less likely to attend 
cardiac rehabilitation. The model has also been successful in explaining psychosocial 
adjustment in other cardiac groups, for example, Steed et al (1999) have utilised it 
successfully in patients with atrial fibrillation. In addition, Walsh et al (2004) 
successfully utilised the CSM to predict prehospital delay following an MI.  
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3.2.2.2 The Common Sense Model and Interventions with MI Patients 
A further advantage of the CSM is that the psychological dimensions it describes are 
potentially modifiable and they afford the opportunity for intervention to reduce 
morbidity and mortality (Petrie et al, 2002). As a result, interventions have been 
developed to modify patients’ cognitions and behaviour to enhance health outcomes. 
For example, Petrie et al (2002) showed that a brief psychological hospital-based 
intervention could change inaccurate and negative illness perceptions of MI, and in 
turn lead to an earlier return to work, less long term disability, and improved cardiac 
rehabilitation attendance.  
 
The intervention consisted of an explanation concerning the pathophysiology of MI 
and an exploration of the patients’ beliefs about the cause to their MI in order to 
address any misconceptions they have. Results at 3-month follow-up showed that the 
intervention caused significant positive changes in patients’ views of their MI. 
Specifically, those in the intervention group had significantly modified their 
perceptions about how long their illness would last and the personal consequences of 
the MI on their life. In addition, the intervention group was more optimistic that their 
illness could be controlled or cured. Furthermore, at follow-up the intervention group 
reported fewer angina symptoms that the controls. Most importantly, the intervention 
group returned to work at a significantly faster rate than the control group at 3 months 
after MI. 
 
The CSM will therefore be used as the guiding theoretical model for this thesis as it is 
a specific model of illness behaviour, which has been used successfully in the past in 
studies with MI patients. It represents a flexible model of behaviour in the event of an 
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MI and is specific enough to explain psychological outcome following MI, and 
specifically health-related behaviour, including adherence. In addition, to our 
knowledge this model has not been used to predict cardiac death or nonfatal 
myocardial infarction specifically. The CSM framework will be used to focus in 
particular on patients’ beliefs about illness. For example, it is proposed that patient 
representations of cause will be important in predicting health-related behaviour such 
as adherence, an important outcome measure in this study.  
 
The CSM will be operationalised in the following way. First, the health threat 
identified is an MI. Second, the cognitive processes being investigated are illness 
perceptions, locus of control, and medication beliefs. In addition personality factors 
(optimism and Type D) are investigated to determine their role with a self-regulatory 
framework. Furthermore, the role of prospective thinking and role and goal 
investment will be examined within the model as these psychological factors have 
been shown to important cognitive pathogens in other health contexts. Third, the 
outcome variables will include health behaviours, focussing on medication adherence, 
as these behaviours are known to be strongly influenced by illness and medication 
cognitions. In addition, adjustment will be assessed through measures of quality of 
life, functional outcome and benefit finding. The thesis will also examine to what 
extent personality (as assessed by Type D), fits within self-regulatory theory to 
enhance our understanding of patient recovery. 
 
In summary, this thesis will use Leventhal’s CSM as a theoretical framework for 
several key reasons. First, it was selected as it applies more specifically to health and 
illness behaviour in comparison to other more general models of self-regulation. 
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Second, as the model applied specifically to health it can capture critical aspects of 
health and illness such as the complexities surrounding medication use which is a key 
aim of the current thesis. Third, previous research on cardiac disease has found that 
patients’ personal models of illness are important in predicting recovery after MI (e.g. 
Byrne, 1982; Maeland & Havik, 1987).  Fourth, previous studies have found 
Leventhal’s CSM to be especially useful in examining health behaviour in cardiac 
patients and to be successful in predicting psychosocial adjustment to cardiac disease 
(Cooper et al, 1999; Petrie et al, 2002; 1996; Steed et al, 1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 59 
Chapter 4: Methodology 
 
4.0 Overview 
This chapter describes the assessment tools that were used in each of the five studies. 
A synopsis of each measure will be given, in order to avoid unnecessary repetition of 
the description of measures in each chapter as there is some overlap in the measures 
utilised in each study. Instead, the methodology section of each study will give only a 
brief description of the measures used. The measures are divided into two categories: 
(i) predictor variables, and (ii) outcome variables. Table 4.1 shows the measures used 
in each study. In addition, Table 4.2 and 4.3 outlines each of the predictor and 
outcome measures used. 
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Table 4.1 Summary of the measures used for each study 
 Measures (Time 1) Measures (Time 2, if applicable) 
Study 1 
(Chapter 5) 
Type D Personality (DS14) 
Health Behaviour (GPHB) 
Social Support (SNSS) 
Neuroticism (EPQR-S) 
 
Study 2 
(Chapter 6) 
Type D Personality (DS14) 
Health Behaviour (GPHB) 
Social Support (SNSS) 
Neuroticism (EPQR-S) 
Type D Personality (DS14) 
Health Behaviour (GPHB) 
Social Support (SNSS) 
Neuroticism (EPQR-S) 
Study 3 
(Chapter 6) 
Type D Personality (DS14) 
Health Behaviour (GPHB) 
Health Behaviour (Weinman) 
Health Behaviour (Ogden) 
Social Support (SNSS) 
Social Support (MOS-SSS) 
Neuroticism (EPQR-S) 
 
Study 4 
(Chapter 7) 
Type D Personality (DS14) 
Health Behaviour (GPHB) 
Social Support (SNSS) 
Neuroticism (EPQR-S) 
Stress Arousal Checklist (SAC) 
 
Study 5 
(Chapter 8) 
Type D Personality (DS14) 
Health Behaviour (GPHB) 
Future Thinking (FTT) 
Optimism (LOT-R) 
Depression (HADS) 
Anxiety (HADS) 
Locus of Control (RLOC) 
Beliefs about Medicines (BMQ) 
Illness Perceptions (BIPQ) 
Delay 
 
Type D Personality (DS14) 
Health Behaviour (GPHB) 
Depression (HADS) 
Anxiety (HADS) 
Beliefs about Medicines (BMQ) 
Medication Adherence (MARS) 
Roles and Goals (RAG) 
Benefit Finding (BF) 
Quality of Life (MACNEW) 
Functional Outcome (FLP) 
 
 
4.1 Predictor Variables 
4.1.1 Type D Personality 
The Type D Personality Scale (DS14; Denollet, 2005) is a 14-item scale comprising 
of 2 subscales (see Appendix 1). A 7-item subscale which measures negative 
affectivity (NA: items 2, 4, 5, 7, 9, 12) and a 7-item subscale measuring social 
inhibition (SI: items 1, 3, 6, 8, 10, 11, 14). Examples of items measuring negative 
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affectivity are ‘I often feel unhappy’, and ‘I am often down in the dumps’. Examples 
for the social inhibition subscale are ‘I often feel inhibited in social interactions’ and 
‘I find it hard to start a conversation’. Respondents rate their personality on a 5-point 
Likert type scale which ranges from 0=false to 4=true (items 1 and 3 were reverse 
scored). The NA and SI scales can be scored as continuous variables (range 0-28) to 
assess these personality traits independently. Participants who score highly on both 
NA and SI using a cut-off point of ≥ 10 on both scales are classified as having a Type 
D personality. Recently, Emons, Meijer and Denollet (2007) demonstrated the 
reliability of this cutoff using item response theory. In addition, they found the 
measurement of NA, SI, and Type D to be comparable across both general and 
clinical populations. Test-retest correlations are 0.82 and 0.72 for the social inhibition 
and negative affectivity scales respectively, indicating that Type D is stable across 
time. In addition, it has high internal validity with Cronbach’s α of 0.88 and 0.86 for 
the negative affectivity and social inhibition subscales respectively (Denollet, 2005). 
It has also been shown that the assessment of Type D personality is not dependent on 
mood or health state (Denollet, 2005).  
 
4.1.2 Social Support 
4.1.2.1 Quality of Social Network and Social Support Scale 
Social support was measured using a shortened version of the Quality of Social 
Network and Social Support Questionnaire (see Appendix 2, SNSS; Dalgard, Bjork & 
Tambs, 1995). It was chosen in order to determine the quality of social support being 
received, as opposed to the quantity of social support available, which is often 
assessed by other social support scales. Although there are a number of scales for 
assessing social support, we chose the SNSS because it was devised for use with 
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general population, non-clinical samples, and it is a brief instrument. The original 
form of the SNSS contains 3 subscales relating to social support received from family, 
friends and neighbours. For the purpose of the current studies, the neighbours network 
was omitted as it was not thought to be relevant for a student population, thereby 
yielding a 9 item scale relating to quality of social support received from friends and 
family e.g. ‘Do you feel that you can count on your friends in the future?’ These can 
either be scored as two continuous variables or combined to give one single score for 
the total network. Response categories vary by question, with participants being asked 
to indicate their strength of agreement with each item. There is no published 
reliability or validity data for the scale. 
 
4.1.2.2 Medical Outcomes Study: Social Support Survey 
The Medical Outcomes Study: Social Support Survey (MOS-SSS; Sherbourne & 
Stewart, 1991) was originally developed for patients in the Medical Outcomes Study 
(see Appendix 3), a two-year study of patients with chronic conditions. It is an 18-
item measure which assesses four separate social support subscales. Firstly, 
emotional/ informational support, an example of an item representing informational 
support is ‘Someone to give you good advice about a crisis. The next subscale is 
tangible support including the item ‘Someone to help you if you were confined to 
bed’. A further subscale is affectionate support, for example ‘Someone who shows 
you love and affection’ and finally the positive social interaction subscale including 
the item ‘Someone to have a good time with’ and an additional item, ‘Someone to do 
things with to help you get your mind off things’. Respondents are asked to indicate 
how often each of the different kinds of support is available to them, ranging from 
‘none of the time’ to ‘all of the time’ Scores on each subscale can be combined to 
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give an overall social support index. A higher score for an individual scale or for the 
overall support index indicates more support. The scale has exhibited good internal 
consistency for each sub-scale (all Alphas >0.91) and good test-retest reliability at 12 
months (r=0.7) (Hays, Sherbourne & Mazel, 1992).  
 
4.1.3 Neuroticism 
This dimension was measured by using the 12-item short version of the neuroticism 
subscale of the revised Eysenck Personality Questionnaire (EPQR-S; Eysenck, 
Eysenck & Barrett, 1985) (Appendix 4). This scale was primarily selected for its 
brevity, and because it is the scale most often used to assess neuroticism. Participants 
are required to make yes/no decisions in response to each item e.g. ‘Are your feelings 
easily hurt?’ The number of ‘yes’ responses are then summed to give a total score for 
neuroticism, with higher scores indicating higher levels of neuroticism. Eysenck and 
Eysenck (1991) demonstrated that the scale has excellent reliability (α=0.88) and 
validity. 
 
4.1.4 Future Thinking 
The future thinking task (FTT; MacLeod et al, 1997) was used to assess prospective 
thinking (see Appendix 5). It requires participants to generate potential future 
experiences (both positive and negative) across three time periods in the future; the 
next week, the next year and the next five to ten years. For positive future thoughts 
participants are told ‘I’d like you to try to think of things that you are looking forward 
to, things that you enjoy’. For negative future thoughts the instruction ‘I’d like you to 
think of things that you’re worried about or not looking forward to’ is given. Order of 
completion of positive and negative conditions is counterbalanced across participants 
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so that half of participants are required to think of negative future thoughts first and 
half are required to think of future positive thoughts first. The order of presentation of 
time periods is constant (week, year, 5-10 years). For each of these time periods the 
participant is given one minute to generate as many thoughts as possible. Participants 
are told that their responses can be trivial or important, whatever comes to mind. They 
are also told that the responses should be things that they think will definitely happen 
or are at least quite likely to happen. Finally, they are told to keep trying until the time 
limit is up. Before administration of the FTT, all participants complete the standard 
verbal fluency task (Lezak, 1976) to assess general cognitive fluency. This task 
requires participants to generate as many words as possible beginning with the three 
letters (F, A, S) with one minute allowed for each letter. 
 
4.1.5 Optimism 
Optimism/ Pessimism was assessed by the Life Orientation Task-Revised (LOT-R; 
Scheier, Carver & Bridges, 1994) (Appendix 6). This is a 10-item scale including 
three positively worded items (e.g. I’m always optimistic about my future’), three 
negatively worded items (e.g. If something can go wrong for me it will’), and four 
filler items (e.g. It’s easy for me to relax). Participants are asked to indicate their 
agreement with these statements on a 5-point scale ranging from ‘I agree a lot’ to ‘I 
disagree a lot’. The scores from the positively and negatively worded items (reverse 
scored) are summed to give an overall score for optimism/pessimism with higher 
scores representing higher levels of dispositional optimism. The test has been shown 
to exhibit good internal consistency (α=0.78) and reliability (Scheier, Carver & 
Bridges, 1994).  
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4.1.6 Locus of Control 
The Recovery Locus of Control Scale (RLOC; Partridge & Johnson, 1989) is a 9-item 
scale developed to measure the internality/externality of an individual’s perceptions of 
control over their recovery (see Appendix 7). Five items reflect internal beliefs, for 
example ‘How I manage in the future depends on me, not on what other people can do 
for me’, and four items are worded to reflect external beliefs, for example ‘My own 
efforts are not very important, my recovery really depends on others’. Participants are 
asked to indicate their level of agreement with each item using a five-point Likert-
type scale from 1 (‘strongly agree’) to 5 (‘strongly disagree’). The scores from the 
items are summed (the external items are reverse scored) so that high scores represent 
high internal beliefs, representing a strong internal locus of control. The RLOC has 
been shown to exhibit good predictive and content validity (Partridge & Johnson, 
1989). In addition, the internal consistency was found to be good-moderate for both 
the internal (α=0.62) and external items (α=0.65) (Partridge & Johnson, 1989). 
 
4.1.7 Beliefs about Medicines 
The Beliefs about Medicines Questionnaire (BMQ; Horne, Weinman & Hankins, 
1999) assesses cognitive representations of medication (see Appendix 8). The BMQ 
comprises two sections. These are the BMQ-Specific which assesses representations 
of medication prescribed for personal use and the BMQ-General which assesses 
beliefs about medicines in general. The BMQ-Specific comprises two scales, one 5-
item scale which assesses personal beliefs about the necessity of prescribed 
medication for controlling their illness (e.g. ‘My health, at present, depends on my 
medicines’) and another 5-item scale which assesses concerns about the potential 
adverse effects of taking the medication (e.g. ‘I sometimes worry about the long-term 
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effects of my medicines.’). The BMQ-General also comprises two scales, consisting 
of 4-items each. The general-overuse scale assesses views about the way in which 
medicines are used by doctors and assesses personal beliefs about the extent to which 
doctors place too much trust in medicines (e.g. ‘Doctors use too many medicines’). 
The general-harm scale assesses beliefs about the intrinsic properties of medicines 
and the degree to which they are perceived by the individual as being harmful (e.g. 
‘All medicines are poisonous’). Respondents indicate their level of agreement with 
each statement on a 5-point Likert-type scale, ranging from 1=strongly disagree to 
5=strongly agree. Scores obtained for the individual items within each scale are 
summed to give a scale score with higher scores indicating stronger beliefs in the 
concepts represented by the scale. Internal consistency for the scale is good, with 
values ranging from 0.65-0.86, in addition the test-retest reliability of the BMQ was 
satisfactory for a 2 week period (Horne, Weinman & Hankins, 1999). 
 
4.1.8 Illness Perceptions 
The Brief Illness Perception Questionnaire (Brief IPQ; Broadbent et al, 2006) is a 9-
item scale designed to quickly assess the cognitive and emotional representations of 
illness (see Appendix 9). Five of the items assess cognitive illness representations: 
consequences (‘How much does your illness affect your life’), timeline (‘How long do 
you think your illness will continue’), personal control (‘How much control do you 
feel you have over your illness’), treatment control (‘How much do you think your 
treatment can help your illness’), and identity (How much do you experience 
symptoms from your illness’). Two of the items assess emotional representations: 
concern (‘How concerned are you about your illness’) and emotions (‘How much 
does your illness affect you emotionally’). One item assesses illness 
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comprehensibility (‘How well do you feel you understand your illness’). All of these 
items are rated using a 0-10 response scale. The final item assesses causal 
representation of the illness by an open-ended response item which asks patients to 
list the three most important causal factors in their illness. The items have good test-
retest reliability (average α=0.7) at 3 and 6 weeks and good predictive validity in 
patients recovering from MI (Broadbent et al, 2006). 
 
4.1.9 Roles and Goals 
The Roles and Goals Questionnaire (RAG; Lam & Power, 1991) assesses an 
individual’s roles and goals across four domains (see Appendix 10). (1) present work; 
(2) the most important interests and hobbies; (3) the most important personal 
relationships; and (4) health and independent living. For domain (1) the respondent 
was asked to specify his/her current employment (if applicable), for domain (2), the 
nature of the hobby or interest, for domain (3), the individual whom the respondent 
considers to be the most important relationship, and in domain (4), the name of any 
illness affecting them. In addition, if there was an important role of goal not covered 
by the above four domains, an extra section was provided for the participant to 
specify what the role of goal was. For each domain the participants are asked a series 
of five questions, and asked to rate their responses on a four-point scale: 1=very little, 
2=moderate amount, 3=quite a lot, and 4=a great deal. For each domain the questions 
assess ‘How much does this [enter domain] make you feel good as a person’, ‘How 
much energy and effort do you put into this [enter domain]’, ‘How successful will you 
be in this [enter domain]’, ‘To what extent does being successful in other areas of 
your life depend on your being successful at [enter domain]’ and finally ‘To what 
extent would life feel meaningless or unhappy without it’. A score for each domain 
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can be computed as well as an overall RAG score. The RAG has been shown to 
exhibit good stability across time with a test-retest correlation of 0.79 at 3 months. 
Furthermore, the scale exhibits good internal consistency at 0.85 (Lam & Power, 
1991). 
 
4.1.10 Stress Arousal 
Stress arousal was assessed by the Stress Arousal Checklist (SACL; Mackay et al, 
1978) (Appendix 11). The SACL contains 30 items which are one-word positive and 
negative adjectives commonly used to describe psychological stress. For the purposes 
of the study described in Chapter 7 the 15 items used to measure arousal were 
eliminated, leaving a 19 item measure of stress (e.g. tense, worried). Respondents are 
asked to read the words and rate how strongly they feel at that moment on a 4-point 
scale ranging from ‘definitely feel’ to ‘definitely do not feel’. When scoring the scale 
if ‘definitely feel’ or ‘slightly feel’ are selected for a positive adjective then a score of 
1 is given, if ‘cannot decide’ or ‘definitely not’ are selected for a negative then a score 
of 1 is given for that item. Otherwise a score of 0 is given. This gives respondents a 
score between 0-19 on the stress index, higher scores represent higher subjective 
feeling of stress. There are no published reports on the reliability of the SACL. 
However, it has been subjected to factor analysis by several researchers to determine 
its internal consistency. Studies by Mackay et al (1978), and Fischer and Donatelli 
(1987) both yielded a two-factor structure, subsequently labelled stress and arousal. In 
addition, the SACL has been shown to have concurrent validity, with scores 
correlating with various physiological measures (Mackay, 1980). 
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Table 4.2 Summary table for the measures for each predictor variable 
Construct Name of 
Measure 
Authors Year Number 
of Items 
Rating Scale 
Type D 
Personality 
Type D 
Personality Scale 
(DS14) 
Denollet 2005 14 5-point scale ranging 
from 0=False to 
4=True 
Social Support Quality of Social 
Network and 
Social Support 
Scale (SNSS) 
Dalgard, 
Bjork & 
Tambs 
1995 9 3 or 4-point scale 
Social Support The Medical 
Outcomes Study: 
Social Support 
Survey (MOS) 
Sherbourne 
& Stewart  
1991 19 5-point scale ranging 
from 1=None of the 
time to 5=All of the 
time 
Neuroticism Eysenck 
Personality 
Questionnaire 
(EPQR-S) 
Eysenck, 
Eysenck & 
Barrett 
1985 12 Yes or No 
Future 
Thinking 
The Future 
Thinking Task 
(FTT) 
MacLeod, 
Pankhania, 
Lee & 
Mitchell 
1997 6 Number of responses 
generated 
Optimism Life Orientation 
Task-Revised 
(LOT-R) 
Scheier, 
Carver & 
Bridges 
1994 10 5-point scale ranging 
from ‘I agree a lot’ to 
‘I disagree a lot’ 
Locus Of 
Control 
The Recovery 
Locus of Control 
Scale (RLOC) 
Partridge & 
Johnston 
 
1989 9 5-point scale ranging 
from ‘strongly agree’ 
to ‘strongly disagree’ 
Beliefs about 
Medicines 
Beliefs about 
Medicines 
Questionnaire 
(BMQ) 
Horne, 
Weinman & 
Hankins 
1999 18 5-point scale ranging 
from ‘strongly 
disagree’ to ‘strongly 
agree’ 
Illness 
Perceptions 
The Brief Illness 
Perceptions 
Questionnaire 
(Brief IPQ) 
Broadbent, 
Petrie, Main 
& Weinman 
2006 10 0 to 10 response scale 
Roles and 
Goals 
The Roles and 
Goals 
Questionnaire 
(RAG) 
Lam & 
Power 
1991 20 4-point scale ranging 
from ‘very little’ to ‘a 
great deal’ 
Stress Arousal Stress Arousal 
Checklist 
Mackay, 
Cox, 
Burrows & 
Lazzarini 
1978 19 4-point scale ranging 
from ‘definitely feel’ 
to ‘definitely do not 
feel’ 
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4.2 Outcome Variables 
4.2.1 Depression and Anxiety 
The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) is a 
14-item self-report measure designed to assess depression and anxiety (see Appendix 
12). It contains two subscales, one 7-item scale relating to depression (items 2, 4, 6, 8, 
10, 12, 14), for example ‘I feel as if I am lacking in energy’, and one 7-item subscale 
relating to anxiety (items 1, 3, 5, 7, 9, 11, 13), for example ‘I feel tense or wound up’. 
Items are rated on a 0-3 point scale indicating strength of agreement with each item. 
The maximum score for each subscale is 21, with higher scores representing higher 
levels of depression or anxiety. With regards to the psychometric properties of the 
HADS, a review by Bjelland, Dahl, Haug & Neckelmann (2002) of 747 studies using 
the HADS found it to be both reliable and valid for use with the general public and in 
a health setting, with α= 0.83 and 0.82 for the anxiety and depression scales 
respectively. 
 
4.2.2 Health Behaviour 
4.2.2.1 General Preventive Health Behaviours Checklist 
The General Preventive Health Behaviours Checklist (GPHB; Amir, 1987) (Appendix 
13) consists of 29-items selected ‘to represent a broad sample of possible preventive 
health behaviours thought to be relevant to a British population’ (Amir, 1987). This 
scale was selected as it is recommended in Wright, Johnston & Weinman’s (1995) 
‘Measures in Health Psychology Portfolio’ and has been used successfully in the past 
in a young healthy population (Ingledew & Brunning, 1999), although it was 
originally used with an elderly population.  Items were chosen from Harris and 
Guten’s (1979) list, for example ‘keep a first-aid kit in the house’ and to reflect the 
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predictive items from the Alameda County Study, for example ‘regularly eat 
breakfast’. Three response categories are offered for each item; ‘always or almost 
always’, ‘sometimes’ and ‘do not do’. When scoring the scale, only the response 
‘always or almost always’ is scored and in each case, the score is 1, the other 
responses are scored as zero. This scoring system is used to reduce the effects of 
social desirability response bias which might lead respondents to say ‘sometimes’ 
rather than ‘no’. This gives a GPHB index from 0 to 29, with higher scores reflecting 
more health behaviours being performed. There is no published evidence of the 
reliability and validity of the scale. 
 
4.2.2.2 General Preventive Health Behaviours Checklist- Brief 
A brief version of the GPHB was also developed (see Appendix 14); this was done in 
order to reduce time taken to complete the scale. The Brief GPHB is an 8-item 
measure. These items were selected as being the eight preventive health behaviours 
on which groups of respondents who were found to be in ‘very good’, ‘good’ and 
‘average to very poor’ health following medical assessment significantly differed 
(Amir, 1987). These items were ‘eat sensibly’, ‘avoid crossing the street against the 
lights’, ‘get enough sleep’, ‘spend time out of doors everyday’, ‘do not smoke’, ‘get 
enough exercise’, ‘avoid letting things get me down’ and ‘get a regular medical 
check-up’. The original scoring system from the GPHB was used. There is no 
reliability data available for this scale as this is the first time the abbreviated scale has 
been used. 
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4.2.2.3 Health Behaviour Scale- Weinman, Petrie, Sharpe & Walker  
The Health Behaviour Scale has been used once previously in Weinman, Petrie, 
Sharpe & Walker’s (2000) study which examined causal attributions in first-time MI 
patients, and is designed to assess health behaviour over an average week (see 
Appendix 15). It is an 11-item self-report scale reflecting a range of health behaviours. 
Items 1-8 ask participants to rate how often they performed a number of health 
behaviours (e.g. physical exercise, 7-8 hours sleep). Responses are made on a 6-point 
scale: ‘never’, ‘once a month’, ‘once a week’, ‘2-3 times a week’, ‘4-5 times per 
week’, and ‘everyday’. The remaining questions ask participants how many minutes 
they spend exercising in an average week, if they use fat-reduced milk, and whether 
they use butter or margarine as a choice of spread. There is no reliability or validity 
data available for this scale, and to my knowledge the scale has not been utilised 
elsewhere. 
 
4.2.2.4 Health Related Behaviours Scale – Ogden & Mtandabari 
The health related behaviours scale was developed by Ogden & Mtandabari (1997) in 
their study of examination stress and changes in mood and health related behaviours 
in students (see Appendix 16). To my knowledge the scale has not been utilised 
elsewhere. Participants are required to complete questions about five health related 
behaviours; smoking, alcohol consumption, eating behaviour, exercise, and sleep. For 
example, for smoking behaviour, participants were asked (a) ‘Do you ever smoke’ 
(Yes / No); (b) ‘Over the last week, on average how many cigarettes have you 
smoked’, and (c) ‘Over the last week, how much have you been craving cigarettes’. 
Questions followed a similar format for each of the behaviours. To our knowledge 
there is no reliability or validity data available for this scale. 
 73 
4.2.3 Benefit Finding 
Benefit finding was measured using a 17-item measure developed by Urcuyo, Boyers, 
Carver & Antoni (2005) (Appendix 17). The measure used the stem ‘Having had a 
heart attack…..’ which was adapted from the original stem of ‘Having had breast 
cancer’, and each item continued by mentioning a potential positive contribution to 
the respondent’s life that might plausibly follow from their experience of having a 
heart attack, for example ‘Having had a heart attack has brought my family closer 
together’. Respondents rate their level of agreement with each item on a 4-point scale 
ranging from ‘I disagree a lot’ (0) to ‘I agree a lot’ (3) with higher scores indicating 
higher levels of benefit finding. The scale has been widely used in studies of benefit 
finding and internal consistency for the measure has been found to be good (α=0.91).  
 
4.2.4 Quality of Life 
Quality of life after myocardial infarction was assessed using the MacNew (Lim et al, 
1993; Valenti et al, 1996) (Appendix 18). This is a heart disease specific health-
related quality of life HRQL) instrument which assesses three major HRQL domains; 
emotional (e.g. ‘In general, how much of the time during the last 2 weeks have you 
felt frustrated, impatient or angry’, physical (e.g. ‘How much shortness of breath have 
you experienced during the last 2 weeks while doing your day-to-day activities’, and 
social (e.g. ‘How often during the last 2 weeks have you felt you were unable to do 
your usual social activities, or social activities with your family’. The instrument 
consists of 27 items, each with a seven-point Likert-type response scale. Domain 
scores are calculated by taking the average of the responses to the items in each 
domain; averaging all 27 items gives a global score. Studies on the psychometric 
properties of the Mac New report it to be valid, reliable (α=0.8), and responsive, 
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simple to administer and the scale has also been shown to be well-accepted by 
patients with myocardial infarction (Lim et al, 1993; Valenti et al, 1996). Furthermore, 
the MacNew was favourably reviewed by Dempster & Donnelly, (2000) in their 
review of HRQL instruments. 
 
4.2.5 Functional Outcome 
The Functional Limitations Profile (FLP; Patrick & Peach, 1989) is the British 
version of the widely used American Sickness Impact Profile (SIP; De Bruin et al, 
1992) (Appendix 19). Patrick and Peach (1989) translated the SIP into British English, 
renamed and rescored it to use British item weights. The aim of the scale is to assess 
changes in function due to ill-health. The scale consists of 136 items within 12 
categories of activity. Four categories were selected for use in study 5. These were 
ambulation, mobility, recreation and social interaction. Each category contains items 
which describe a restriction in activity (e.g. I walk more slowly) and the respondents 
are required to indicate whether the item applied to them today and if it is due to their 
health. Scores for each category are calculated by adding the item-weighted values for 
each item which the respondent has endorsed, and considers is due to their health. 
This total is then divided by the maximum possible score for that category, and 
multiplied by 100 to obtain the FLP category score. Psychometric properties of the 
scale are good; a review by De Bruin et al (1992) of 120 studies using measures of 
functional outcome concluded that it was a good, valid and reliable instrument. In 
addition, Charlton et al (1983) have also reported the FLP to have acceptable 
reliability and validity, with a test-retest reliability of 0.95 for the overall scale, 0.98 
for the physical dimension, and 0.85 for the psychosocial scale. 
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4.2.6 Medication Adherence 
The Medication Adherence Report Scale (MARS; Horne, Weinamn & Hankins, 1999) 
was developed to measure adherence to a wide-range of medication regimes (see 
Appendix 20). It assesses how often patients have been non-adherent, by assessing 
various non-adherent behaviours. The 5-item scale asks respondents to rate the 
frequency with which they engage in each of five aspects of non-adherent behaviour, 
for example ‘I forget to take them’ on a five point scale (5=never; 4=rarely; 
3=sometimes; 2=often; 1=very often). Scores for each of the 5 items are summed to 
give a scale score ranging from 5 to 25, where higher scores indicate higher levels or 
reported adherence. The instructions for the MARS are phrased in a non-threatening 
manner, making non-adherent responses more acceptable in order to reduce the social 
pressure on patients to under-report non-adherence, which is a problem in this field. 
The MARS has exhibited high internal reliability (α= 0.83) and high test-retest 
reliability, r=0.97 (Horne, Weinman & Hankins, 1999). Table 4.3 outlines the 
measures used for each of the outcome variables  
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Table 4.3 Summary table for the measures used for the outcome variables 
Construct Name of 
Measure 
Authors Year Number 
of Items 
Rating Scale 
Depression and 
Anxiety 
The Hospital 
Anxiety and 
Depression Scale 
(HADS) 
Zigmond & 
Snaith 
1983 14 0-3 point scale 
Health 
Behaviour 
General 
Preventive Health 
Behaviours 
Checklist 
(GPHB) 
Amir 1987 29 Three response 
categories; 
‘always’, 
‘sometimes’ and 
‘do not do’ 
Health 
Behahviours 
General 
Preventive Health 
Behaviours 
Checklist –Brief  
Amir 1987 8 Three response 
categories; 
‘always’, 
‘sometimes’ and 
‘do not do’ 
Health 
Behaviour 
Health Behaviour 
Scale 
Weinman, 
Petrie, 
Sharpe & 
Walker 
2000 11 6-point scale 
ranging from 
‘Never’ to 
‘Everyday’. 
Health 
Behaviour 
Health Related 
Behaviours Scale 
Ogden & 
Mtandabari 
1997 5 domains Yes/No, frequency 
response and 5-
point scale ranging 
from ‘not at all’ to 
‘extremely’ 
Benefit 
Finding 
Benefit Finding Urcuyo, 
Boyers, 
Carver & 
Antoni 
2005 17 4-point scale 
ranging from ‘I 
disagree a lot’ to ‘I 
agree a lot’ 
Quality of Life MacNew Valenti, 
Lim, Heller 
& Knapp 
1996 27 7-point scale 
Functional 
Outcome 
The Functional 
Limitations 
Profile (FLP) 
Patrick & 
Peach 
1989 4 
categories 
Yes/ No 
Medication 
Adherence 
Medication 
Adherence Report 
Scale (MARS) 
Horne, 
Weinman & 
Hankins 
1999 5 5-point scale 
ranging from 
‘never’ to ‘very 
often’ 
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Chapter 5: Prevalence of Type D Personality in the UK and Ireland: 
Associations with Health Behaviour and Social Support 
5.0 Abstract 
Background: Type D personality (high negative affectivity and high social inhibition) 
is predictive of adverse outcome and psychological distress in patients with coronary 
heart disease (CHD). However, the mechanisms by which Type D affects health are 
unknown. It was predicted that (a) Type D individuals would engage in less health-
related behaviour and (b) have lower levels of social support than non-Type D 
individuals. A further aim was to investigate the prevalence of the Type D personality 
pattern in a British population for the first time. 
Methods: A cross-sectional design was employed. One thousand and twelve healthy 
young adults (225 males, 787 females, mean age: 20.7 years) from throughout the UK 
completed measures of Type D personality (DS14), health behaviours (GPHB), social 
support (SNSS) and neuroticism (EPQR-S). 
Findings: The prevalence of Type D was found to be 38.5%, significantly higher than 
reported in other European countries. In addition, Type D individuals reported 
performing significantly fewer health-related behaviours and lower levels of social 
support than non-Type D individuals. These relationships remained significant after 
controlling for neuroticism. 
Discussion: The link between Type D and CHD may be explained by Type D 
individuals performing fewer health related behaviours and experiencing less social 
support than non-Type D individuals.  
_______________________ 
A paper based on this chapter is in press in the Journal of Psychosomatic Research: 
Williams, L., O'Connor, R.C., Howard, S., Hughes, B.M., Johnston, D.W., Hay, J.L., O'Connor, D.B., 
Lewis, C.A., Ferguson, E., Sheehy, N., Grealy, M.A. & O'Carroll, R.E. (in press). Type D Personality 
Mechanisms of Effect: The Role of Health-Related Behaviour and Social Support. Journal of 
Psychosomatic Research. 
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5.1 Introduction 
As described in Chapter 2, there is growing evidence to suggest a potential link 
between Type D and CHD. However, the question remains as to the specific 
mechanisms by which Type D is associated with CHD. There are several possibilities 
which may help to explain the link between Type D and cardiac morbidity and 
mortality. One possibility is that Type D may be linked to ill-health through 
psychophysiological mechanisms (e.g. cardiovascular reactivity). A second possibility 
is that Type D may affect health through more psycho-social mechanisms. The 
current study will examine two possible psychosocial mechanisms (health behaviour 
and social support). Pedersen & Denollet (2006) have outlined several possible 
mechanisms which may link Type D and poor prognosis, these are shown in Figure 
5.1. The current chapter focuses on the role of psychosocial mechanisms, whereas 
psychophysiological mechanisms are described further in Chapter 7, Section 7.1.6. 
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Figure 5.1 Potential mechanisms linking Type D personality with adverse clinical 
outcome, adapted from Pedersen & Denollet (2006). 
 
5.1.1 Type D Personality and Psychosocial Mechanisms 
Mechanisms linking Type D and ill-health may operate indirectly through behavioural 
mechanisms including health related behaviours, thus Type D personality could cause 
damage to the cardiovascular system by influencing lifestyle choices and practices. It 
is this possibility which is the focus of the current study. Type D may be associated 
with unhealthy behaviour such as smoking, poor diet and lack of exercise which 
would in turn will lead to an increased risk of mortality and morbidity. For example, 
poor diets are associated with hypertension and coronary heart disease (Knoops et al, 
2004) and exercise decreases blood pressure and the risk for morbidity and mortality 
in CHD (Kahn, 1963).  
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Unhealthy 
lifestyle 
Activation of 
the HPA-axis 
Hemostatic 
changes 
Cardio-vascular 
reactivity 
Release of 
stress hormones 
Inflammation 
Adverse Clinical Outcome 
Endothelial 
damage 
Genes 
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Not only would establishing a relationship between Type D and health behaviour be 
important in explaining the mechanism between Type D and ill-health, it may also 
suggest that Type D may be a risk factor for poor health in general. Furthermore, the 
Type D construct has previously been criticised as not providing an obvious 
opportunity for treatment strategies (Lesperance & Frasure-Smith, 1996) due to the 
fact that personality is generally considered to be stable across time and situations. 
However, if Type D is associated with health related behaviour, then this would 
provide a clear target for intervention as health behaviours are potentially modifiable.  
 
To date the relationship between Type D and health behaviours has not been 
investigated specifically. However, Pedersen et al (2004) found a relationship 
between Type D status and smoking in their study of CHD patients. Type D 
individuals were more likely to smoke compared to non-Type D individuals (37% vs. 
29%). In addition, it is known that socially inhibited individuals are less likely to 
engage in health-promoting behaviour (Kirkcaldy, Shephard & Siefen, 2002). 
Furthermore, Schiffer and colleagues recently investigated a further possible 
behavioural link between Type D and adverse prognosis. In their study of CHF 
patients they found that those patients with a Type D personality showed sub-optimal 
consultation behaviour as they were less likely to report their cardiac symptoms to 
their nurse or cardiologist, despite experiencing more cardiac symptoms than non-
Type D individuals (Schiffer et al 2007). Therefore, it is important to further 
investigate the relationship between Type D and health behaviour using a more 
comprehensive measure of health behaviour.  
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A further mechanism by which Type D may influence health outcomes is via poor 
social support. People with Type D personality are known to experience higher levels 
of perceived social alienation and to be more socially withdrawn than non-Type D 
individuals (Denollet et al, 1996), which may in turn lead to a reduced social support. 
This is important as an inverse association has been demonstrated between social 
support and mortality (Berkman & Syme, 1979), demonstrating that individuals with 
higher levels of social support have better health outcomes. Therefore, Type D 
individuals may have a poorer outcome due to lower levels of social support. Indeed, 
a recent study by van den Broek et al (2007) found that Type D patients without a 
partner reported more symptoms of anxiety and depression compared to Type D 
patients with a partner. 
 
5.1.2 Type D Personality Prevalence Rate  
A further primary research objective was to investigate the prevalence of Type D 
personality in a British population. To our knowledge, no other studies have 
investigated Type D personality in a population from the UK. There currently exists 
no data on the Type D construct within either British or American populations. Indeed, 
Denollet has pointed to the fact that “more research is needed to examine the cross-
cultural validity of Type D” (Denollet, 2005, p95) in order to extend the findings 
which have been largely based on Belgian and Dutch cardiac patients. Therefore, a 
further aim of this study is to investigate the prevalence of Type D personality within 
the UK and Ireland. 
 
In addition, because the Type D construct has been criticised as being just another 
measure of negative affectivity or neuroticism (Lesperance & Frasure-Smith, 1996), 
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the current study will test whether any relationships demonstrated between Type D 
and social support, and Type D and health-related behaviour remain after controlling 
for the effects of neuroticism. 
 
5.1.3 Hypotheses 
The hypotheses for the current study are as follows;  
(i) due to high rates of CHD in the UK and Ireland it is hypothesised that prevalence 
rates of Type D personality may be higher in the UK and Ireland than the rates 
established previously in the rest of Europe;  
(ii) Type D personality will be associated with lower levels of perceived social 
support;  
(iii) Type D personality will be associated with maladaptive health behaviours, and  
(iv) these relationships will remain after controlling for the effects of neuroticism. 
 
5.2 Methodology 
5.2.1 Participants 
In total, 1012 healthy young adults took part in this study (787 females, 225 males). 
They were an opportunity sample recruited from eight universities throughout the UK 
and Ireland. Three hundred and sixty nine participants (267 females, 102 males) were 
recruited from three Scottish Universities, 240 participants (199 females, 41 males) 
were recruited from two English Universities, 193 participants (158 females, 35 males) 
were recruited from two Universities in Northern Ireland and 210 participants (163 
females, 47 males) from one university in the Republic of Ireland. The mean age of 
the participants was 20.7 years (SD=4.94) and the ages ranged from 17-56 years. The 
men (mean=20.8, SD=5.16) and women (mean=20.7, SD=4.87) did not differ 
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significantly in terms of age, t (1, 1010) = 0.152, ns. In addition, the nationalities did 
not differ significantly in terms of age, F (5, 1006)= 0.740, ns, or gender  χ² (6, 
N=1012)=6.59, ns. 
 
I collected the data from one of the Scottish Universities, while collaborators 
collected the remaining data. Madeleine Grealy from Strathclyde University, and Julia 
Hay and Derek Johnston from Aberdeen University collected the remaining Scottish 
data. Chris Lewis from Ulster University and Noel Sheehy from Liverpool John 
Moore’s University collected the data from Northern Ireland. In addition, Daryl 
O’Connor from Leeds University, and Eamonn Ferguson from Nottingham University 
collected the English data. Finally, Brian Hughes and Siobhan Howard from NUI 
Galway collected the data from the Republic of Ireland. 
 
5.2.2 Measures 
Socio-demographic variables included age, gender, nationality (whether participants 
identified as being British, Scottish, English etc.) and country of birth. In addition, all 
participants were asked to complete the following psychological measures: 
 
5.2.2.1 Type D Personality  
Type D Personality was assessed using the Type D Personality Scale (DS14; Denollet, 
2005). This is a 14-item scale comprising of 2 subscales (see Appendix 1). A 7-item 
subscale which measures negative affectivity, and a 7-item subscale measuring social 
inhibition. Both subscales were internally consistent in the current study (Cronbach’s 
α =.85 and .82 for NA and SI respectively). 
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5.2.2.2 Health Behaviour  
Health behaviour was measured using a shortened version of the General Preventive 
Health Behaviours Checklist (GPHB; Amir, 1987) (see Appendix 14). The original 
form of this measure comprises 29 behaviours, including items drawn from the 
Alameda County study (Belloc & Breslow, 1972). This measure was shortened to 
eight items for use in the current study. These items were selected as being the eight 
preventive health behaviours on which groups of respondents who were found to be in 
‘very good’, ‘good’ and ‘average to very poor’ health following medical assessment 
significantly differed (Amir, 1987). Cronbach’s α for the present sample is .42 
indicating low internal consistency. However, for the purposes of the current study, 
the behaviours are not intended to be considered as a scale, but rather as separate 
items in order to examine the relationship between Type D and specific health 
behaviours.  
 
5.2.2.3 Neuroticism  
Neuroticism was assessed as some theorists believe that Type D may be just another 
measure of neuroticism or depression (e.g. Lesperance & Frasure-Smith, 1996), 
therefore by including a measure of neuroticism it can be examined whether any 
relationships between Type D and health behaviour or social support remain 
significant after controlling for the presence of neuroticism. This dimension was 
measured by using the 12-item short version of the neuroticism subscale of the 
revised Eysenck Personality Questionnaire (EPQR-S) (Eysenck, Eysenck & Barrett, 
1985) (see Appendix 4). This measure was found to be internally consistent in the 
current study (Cronbach’s α=.77). 
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5.2.2.4 Social Support  
Social support was measured using a shortened version of the Quality of Social 
Network and Social Support Questionnaire (SNSS; Dalgard, Bjork & Tambs, 1995) 
(see Appendix 2). Cronbach’s α=.64 demonstrating acceptable internal consistency 
for the present sample. Although it could be argued that this measure does not meet 
Nunnally’s (1978) criterion of α=.70 for internal consistency, this would have acted 
only to attenuate the strength of the relationship between the variables. 
 
5.2.3 Procedure 
All participants were recruited during undergraduate psychology classes and asked to 
complete the questionnaire pack, they were given a brief introduction of what the 
study would require and invited to participate. Ethical approval had been obtained 
from each of the University Psychology Department’s ethics committee prior to 
testing.  
 
5.2.4 Statistical Analyses 
In order to test whether the Type D prevalence rate observed in the current sample is 
significantly different from that observed in other studies z-tests for the equality 
between proportions were calculated. A multivariate analysis of variance was 
employed to examine the differences between Type D and non-Type D individuals on 
levels of social support and neuroticism. In addition, due to the assertion of some 
authors that Type D is simply another measure of negative affect an analysis of 
covariance (with Neuroticism as the covariate) and a formal test of mediation were 
performed following Baron and Kenny’s (1986) conditions for mediation. In order to 
examine any differences between Type D and non-Type D individuals on the health 
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behaviour items, a series of chi-square analyses were performed. Following this, 
Baron and Kenny’s conditions for mediation (1986) were tested in order to determine 
the mediating effect of neuroticism on the relationship between Type D and the health 
behaviours. 
 
5.3 Results 
5.3.1 Prevalence of Type D Personality 
From the sample of 1012 participants, 390 (312 females and 78 males) were 
classified as Type D (38.5%) by using the recommended cut off point of ≥ 10 on both 
NA (M=11.61; SD=5.41) and SI (M=10.27; SD=5.19) sub-scales. This corresponds to 
39.6% of females and 34.7% of males being categorised as having a Type D 
personality. There was no effect of gender on Type D status, χ² (1, N=1012)=1.83, ns. 
In addition, there was no significant effect of nationality on Type D classification, χ² 
(6, N=1012)=16.32, ns. Z-tests for the equality between two proportions were 
calculated to determine if the Type D prevalence found in this study is significantly 
higher than that found in other countries. It was found that the prevalence in the UK 
and Ireland established in the current study is significantly higher than that of Holland 
(21%) (Denollet, 2005) (z=3.6, p<0.001), Italy (28%) (Gremigni & Sommaruga, 2005) 
(z=2.3, p<0.05) and Germany (25%) (Grande et al, 2004) (z=6.6, p<0.001).   
 
5.3.2 Type D Personality, Social Support and Neuroticism 
A MANOVA was carried out to examine differences between Type D and non-Type 
D individuals in their levels of social support and neuroticism. Gender was also 
entered as a factor in the analysis. Type D individuals reported significantly lower 
levels of social support (M=12.74; SD=3.7) than non-Type D individuals (M=14.68; 
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SD=3.06; F(1,1010)=127.48, p<0.001). In addition, females (M=13.09; SD=3.0) 
reported significantly higher rates of social support than males (M=12.67; SD=3.23; 
F(1,1010)=5.27, p<0.05). There was no gender x Type D interaction F(1,1010)=1.56, 
ns. Cohen’s d = 0.57, indicating a medium effect size for Type D on social support. 
 
 In addition, levels of neuroticism were significantly higher in the Type D participants 
(M=7.17; SD=2.69) compared to the non-Type D individuals (M=4.83; SD=2.8; F(1, 
1010)=303.86, p<0.001). Again, there was an effect of gender on neuroticism, with 
females (M=5.95; SD=2.9) reporting significantly higher levels of neuroticism 
compared to males (M=4.8; SD=3.2; F(1,1010)=26.49, p<0.001). There was no 
gender x Type D interaction, F(1,1010)=2.85, ns. Cohen’s d = 0.85, indicating a large 
effect size for the effect of Type D on neuroticism. Furthermore, ANCOVA revealed 
that the relationship between social support and Type D remained significant after 
controlling for the effects of neuroticism, with Type D individuals reporting 
significantly lower levels of social support (M=11.72; SD=2.99) than non-Type D 
individuals (M=13.82; SD=2.81; F(1,1109)=41.5, p<0.001).  
 
Formal mediation analysis was also carried out in order to determine if neuroticism 
mediates the relationship between Type D and social support. Following the 
procedure outlined by Baron and Kenny (1986), to test for mediation, a series of 
hierarchical regressions were performed.  According to Kenny et al. (1998), mediation 
is demonstrated when the following conditions are met:  (1) the independent variable 
(i.e., Type D) affects the mediator (i.e., neuroticism); (2) the independent variable 
affects the dependent variable (i.e., social support); (3) the mediator affects the 
dependent variable when the independent variable is controlled for and; (4) full 
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mediation is confirmed when the association between the independent variable and 
dependent variable is reduced to non-significance after the effect of the mediator is 
controlled for.  If conditions 1-3 are met partial mediation is indicated.  Sobel tests 
were also conducted in each case in order to determine if there had been a significant 
reduction in the relationship between the dependent and independent variables (Baron 
and Kenny, 1986). 
 
Initial regression analysis showed that Type D significantly predicted neuroticism 
indicating that condition 1 for mediation was met, β=0.481, t(1011)=17.43, p<0.001. 
Type D was a significant predictor of social support at step 1, β=-0.335, t(1011)=-
11.29, p<0.001) indicating that condition 2 for mediation was met. Condition 3 was 
met because when neuroticism entered the equation at step 2 it significantly predicted 
social support, β=-0.2, t(1011)=-6.0, p<0.001, and reduced the beta weight for Type D, 
β=-0.239, t(1011)=-7.2, p<0.001), but not to non-significance. Therefore, given that 
condition 4 was not met, partial mediation is indicated. A Sobel test confirmed the 
relationship between Type D and social support has been significantly reduced, z=-
5.65, p<0.001.  
 
5.3.3 Type D Personality and Health Behaviour 
Chi-square analysis revealed significant differences between Type D and non-Type D 
participants on health behaviours as presented in Table 5.1. Type D individuals were 
significantly less likely to eat sensibly (χ² (2, N=1012)=3.62, p<0.05) compared to 
non-Type D individuals. In addition, they were significantly less likely to spend time 
outdoors (χ² (2, N=1012)=14.23, p<0.001) compared to non-Type D participants. 
Furthermore, Type D individuals were significantly less likely than non-Type D 
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individuals to get a regular medical check-up (χ² (2, N=1012)=4.02, p<0.05). Type D 
participants were also significantly less likely to avoid letting things get them down 
compared to non-Type D participants (χ² (2, N=1012)=66.54, p<0.001). There were 
no significant differences between Type D and non-Type D individuals with regards 
to getting enough sleep (χ² (2, N=1012)=0.53, p=0.257), smoking (χ² (2, N=1012)=1.2, 
ns), getting enough exercise (χ² (2, N=1012)=2.18, ns) or avoiding crossing the streets 
against the traffic lights (χ² (2, N=1012)=0.03, ns).  
 
Table 5.1 Type D personality and health-related behaviour 
 Type D  Non-Type D    
Health 
Behaviour 
Do not do or 
sometimes 
do 
Always Do not do or 
sometimes 
do 
Always χ² p 
Eat Sensibly 275 121 392 224 3.62 .033 
Avoid crossing 
the street 
against the 
traffic lights 
324 72 501 115 .038 .457 
Get enough 
sleep 
288 108 435 181 .526 .257 
Spend time 
outdoors 
everyday 
202 194 240 376 14.23 <.00
1 
Do not smoke 
 
149 247 253 363 1.20 .152 
Get enough 
exercise 
322 74 477 139 2.19 .81 
Avoid letting 
things get me 
down 
360 36 425 191 66.54 <.00
1 
Get a regular 
medical check-
up 
348 48 513 103 4.02 .027 
 
 
Formal mediation analyses were conducted to determine if neuroticism mediates the 
effect of Type D on health-related behaviours. Initial regression analysis showed that 
Type D significantly predicted neuroticism indicating that condition 1 for mediation 
 90 
was met, β=0.481, t(1011)=17.43, p<0.001. Each of the significant Type D-health 
behaviour relationships will now be considered in turn. For eat sensibly, Type D was 
not a significant predictor at step 1, β=-0.06, t(1011)=-1.9, ns, therefore condition 2 
for mediation was not met.  
 
For spend time outdoors, Type D was a significant predictor at step 1, β=-0.119, 
t(1011)=-3.8, p<0.001, indicating that condition 2 for mediation has been met. 
Neuroticism then entered the equation at step 2, significantly predicting eat sensibly, 
β=-0.014, t(1011)=-0.087, p<0.05 and reducing the beta weight for Type D to β=-
0.077, t(1011)=-2.17, p<0.05 indicating that condition 3 for mediation was met. As 
the relationship between Type D and eat sensibly was not reduced to non-significance, 
condition 4 for mediation was not met, indicating that partial mediation has occurred. 
A Sobel test confirmed that the relationship between Type D and eat sensibly had 
been significantly reduced, z=-2.31, p<0.05. 
 
For get a regular medical check-up, Type D was a significant predictor at step 1, β=-
0.063, t(1011)=-2.01, p<0.05, fulfilling condition 2 for mediation. However, condition 
3 for mediation was not met as neuroticism did not predict medical check-up when 
entered at step 2, β=-0.005, t(1011)=-0.14, ns, thus indicating that neuroticism does 
not mediate the relationship between Type D and medical check-up. 
 
For avoid letting things get them down, Type D was a significant predictor at step 1, 
β=-0.256, t(1011)=-8.43, p<0.001 fulfilling condition 2 for mediation. Neuroticism 
then entered the equation at step 2, significantly predicting the behaviour, β=-0.376, 
t(1011)=-11.54, p<0.001 and reducing the beta weighting of Type D to β=-0.075, 
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t(1011)=-2.31, p<0.05, fulfilling condition 3 for mediation. As the relationship 
between Type D and avoid letting things get them down was not reduced to non-
significance condition 4 for mediation was not met, indicating that partial mediation 
has occurred. A Sobel test confirmed that the relationship between Type D and avoid 
letting things get me down had been reduced, z=-8.93, p<0.001. 
 
5.4 Discussion 
The study had four main aims: (i) to investigate the prevalence rate of Type D 
personality in a healthy young British sample, (ii) to further investigate the 
relationship with Type D personality and social support, (iii) to investigate whether 
there is a relationship between Type D personality and health related behaviour, and 
(iv) to investigate if these relationships remain significant after controlling for 
neuroticism.  
 
5.4.1 Prevalence Rate 
The first aim of the study was to establish a prevalence rate for Type D personality in 
the UK. This is the first study to have examined Type D within a UK population. A 
prevalence rate of 39% was found using the standard Type D classification cut off 
points of ≥ 10 on both NA and SI subscales (no regional differences were found 
across the UK). This compares to rates of between 21% and 32.5% found elsewhere 
in Europe (Grande et al, 2004; Gremigni & Sommaruga, 2005; Denollet et al, 2005). 
A list of prevalence rates in healthy and cardiac participants established using the 
DS14 is given in Table 5.2.  
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Table 5.2 Type D Prevalence Rates in Europe 
Country Type D Prevalence- Healthy 
Participants 
Type D Prevalence- 
Cardiac Participants 
UK & IRELAND (present 
study) 
39% 33.9% (Chapter 8) 
GERMANY (Grande et al, 
2004) 
32.5% 25% 
ITALY (Gremigni & 
Sommaruga, 2005) 
n/a 28% 
HOLLAND (Denollet, 
2005) 
21% 28% 
 
It is important to consider reasons why the Type D rate is higher within the UK. There 
are a number of possibilities. First, it could represent a cultural difference between the 
UK and the rest of Europe. People from the UK are commonly thought to be more 
socially inhibited and less likely to show emotion than people from other cultures 
(Todd & Shapira, 1974). This so-called ‘British stiff upper lip’ could lead to increased 
scores in social inhibition, one of the components of Type D Personality. 
 
The high rate of Type D personality observed may reflect the high rates of CHD 
found in the UK and Ireland (Allender et al, 2006; Peterson et al, 2005). At the 
moment it is unclear if Type D is a predictor of CHD or only a predictor of recovery 
in patients with already established CHD. If Type D is established as a predictor of 
CHD then it should not be surprising that the prevalence rate in the UK is higher than 
in other countries. One important way in which the Type D research needs to develop 
is by the identification of the direction of causality by which Type D affects health. 
This is needed in order to identify if Type D is a contributory factor for CHD or if it is 
important only as a predictor of recovery in patients with established CHD. 
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However, a further possibility is that the rate is high due to the nature of the sample. 
For example, the sample is younger than has been used in previous research and 
consists of university students who are known to suffer from high rates of 
psychological distress (Furr et al, 2001). This factor could have led to elevated scores 
on the social inhibition and negative affectivity subscales and consequently an 
increased Type D prevalence rate. However, Type D is suggested to be a stable 
personality trait, so should not change across the lifetime, however to-date stability 
has only been demonstrated over a 3-month period (Denollet, 2005). Furthermore, the 
sample is predominantly female which also contrasts with previous studies which 
have been carried out largely on male cardiac patients. It is important to consider 
whether a scale that has been developed primarily for the use with older male 
participants with health problems can be readily applied to a predominantly female, 
younger population with no health problems? A previous study from Pedersen & 
Middel (2001) found higher rates of Type D among female participants (41%) 
compared to males (26%). However, no other studies report any gender differences in 
prevalence rates. 
 
A further consideration is the current recommended classification cut-off points. 
Denollet (2005) has suggested using a cut-off of ≥10 on both the social inhibition and 
negative affectivity subscales of the DS14. This recommendation was based on a 
median split of the NA and SI scores among the cardiac patients used in the study 
which validated the new DS14 scale (Denollet, 2005). Prior to this there had been no 
standard way of assessing Type D. It may be important to consider alternative ways of 
classifying Type D, for example by using a more stringent cut-off or by developing 
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different cut-off points for males and females, for different age groups or for healthy 
and non-healthy participants. 
 
5.4.2 Type D Personality and Social Support 
The present study also extends previous research on the relationship between Type D 
and social support by suggesting that Type D individuals report lower levels of 
perceived social support than non-Type D’s. This is consistent with Denollet et al’s 
finding that Type D individuals reported increased levels of social alienation 
(Denollet et al, 1996). The present findings suggest that Type D may influence health 
indirectly via impaired social support. The importance of social support within a 
health context has been established for a number of years, with evidence consistently 
suggesting an inverse relationship between social support and mortality (Berkman & 
Syme, 1979).  
 
5.4.3 Type D Personality and Health Behaviour 
A further aim of the current study was to investigate the relationship between Type D 
personality and health-related behaviour, as this may represent one way in which 
Type D has an adverse effect on health. It was hypothesised that Type D individuals 
would perform fewer health-related behaviours (e.g. eating sensibly, taking regular 
exercise) compared to non-Type D’s and that this would in turn cause damage to the 
cardiovascular system. Type D individuals were found to perform fewer health-
related behaviours. Type D individuals were found to spend less time outdoors, they 
were less likely to eat sensibly they failed to avoid letting things get them down and 
were less likely to get a regular medical check-up compared to non-Type D’s. These 
relationships remained significant in the presence of neuroticism, with only the 
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relationships between Type D and avoid letting things get me down, and Type D and 
spending time outdoors being partially mediated by neuroticism 
 
The relationship observed in the current study between Type D and unhealthy 
behaviour supports the previous finding that Type D individuals are more likely to be 
smokers than non-Type D individuals (Pedersen et al, 2004). This suggests that Type 
D individuals are more likely to engage in detrimental health practices which may in 
part explain the link between Type D and ill-health. This is an important finding for 
two reasons. Firstly, it suggests that Type D may represent a global health risk, which 
might be associated with poor health in general rather than specific to cardiac 
problems. Secondly, if Type D does influence health indirectly via health behaviours, 
then this provides one possible route for interventions by helping individuals to 
modify their behaviours. 
 
5.4.4 Limitations 
Limitations of the present study should be noted. Firstly, the generalisability of the 
findings to a cardiac population is limited by the fact that the sample consisted of 
healthy young adults. In addition, the study is limited by its cross-sectional design. 
Furthermore, although neuroticism is controlled for, we acknowledge that it would 
also have been beneficial for the current study to include a measure of depression to 
examine if it has any confounding effect on the observed relationship between Type D 
and health related behaviour. Additionally, it would have been beneficial to include a 
prospective dimension in the study. Similarly, the addition of an outcome measure 
(e.g. health status) would have made it possible to demonstrate a pathway between 
Type D, health behaviours and health outcome. At the moment it is only possible to 
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demonstrate an association between Type D and health behaviour. Also, this study 
relied exclusively on self-report measures, incorporating both objective and subjective 
measures would be beneficial in further research. 
 
5.4.5 Conclusions and Future Research 
The current study has extended the existing research on Type D personality in several 
key ways. First, it has added to the cross-cultural evidence on Type D by identifying, 
for the first time, the prevalence of Type D personality in the UK, which was 
established as 39%. Second, two possible mechanisms by which Type D may 
indirectly influence health have been identified. Previous findings on the link between 
Type D personality and social alienation have been extended by finding that in a 
healthy population, Type D individuals have lower levels of perceived social support 
compared to non-Type D’s. Additionally, the relationship observed in the current 
study between Type D and unhealthy behaviour provides a further route by which 
Type D may affect health and also represents a potential route for intervention. 
Furthermore, the relationships between Type D and social support and Type D and 
health behaviours could not be explained by neuroticism. 
 
Future research is needed to test if these are robust and replicable findings, and to 
investigate if the relationship between Type D and health behaviour is consistent over 
time. In addition future research should aim to investigate further direct and indirect 
mechanisms by which Type D personality affects health. This should be done 
prospectively with cardiac patients. 
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The following chapter will describe two studies which investigate further the 
relationship between Type D and health related behaviour. The first, involved healthy 
participants completing measures at two time points, in order to investigate if the 
relationship observed here between Type D and health behaviour is consistent across 
time. The second study, also investigating Type D and health behaviour, uses several 
measures of health-related behaviour and social support in order to extend the 
evidence on possible Type D mechanisms of effect. 
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Chapter 6: Type D Personality, Health Behaviour and Social Support: 
Further Evidence 
 
6.0 Abstract 
 
Background: The results reported in Chapter 5 suggest that Type D personality is 
associated with both impaired social support and lower levels of health-related 
behaviour. Moreover, these relationships were found to remain significant after 
controlling for neuroticism. Hence, the central focus of the two studies reported in this 
chapter was to extend our knowledge of these relationships. Experiment 6.1 
investigates the relationship between Type D personality, social support, health-
related behaviour and neuroticism, and the stability of each of these measures over 
time. Experiment 6.2 utilises further measures of social support and health-related 
behaviour in order to further our understanding of the specific nature of the 
relationship between Type D, health-related behaviour and social support. 
Methods: In Experiment 6.1, 204 healthy young adults completed measures of Type 
D personality (DS14; Denollet, 2005), social support (SNSS; Dalgard, Bjork & 
Tambs, 1995), health-related behaviour (GPHB; Amir, 1987) and neuroticism 
(EPQR-S; Eysenck, Eysenck & Barrett, 1985). One hundred and four participants 
(51% follow-up) completed the same measures approximately 12 weeks later. In 
Experiment 6.2, 211 healthy young adults completed measures of Type D personality 
(DS14; Denollet, 2005), two measures of social support (SNSS; Dalgard, Bjork & 
Tambs; MOS-SSS; Sherbourne & Stewart, 1991), three measures of health-related 
behaviour (GPHB-Brief; Amir, 1987; Weinman, Petrie, Sharpe & Walker, 2000; 
Ogden & Mtandabari, 1997), and neuroticism (EPQR-S; Eysenck, Eysenck & Barrett, 
1985). 
Findings: The prevalence of Type D personality was found to be 43.6% and 39.3% in 
Experiment 6.1 and Experiment 6.2 respectively. In addition, Type D individuals 
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reported significantly lower levels of social support in both studies, even after 
controlling for neuroticism. Experiment 6.1 also found that Type D individuals 
reported significantly fewer health-related behaviours compared to non-Type D 
individuals. However, Experiment 6.2 failed to replicate the majority of the findings 
relating to health behaviour.  In addition, the Type D construct was found to be 
reasonably stable over time, with 76.7% of the sample being classified in the same 
way across both time points. 
Discussion: The findings of both studies provide further evidence for the possible role 
of health-related behaviour and social support in explaining the link between Type D 
and adverse prognosis in cardiac patients. 
 
6.1 Introduction 
 
The findings reported in Chapter 5 (see Section 5.3.3) are suggestive of a relationship 
between Type D personality and health-related behaviour, and Type D personality and 
social support. Moreover, these relationships remained significant after controlling for 
neuroticism. These findings are important as they provide evidence of two possible 
mechanisms by which Type D may affect adverse clinical prognosis in cardiac 
patients. Given these promising findings, the current chapter describes two studies 
which sought to investigate these relationships further. 
 
The first study aims to investigate the relationship between Type D personality and 
health-related behaviour, and Type D and social support. It also investigates the 
stability of Type D personality and the other constructs over time by assessing 
participants on these measures at two time points 3-5 months apart. The second study 
utilises a number of measures of social support and health-behaviour. This was done 
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primarily to determine if the relationships between Type D and health-related 
behaviour, and Type D and social support that were established in Chapter 5 are 
robust.  Using multiple measures of social support allows us to provide more detail 
regarding the precise relationship between Type D personality and the various types 
of social support available. In addition, the multiple measures of health behaviour will 
provide a more comprehensive assessment of health-related behaviour, thus providing 
further evidence relating to the exact nature of the relationship between Type D 
personality and specific health-related behaviours. In addition, the measure of health 
behaviour used in the previous study was limited in its scope, and used a very 
simplistic scoring system which may lack sensitivity. 
 
6.1.1 Hypotheses 
The hypotheses for the current chapter are as follows; 
(i) Type D personality will be associated with lower levels of perceived social support; 
(ii) Type D personality will be associated with lower levels of health-related 
behaviour; 
(iii) these relationships will remain after controlling for the effects of neuroticism; 
(iv) Type D personality will be a stable construct over time. 
 
Experiment 6.1 
6.2 Methodology 
6.2.1 Participants and Procedure 
Participants were 204 healthy young adults (41 males, 163 females, age M=22.2 yrs, 
SD=6.97 yrs) who took part in the study for course credit. This sample was also used 
as one of the Scottish samples in Chapter 5 (section 5.2.1).  The men (M=21.05, 
SD=5.96) and women (M=22.47, SD=7.19) did not differ significantly in terms of age 
 101 
t (1, 202) = -1.17, ns. Prior to beginning the study, all participants were informed that 
participation was voluntary and confidential, and even if they agreed, they were free 
to withdraw at any stage. Ethical approval had been obtained from the University 
Psychology Department’s ethics committee. 
 
At Time 1, participants (n=204) completed a questionnaire pack including self-report 
measures of Type D personality, neuroticism, social support and health-related 
behaviour. Of this initial sample, 104 participants went on to complete the same self-
report measures again at Time 2, between 12 and 20 weeks after time 1 (M=15.2, 
SD=2.34), representing a 50.9% response rate at Time 2. Participants not completing 
the Time 2 measures did not differ significantly from those who did with regards to 
age (t (1, 202)=-0.91, ns) or gender (χ² (2, N=204)=2.94, ns). In addition, they did not 
differ on any of the time 1 measures; social support (t (1, 202) =-0.68, ns), 
neuroticism (t (1, 202)=-6.9, ns), Type D (χ² (2, N=204)=0.51, ns), or health 
behaviour; eat sensibly (χ² (2, N=204)=0.43, ns), smoking (χ² (2, N=204)=0.61, ns), 
regular exercise (χ² (2, N=204)=0.58, ns), get enough sleep (χ² (2, N=204)=0.39, ns), 
spend time outdoors (χ² (2, N=204)=0.62, ns), avoid letting things get them down (χ² 
(2, N=204)=0.57, ns), or get a regular medical check-up (χ² (2, N=204)=0.61, ns). 
 
6.2.2 Measures 
6.2.2.1 Type D Personality 
Type D Personality was assessed using the Type D Personality Scale (DS14; Denollet, 
2005). It comprises 2 subscales (see Appendix 1). A 7-item subscale which measures 
negative affectivity, and a 7-item subscale measuring social inhibition. Both subscales 
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were internally consistent in the current study (Cronbach’s α =.88 and .85 for NA and 
SI respectively). 
 
6.2.2.2 General Preventive Health Behaviours Checklist-Brief (Amir, 1987) 
Health behaviour was measured using a shortened version of the General Preventive 
Health Behaviours Checklist (GPHB; Amir, 1987) (see Appendix 14). The original 
form of this measure comprises 29 behaviours, including items drawn from the 
Alameda County study (Belloc & Breslow, 1972). This measure was shortened to 
eight items for use in the current study. Cronbach’s α for the present sample is .36 
indicating low internal consistency. However, for the purposes of the current study, 
the behaviours are not intended to be considered as a scale, but rather as separate 
items in order to examine the relationship between Type D and specific health 
behaviours.  
 
6.2.2.3 Social Support 
Social support was measured using a shortened version of the Quality of Social 
Network and Social Support Questionnaire (SNSS; Dalgard, Bjork & Tambs, 1995) 
(see Appendix 2). Cronbach’s α=.74 indicating good internal consistency in the 
current sample. 
 
6.2.2.4 Neuroticism 
This dimension was measured by using the 12-item short version of the neuroticism 
subscale of the revised Eysenck Personality Questionnaire (EPQR-S) (Eysenck, 
Eysenck & Barrett, 1985) (see Appendix 4). This measure was found to be internally 
consistent in the current study (Cronbach’s α=.80). 
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6.2.3 Statistical Analyses 
First, a MANOVA was performed to examine the differences between Type D and 
non-Type D individuals on levels of social support and neuroticism. In addition, 
cohen’s d is used to provide an index of effect size. Cohen (1988) defined effect sizes 
as small, d=.2, medium, d=.5, and large, d=.8. Second, in order to test for the 
influence of neuroticism on the relationship between Type D and social support a 
formal test of mediation was performed using Baron and Kenny’s (1986) conditions 
for mediation. Third, Chi-square analyses were performed to examine any differences 
between Type D and non-Type D individuals on health-related behaviour. In addition, 
formal tests of mediation were again computed to examine the influence of 
neuroticism on the relationship between Type D and health-related behaviour. An 
alpha level of p<0.05 is used throughout. 
 
In order to assess the stability of neuroticism and social support, correlation analyses 
were conducted. The Kappa statistic (K) and percent agreement between responses 
(the proportion of participants who were grouped the same for Time 1 and Time 2) 
was used to determine the stability of the categorical variables (Type D and health 
behaviour). The strength of agreement between responses to categorical variables 
using kappa is defined as poor to fair (0.00-0.40), moderate (0.41-0.60), substantial 
(0.61-0.80) and almost perfect (0.81-1.0) (Landis & Koch, 1977). Percent agreement 
values greater than 66% are classified as fair (Portney & Watkins, 2000). 
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6.3 Results 
6.3.1 Stability of the Measures over Time 
In order to investigate the stability of social support and neuroticism over time 
correlation analyses were conducted. It was found that Time 1 social support was 
highly correlated with Time 2 social support, r(102)=.76, p<.001. In addition, a paired 
samples t-test revealed that there was no change in social support over time t(1, 
103)=-1.08, ns.  For neuroticism, Time 1 scores were moderately correlated with 
Time 2 levels, r(102)=.65, p<.001. A paired samples t-test again revealed no 
significant change in neuroticism scores over time t(1, 103)=1.063, ns. These results 
indicate that both social support and neuroticism showed acceptable levels of stability 
over time. 
 
When assessing the stability of the Type D construct over time, it was found that 
76.7% (as shown in Table 6.1) of the sample were classified the same (either Type D 
or non-Type D) on both occasions, K=0.53, indicating substantial strength of 
agreement between classification of Type D personality at Time 1 and Time 2. For 
health behaviour, the stability of each item is considered in turn. The percentage 
agreement and kappa values are presented in Table 6.1. The percentage agreements 
ranged from 75.4% to 87.2% indicating a good level of agreement on all items. In 
addition, kappa values ranged from 0.43 to 0.67 indicating moderate to substantial 
agreement between Time 1 and Time 2. 
 
 
 
 
 105 
Table 6.1 Classification of Type D at Time 1 (T1) and Time 2 (T2) 
 
 
 
 
 
Table 6.2. Percentage agreement and kappa values for the health behaviour items 
between Time 1 and Time 2. 
 
Health 
Behaviour 
Percentage 
Agreement 
Kappa 
(K) 
Eat Sensibly 83.6% 0.54 
Avoid crossing 
the street 
against the 
traffic lights 
87.2% 0.53 
Get enough 
sleep 
82.4% 0.48 
Spend time 
outdoors 
everyday 
78.8% 0.55 
Do not smoke 
 
80.2% 0.52 
Get enough 
exercise 
87.1% 0.67 
Avoid letting 
things get me 
down 
83.7% 0.56 
Get a regular 
medical check-
up 
75.4% 0.43 
 
6.3.3 Type D Personality, Social Support and Neuroticism 
A MANOVA was carried out to examine differences between Type D and non-Type 
D individuals in their levels of social support and neuroticism at Time 1. Gender was 
also entered as a factor in the analysis. Type D individuals reported significantly 
lower levels of social support (M=11.22; SD=3.24) than non-Type D individuals 
 Type D T1 Non-Type D T1 
Type D T2 34 12 
Non-Type D T2 11 47 
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(M=13.79; SD=2.95; F(1,202)=34.84, p<.001). In addition, females reported higher 
levels of social support (M=12.95; SD=3.23) compared to males (M=11.56; SD=3.5; 
F(1,202)=8.01, p<0.05). However, there was no significant interaction between Type 
D and gender F(1,202)=0.62, ns. Cohen’s d=0.1, indicating a small effect size for 
Type D on social support. 
 
In addition, levels of neuroticism were significantly higher in the Type D participants 
(M=7.55; SD=2.72) compared to the non-Type D individuals (M=4.6; SD=2.94; F(1, 
202)=53.88, p<.001). Cohen’s d=1.04, indicating a large effect size. There was no 
effect of gender of neuroticism F(1,202)=0.06, ns).  Furthermore, ANCOVA revealed 
that the relationship between social support and Type D remained significant after 
controlling for the effects of neuroticism, with Type D individuals reporting 
significantly lower levels of social support (M=11.79; S.E=0.33) than non-Type D 
individuals (M=13.35; S.E=0.29; F(1,201)=11.23, p<.01).  
 
6.3.4 Mediation Analyses on Type D, Neuroticism and Social Support 
Formal mediation analysis was also carried out in order to determine if neuroticism 
mediates the relationship between Type D and social support at Time 1. Following the 
procedure outlined by Baron and Kenny (1996), to test for mediation, a series of 
hierarchical regressions were performed (see Chapter 5, section 5.3.3 for details on 
the conditions for mediation). 
 
Initial regression analysis showed that Type D significantly predicted neuroticism 
indicating that condition 1 for mediation was met, β=0.459, t(203)=7.34, p<.001. 
Type D was a significant predictor of social support at step 1, β=-0.384, t(203)=-
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5.902, p<.001) indicating that condition 2 for mediation was met. Condition 3 was 
met because when neuroticism entered the equation at step 2 it significantly predicted 
social support, β=-0.328, t(203)=-4.71, p<.001, and reduced the beta weight for Type 
D, β=-0.223, t(203)=-3.35, p<.01), but not to non-significance. Therefore, given that 
condition 4 was not met, partial mediation is indicated. A Sobel test confirms that 
there is a significant reduction in the relationship between Type D and social support, 
z=-3.98, p<.001. 
 
6.3.5 Type D Personality, Health-Related Behaviour and Neuroticism 
Chi-square analyses were conduced to determine the differences between Type D and 
non-Type D individuals on each of the eight health behaviours at Time 1, as presented 
in Table 6.1. It was found that Type D individuals were significantly less likely to eat 
sensibly (χ² (2, N=204)=14.77, p<.001)  compared to non-Type D individuals. In 
addition, they were significantly more likely to be smokers compared to non-Type D 
individuals (χ² (2, N=204)=4.97, p<.05). Furthermore, Type D individuals were 
significantly less likely to engage in regular exercise compared to non-Type D 
individuals (χ² (2, N=204)=3.89, p<.05). There were no significant differences 
between Type D and non-Type D individuals with regards to getting enough sleep (χ² 
(2, N=204)=.003, ns), spending time outdoors (χ² (2, N=204)=3.11, ns), avoid letting 
things get them down (χ² (2, N=204)=1.15, ns), and get a regular medical check-up (χ² 
(2, N=204)=.004, ns). 
 
 
 
 
 108 
Table 6.2 Type D personality and health-related behaviour at Time 1 
 Type D  Non-Type D    
Health 
Behaviour 
Do not do or 
sometimes 
do 
Always Do not do or 
sometimes 
do 
Always χ² p 
Eat Sensibly 81 8 79 36 14.78 <.001 
Avoid crossing 
the street 
against the 
traffic lights 
73 16 97 18 .195 ns 
Get enough 
sleep 
73 16 94 21 .003 ns 
Spend time 
outdoors 
everyday 
49 40 49 66 3.11 ns 
Do not smoke 
 
21 68 44 71 4.97 <.05 
Get enough 
exercise 
70 19 76 39 3.89 <.05 
Avoid letting 
things get me 
down 
83 6 111 4 1.15 ns 
Get a regular 
medical check-
up 
73 16 93 22 .04 ns 
 
 
6.3.5 Mediation Analyses of Type D, Neuroticism and Health-Related Behaviour at 
Time 1 
Formal mediation analyses were conducted to determine if neuroticism mediates the 
effect of Type D on health-related behaviours at time 1. Initial regression analysis 
showed that Type D significantly predicted neuroticism indicating that condition 1 for 
mediation was met, β=0.459, t(203)=7.34, p<.001. Each of the significant Type D-
health behaviour relationships is now considered in turn.  
 
For eat sensibly, Type D was a significant predictor at step 1, β=-0.269, t(203)=-
3.971, p<.001, indicating that condition 2 for mediation has been met. However, 
condition 3 for mediation was not met as neuroticism did not predict eat sensibly 
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when entered at step 2, β=-0.095, t(203)=-1.243, ns, thus indicating that neuroticism 
does not mediate the relationship between Type D and eat sensibly at Time 1. 
 
For do not smoke, Type D was a significant predictor at step 1, β=0.156, 
t(203)=2.246, p<.05, indicating that condition 2 for mediation has been met. However, 
condition 3 for mediation was not met as neuroticism did not predict do not smoke 
when entered at step 2, β=0.075, t(203)=0.959, ns, thus indicating that neuroticism 
does not mediate the relationship between Type D and do not smoke at Time 1. 
 
For get enough exercise, Type D was a significant predictor at step 1, β=-0.138, 
t(203)=-1.982, p<.05, indicating that condition 2 for mediation has been met. 
Condition 3 was met because when neuroticism entered the equation at step 2 it 
significantly predicted get enough exercise, β=-0.155, t(203)=-1.988, p<.05, and 
reduced the beta weight for Type D, β=-0.067, t(203)=-0.862, ns), to non-significance 
indicating that neuroticism fully mediates the relationship between Type D and get 
enough exercise at Time 1. A Sobel test confirms that the relationship between Type 
D and get enough exercise has been significantly reduced (z=-4.23, p<.001). 
 
6.4 Discussion 
There were three main aims in the current study. They were; (i) to investigate the 
relationship between Type D and social support, and Type D and health-related 
behaviour; (ii) to determine if these relationships remain significant after controlling 
for neuroticism, and (iii) to investigate the stability of Type D over time. 
 
 
 110 
6.4.1 Type D, Social Support and Neuroticism 
The present study also replicated the findings from Chapter 5, Section 5.3.2 and other 
studies (e.g. Denollet et al, 1996) with regards to the relationship between Type D and 
social support. It was found that Type D individuals reported significantly lower 
levels of perceived social support compared to non-Type D individuals. Again 
suggesting that impaired social support may represent one mechanism by which Type 
D leads to ill-health. In addition, the relationship between Type D and social support 
was only partially mediated by neuroticism. 
 
6.4.2 Type D, Health-Related Behaviour and Neuroticism 
Another aim of the current study was to investigate the relationship between Type D 
and health-related behaviour. It was found that Type D individuals performed 
significantly fewer health-related behaviours compared to non-Type D individuals. 
Specifically, Type D individuals were less likely to eat sensibly or take part in regular 
exercise, and were more likely to be smokers compared to non-Type D individuals. 
Moreover, the relationships between Type D and eat sensibly, and Type D and 
smoking were not mediated by neuroticism. These findings are consistent with the 
relationships between Type D and health behaviour that were reported in Chapter 5 
(Section 5.3.3) and suggest a possible mechanism to explain the link between Type D 
and adverse prognosis in cardiac patients.  
 
6.4.3 Stability of the Type D Construct 
The final aim of the current study was to determine the stability of the Type D 
construct, and the other measures being used, over time. All of the measures 
demonstrated good stability. With regards to Type D, it was found that 76.7% of the 
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sample were classified the same (either Type D or non-Type D) at both time points, 
indicating a good level of consistency over time. Indeed, as Type D personality is 
intended to reflect a stable personality trait it would be expected that the agreement 
between Time 1 and Time 2 scores would be high. Although, the percentage 
agreement score of 76.7% is high, it means that almost one quarter of the sample were 
not being classified in the same way across the two time points. If Type D personality 
does indeed reflect a stable personality trait then perhaps the level of agreement 
across the two time-points should have been higher. Moreover, these measurements 
were only taken on average 3 months apart. Pelle et al (in press) report similar 
findings on the stability of the Type D construct, with 81% of cardiac patients being 
classified the same at two time points, three months apart. It is important for future 
research to investigate the stability of the Type D construct further, over longer 
periods of time, in order to determine if Type D does reflect a stable personality trait 
or something that may be more changeable over time.  
 
6.4.4 Limitations 
There are several limitations of the current study that should be noted. First, the 
generalisability of the findings to a cardiac population is limited by the fact that the 
sample consisted of healthy young adults. Second, the length of follow-up could have 
been longer in order to investigate the consistency of the measures over a greater 
period of time. Third, the health-behaviour measure that was used is limited in its 
scope and does not provide information on the full range of possible health-related 
behaviours, e.g. alcohol consumption. The problems associated with the assessment of 
health behaviour are discussed further in Section 6.8.2. 
 
 112 
6.4.5 Conclusions and Future Research 
The current study has extended the existing evidence on Type D in several key ways. 
First, it has provided further information on the prevalence rate of Type D in the UK, 
by finding a prevalence rate of 43% in the current sample. Second, it has replicated 
the findings from Chapter 5 concerning the relationships between Type D and social 
support, and Type D and health-related behaviour. Specifically, it was found that 
Type D individuals report significantly lower levels of social support and health-
related behaviour compared to non-Type D individuals. Additionally, these 
relationships remained significant after controlling for neuroticism. Thus, a lack of 
health-related behaviour and social support may represent potential mechanisms by 
which Type D may affect health.  
 
Future research should incorporate a longer follow-up period in order to further 
investigate the consistency of the Type D and social support, and Type D and health-
related behaviour relationships over a longer period of time. In addition, it would be 
beneficial to assess participants on a wider range of health-behaviours (this has been 
done in study 2). Finally, it is important to assess these relationships prospectively 
with cardiac patients (see Chapter 8). 
      
Experiment 6.2 
The second study utilises a number of measures of social support and health-
behaviour. This was done primarily to determine if the relationships between Type D 
and health-related behaviour, and Type D and social support that were established in 
Chapter 5 are robust.  Using multiple measures of social support allows us to provide 
more detail regarding the precise relationship between Type D personality and the 
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various types of social support available. In addition, the multiple measures of health 
behaviour will provide a more comprehensive assessment of health-related behaviour, 
thus providing further evidence relating to the exact nature of the relationship between 
Type D personality and specific health-related behaviours. In addition, the measure of 
health behaviour used in the previous study was limited in its scope, and used a very 
simplistic scoring system which may lack sensitivity. 
 
6.5 Methodology 
6.5.1 Participants and Procedure 
Participants were a new sample of 211 healthy young adults (35 males, 176 females, 
age M=21.23; SD=7.67). The men (M=21.17; SD=8.56) and women (M=21.24; 
SD=7.51) did not differ significantly in terms of age t (1, 209) = -.047, ns. 
Participants were recruited via an online experiment system, they received course 
credit in return for participation. All participants were informed that their participation 
was voluntary and confidential, in addition, they were told that they could withdraw 
from the study at any stage even after giving initial consent. All participants 
completed the following self-report measures outlined in the following section. 
Participants completed the measures online. 
 
6.5.2 Measures 
6.5.2.1 Type D Personality 
Type D Personality was assessed using the Type D Personality Scale (DS14; Denollet, 
2005), which is a 14-item scale comprising of 2 subscales (see Appendix 1). A 7-item 
subscale which measures negative affectivity, and a 7-item subscale measuring social 
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inhibition. Both subscales were internally consistent in the current study (Cronbach’s 
α =.86 and .82 for NA and SI respectively). 
 
6.5.2.2 Neuroticism 
This dimension was measured by using the 12-item short version of the neuroticism 
subscale of the revised Eysenck Personality Questionnaire (EPQR-S) (Eysenck, 
Eysenck & Barrett, 1985) (see Appendix 4). This measure was found to be internally 
consistent in the current study (Cronbach’s α=.75). 
 
6.5.2.3 Social Support 
6.5.2.3.1 Quality of Social Network and Social Support Questionnaire (Dalgard, 
Bjork & Tambs, 1995) 
A shortened version of the Quality of Social Network and Social Support 
Questionnaire (SNSS; Dalgard, Bjork & Tambs, 1995) was used as a measure of 
perceived social support (see Appendix 2). Cronbach’s α=.70 indicating good internal 
consistency in the current sample. 
 
6.5.2.3.2 Medical Outcomes Study: Social Support Survey (Sherbourne & Stewart, 
1991) 
The Medical Outcomes Study: Social Support Survey (MOS-SSS; Sherbourne & 
Stewart, 1991) (see Appendix 3) is an 18-item measure which assesses four separate 
social support subscales; emotional/ informational support, tangible support, 
affectionate support, and positive social interaction. Cronbach’s α=0.94 for the overall 
scale in the current sample, indicating excellent internal consistency. Each of the 
subscales also demonstrated excellent internal consistency; Cronbach’s α=0.93; 0.93, 
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0.90, and 0.87 for emotional/informational support, tangible support, affectionate 
support, and positive social interaction respectively. 
 
6.5.2.4 Health-Related Behaviour 
6.5.2.4.1 General Preventive Health Behaviours Checklist-Brief (Amir, 1987) 
Health behaviour was measured using a shortened version of the General Preventive 
Health Behaviours Checklist (GPHB; Amir, 1987) (see Appendix 14). The original 
form of this measure comprises 29 behaviours, including items drawn from the 
Alameda County study (Belloc & Breslow, 1972). This measure was shortened to 
eight items for use in the current study. Cronbach’s α for the present sample is .34 
indicating low internal consistency. However, for the purposes of the current study, 
the behaviours are not intended to be considered as a scale, but rather as separate 
items in order to examine the relationship between Type D and specific health 
behaviours.  
 
6.5.2.4.2 Health Behaviour Scale- Weinman, Petrie, Sharpe & Walker (2000)  
This Health Behaviour Scale (see Appendix 15) was used in Weinman, Petrie, Sharpe 
& Walker’s (2000) study which examined causal attributions in first-time MI patients, 
and is designed to assess health behaviour over an average week. It is an 11-item scale 
reflecting a range of health behaviours. Internal consistency is not reported for this 
measure as it is not to be considered as a scale. 
 
6.5.2.4.3 Health Related Behaviours – Ogden & Mtandabari (1997) 
The health related behaviours measure (see Appendix 16) was developed by Ogden & 
Mtandabari (1997) in their study of examination stress and changes in mood and 
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health related behaviours. Participants are required to complete questions about five 
health related behaviours; smoking, alcohol consumption, eating behaviour, exercise, 
and sleep. Again, internal consistency is not reported as the items are not considered 
to be a scale. 
 
6.5.3 Statistical Analyses 
First, a MANOVA was performed to examine the differences between Type D and 
non-Type D individuals on levels of social support and neuroticism. An alpha level of 
p<0.05 is used throughout. In addition, cohen’s d is used to provide an index of effect 
size. Cohen (1988) defined effect sizes as small, d=.2, medium, d=.5, and large, d=.8.  
Second, in order to test for the influence of neuroticism on the relationship between 
Type D and social support a formal test of mediation was performed using Baron and 
Kenny’s (1986) conditions for mediation. Third, chi-square analyses were performed 
to examine any differences between Type D and non-Type D individuals on health-
related behaviour. In addition, formal tests of mediation were again computed to 
examine the influence of neuroticism on the relationship between Type D and health-
related behaviour. 
 
6.6 Results 
6.6.1 Type D Personality, Social Support and Neuroticism 
A MANOVA was carried out to examine the differences between Type D and non-
Type D individuals in their levels of social support and neuroticism. In addition, 
gender was included as a factor in the analysis. Type D individuals reported 
significantly higher levels of neuroticism (M=8.06; SD=2.27) compared to non-Type 
D individuals (M=4.5; SD=2.86; F(1, 209)=91.44, p<.001), and there was also an 
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effect of gender on neuroticism, with females (M=6.11, SD=3.1) reporting 
significantly higher levels of neuroticism compared to males (M=4.86; SD=3.28 F(1, 
209)=7.49, p<.01.) However, there was no interaction between Type D and gender 
F(1, 209)=0.84, ns. Cohen’s d=1.4 indicating a large effect size for the effect of Type 
D on neuroticism. 
 
In addition, Type D participants reported lower levels of perceived social support 
(M=11.11; SD=3.07), as assessed by the SNSS, compared to non-Type D participants 
(M=13.62; SD=2.87; F(1,209)=36.34, p<.001). Cohen’s d=0.84 indicating a large 
effect size. There was no effect of gender on social support as assessed by the SNSS 
F(1,209)=0.01, ns. Furthermore, Type D individuals reported lower levels of social 
support (M=3.74; SD=0.76), as assessed by the MOS-SSS, compared to non-Type D 
individuals (M=4.1; SD=0.66; F(1, 209)=13.15, p<.001), cohen’s d=0.5 indicating a 
medium effect size. Again, there was no effect of gender on social support 
F(1,209)=1.05, ns. In addition, on closer examination of the MOS-SSS subscales, it 
was found that Type D individuals (M=3.64; SD=0.86) reported significantly lower 
levels of emotional/informational support compared to non-Type D individuals 
(M=4.02; SD=0.78; F(1, 209)=11.46, p<.01, cohen’s d=0.46 indicating a medium 
effect size. Type D individuals (M=3.68, SD=1.08) reported significantly less tangible 
support than non-Type D individuals (M=4.07; SD=0.96; F(1, 209)=7.43, p<.01), 
cohen’s d=0.38 indicating a small to medium effect size. In addition, Type D 
participants (M=3.79; 1.08) reported lower levels of affectionate support compared to 
non-Type D participants (M=4.23; 0.95; F(1, 209)=9.388, p<.01), cohen’s d=0.43 
indicating a medium effect size. However, there were no significant differences 
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between Type D (M=4.01; SD=0.66) and non-Type D individuals on reported positive 
social interaction (M=4.18; SD=0.71; F(1, 209)=2.472, ns). 
 
A series of MANCOVA were then computed to determine if the relationships 
between Type D and social support remained significant after controlling for 
neuroticism. It was found that the relationship observed between Type D and social 
support (as measured by the SNSS), remained significant after controlling for 
neuroticism with Type D individuals (M=11.67; S.E=0.36) reporting significantly less 
perceived social support compared to non-Type D individuals (M=13.25; S.E=0.28; 
F(1, 208)=10.63, p<.01). Type D individuals (M=3.78; S.E=0.09) also reported 
significantly less social support (as assessed by the MOS-SSS), compared to non-
Type D individuals (M=4.08; S.E=0.07; F(1, 208)=6.41, p<.05) after controlling for 
neuroticism. Furthermore, on examination of the sub-scales of the MOS-SSS, it was 
found that the Type D participants (M=3.66; S.E=0.1) reported significantly less 
emotional/informational support compared to non-Type D’s (M=4.0; S.E=0.08; F(1, 
208)=6.62, p<.05) after controlling for neuroticism. Type D individuals (M=3.66; 
S.E=0.13) also reported significantly less tangible social support compared to non-
Type D’s (M=4.09; S.E=0.09; F(1, 208)=6.5, p<.05) in the presence of neuroticism. 
However, there were no significant differences between Type D participants (M=3.7; 
S.E=0.13) and non-Type D participants (M=4.09; S.E=0.97; F(1, 208)=2.91, ns) in 
affectionate support after controlling for neuroticism. 
 
6.6.2 Mediation Analysis for Type D, Social Support and Neuroticism 
Formal mediation analysis was also carried out to determine if neuroticism mediates 
any of the relationships observed between Type D and social support. Initial 
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regression analysis showed that Type D significantly predicted neuroticism indicating 
that condition 1 for mediation was met, β=0.552, t(210)=9.56, p<.001. Each of the 
significant Type D-social support relationships is now considered in turn. 
 
For perceived social support (as assessed by the SNSS), Type D was a significant 
predictor at step 1, β=-0.385, t(210)=-6.03, p<.001, indicating that condition 2 for 
mediation has been met. Neuroticism then entered the equation at step 2 significantly 
predicting perceived social support, β=-0.257, t(210)=-3.44, p<.01 and reducing the 
beta weight for Type D to β=-0.243, t(210)=-3.26, p<.01 indicating that condition 3 
for mediation was met. As the relationship between Type D and perceived social 
support was not reduced to non-significance, condition 4 for mediation was not met, 
indicating that partial mediation has occurred. A Sobel test confirmed that relationship 
between Type D and social support was reduced, z=-3.25, p<.01. 
 
For social support (as assessed by the overall score on the MOS-SSS), Type D was a 
significant predictor at step 1, β=-0.243, t(210)=-3.62, p<.001, indicating that 
condition 2 for mediation has been met. However, condition 3 for mediation was not 
met as neuroticism did not predict social support when entered at step 2, β=-0.072, 
t(210)=-0.89, ns, thus indicating that neuroticism does not mediate the relationship 
between Type D and social support. For emotional/informational support, Type D was 
a significant predictor at step 1, β=-0.228, t(210)=-3.39, p<.01, indicating that 
condition 2 for mediation has been met. However, condition 3 for mediation was not 
met as neuroticism did not predict emotional/informational social support when 
entered at step 2, β=-0.036, t(210)=-0.45, ns, thus indicating that neuroticism does not 
mediate the relationship between Type D and emotional/informational social support. 
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For tangible social support, condition 2 for mediation was met as Type D is a 
significant predictor at step 1, β=-0.389, t(210)=-2.73, p<.01. However, again 
neuroticism was not a significant predictor at step 2, β=0.042, t(210)=0.59, ns, 
therefore condition 3 for mediation was not met indicating that neuroticism does 
mediate the Type D-tangible social support relationship. Finally, for affectionate 
support, Type D was a significant predictor at step 1, β=-0.207, t(210)=-3.06, p<.01, 
indicating that condition 2 for mediation has been met. However, neuroticism was not 
a significant predictor of affectionate support when entered at step 2, β=-0.126, 
t(210)=-1.56, ns, therefore condition 3 for mediation was not met, indicating that 
neuroticism does not mediate the relationship between Type D and affectionate social 
support. 
 
6.6.3 Type D Personality and Health-Related Behaviour 
The first measure of health behaviour to be considered is the GPHB. Chi-square 
analysis was performed in order to investigate the differences between Type D and 
non-Type D individuals on each of the eight health behaviours of this scale. Type D 
individuals were found to be significantly more likely to smoke compared to non-
Type D individuals (χ² (2, N=211)=4.27, p<.05). In addition, Type D individuals were 
significantly less likely to avoid letting things get them down compared to non-Type 
D individuals (χ² (2, N=211)=22.78, p<.001). However, there were no significant 
differences between Type D and non-Type D individuals on any of the other health-
behaviours; eat sensibly (χ² (2, N=211)=0.8, ns), avoid crossing the street against the 
traffic lights (χ² (2, N=211)=0.343, ns), get enough sleep (χ² (2, N=211)=1.37, ns), 
spend time outdoors (χ² (2, N=211)=2.19, ns), get enough exercise (χ² (2, 
N=211)=0.71, ns), and get a regular medical check-up (χ² (2, N=211)=2.33, ns). 
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Table 6.3 Type D personality and health-related behaviour (GPHB) 
 Type D  Non-Type D    
Health 
Behaviour 
Do not do or 
sometimes 
do 
Always Do not do or 
sometimes 
do 
Always χ² p 
Eat Sensibly 55 28 77 51 .80 ns 
Avoid crossing 
the street 
against the 
traffic lights 
67 16 99 29 .34 ns 
Get enough 
sleep 
59 24 81 47 1.37 ns 
Spend time 
outdoors 
everyday 
39 44 47 81 2.20 ns 
Do not smoke 
 
21 62 50 78 4.72 p<.05 
Get enough 
exercise 
67 16 97 31 .71 ns 
Avoid letting 
things get me 
down 
80 3 89 39 22.78 <.001 
Get a regular 
medical check-
up 
76 7 108 20 2.33 ns 
 
Formal mediation analyses were performed to determine the influence of neuroticism 
on the relationship between Type D and smoking behaviour, and Type D and avoid 
letting things get me down. For smoking, Type D was a significant predictor at step 1, 
β=.142, t(210)=2.08, p<.05, indicating that condition 2 for mediation has been met. 
However, condition 3 for mediation was not met as neuroticism did not predict 
smoking when entered at step 2, β=0.042, t(210)=0.515, ns, thus indicating that 
neuroticism does not mediate the relationship between Type D and smoking 
behaviour. For avoid letting things get them down, condition 2 for mediation was met 
as Type D is a significant predictor at step 1, β=-0.329, t(210)=-5.029, p<.001. 
Neuroticism then entered the equation at step 2 significantly predicting avoid letting 
things get them down, β=-0.426, t(210)=-5.853, p<.001 and reducing the beta weight 
for Type D to β=-0.094, t(210)=-1.287, ns indicating that condition 3 for mediation 
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was met. As the beta weight for Type D was reduced to non-significance it was found 
that neuroticism fully mediates the relationship between Type D and avoid letting 
things get them down. Sobel test confirmed that the relationship between Type D and 
avoid letting things get them down had been significantly reduced (z=-1.29, p<.05). 
 
The second measure of health-related behaviour to be considered is Weinman, Petrie, 
Walker & Sharpe’s (2000) measure. A MANOVA was performed to examine the 
differences between Type D and non-Type D individuals on each of the health 
behaviours in the scale (as shown in Table 6.4). It was found that Type D individuals 
(M=3.08; SD=1.27) were significantly less likely to get 7-8 hours sleep each night 
compared to non-Type D individuals (M=3.68; SD=1.28; F(1, 209)=10.96, p<.01). 
However, there were no differences between the Type D individuals and non-Type D 
individuals on any of the remaining health behaviours as shown in Table 6.4. A 
formal test of mediation was performed to test the influence of neuroticism on the 
relationship between Type D and getting 7-8 hours sleep each night. Type D was a 
significant predictor at step 1, β=-0.223, t(210)=-3.31, p<.01, indicating that 
condition 2 for mediation has been met. Neuroticism then entered the equation at step 
2 significantly predicting getting 7-8 hours sleep, β=-0.171, t(210)=-2.13, p<.05, 
reducing the beta weight for Type D to non-significance β=-0.129, t(210)=-1.61, ns 
indicating that condition 3 for mediation was met and that neuroticism fully mediates 
the relationship between Type D and getting 7-8 hours sleep each night. Sobel test 
confirmed that the relationship between Type D and getting 7-8 hours sleep each 
night has been reduced (z=-2.03, p<.05). 
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Table 6.4 Type D Personality and Health-related Behaviour (Weinman, Petrie, 
Walker & Sharpe, 2000) 
 Type D  Non-Type D    
Health 
Behaviour 
Mean SD Mean  SD F p 
Exercise 2.83 1.26 2.93 1.22 .32 ns 
Take vitamins 1.47 2.0 1.59 2.17 .15 ns 
Take 
alternative 
remedies 
.55 1.33 .71 1.31 .65 ns 
Eat 5+ fruit & 
veg daily 
2.58 1.22 2.67 1.44 .28 ns 
Eat breakfast 3.72 1.43 3.63 1.59 .21 ns 
Eat fried food 3.24 .92 3.05 1.01 1.99 ns 
Drink alcohol 2.69 1.1 2.57 1.24 .48 ns 
Get 7-8 hours 
sleep 
3.08 1.27 3.68 1.28 10.96 p<.01 
 
The third measure of health-related behaviour to be considered is Ogden & 
Mtandabari’s (1997) measure. Each of the five domains of behaviour (smoking, 
alcohol, eating, sleeping and exercise) will be considered in turn. For smoking 
behaviour, chi-square analysis showed that there were no significant differences 
between Type D and non-Type D individuals on whether they ever smoked (χ² (2, 
N=211)=.306, ns). In addition, a MANOVA revealed that there were no differences 
between Type D individuals [day: (M=0.92; SD=3.27), week: (M=5.5; SD=20.59)] 
and non-Type D individuals on how many cigarettes they smoked each day or each 
week [day: (M=1.56; SD=3.95; F(1, 209)=1.54, ns), week (M=10.36; SD=26.44; F(1, 
209)=2.01, ns)]. In addition, there were no significant differences between the Type D 
participants (M=.227; SD=0.91) and non-Type D participants in cigarette craving 
(M=0.55; SD=1.17; F(1, 209)=3.16, ns). 
 
 124 
For alcohol consumption, chi-square analysis revealed no significant differences 
between Type D and non-Type D individuals on whether they ever drank alcohol (χ² 
(2, N=211)=.352, ns). In addition, a MANOVA revealed that there were no 
differences between Type D individuals [day: (M=1.06; SD=1.19), week: (M=8.26; 
SD=7.8)] and non-Type D individuals on how many alcoholic drinks they had each 
day or each week [day: (M=1.31; SD=1.56; F(1, 209)=1.50, ns), week (M=9.22; 
SD=10.26; F(1, 209)=.530, ns)]. In addition, there were no significant differences 
between the Type D participants (M=1.54; SD=0.77) and non-Type D participants in 
craving alcohol (M=1.38; SD=0.69; F(1, 209)=1.41, ns). 
 
For sleeping behaviour, ANOVA revealed that Type D individuals (M=6.84; SD=1.43) 
slept for significantly fewer hours each night compared to non-Type D individuals 
(M=7.61; SD=2.42; F(1, 209)=6.79, p<.01). Formal mediation analysis was therefore 
calculated to determine the influence of neuroticism on the relationship between Type 
D and hours slept each night. Type D was a significant predictor at step 1, β=-1.74, 
t(210)=-2.56, p<.05, indicating that condition 2 for mediation has been met.  However, 
condition 3 for mediation was not met as Neuroticism did not predict hours slept 
when entered at step 2, β=-).001, t(210)=-0.018, ns, thus indicating that neuroticism 
does not mediate the relationship between Type D and hours slept each night.  
 
For exercising behaviour, ANOVA showed that there were no significant differences 
in hours spent exercising each week for Type D participants (M=3.57; SD=3.6) 
compared to non-Type D participants (M=4.62; SD=4.97; F(1, 209)=2.73, ns). 
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For eating behaviour, a MANOVA revealed that Type D individuals (M=3.21; 
SD=2.67) were significantly less likely to have time to eat compared to non-Type D 
individuals (M=2.51; SD=2.44; F(1, 209)=3.95, p<.05). Mediation analysis was then 
performed to determine the influence of neuroticism on the observed relationship 
between Type D and having time to eat. Condition 2 for mediation was not met as 
neuroticism is not a significant predictor of time to eat at step 1, β=0.132, 
t(210)=1.926, ns. 
 
 There were no significant differences between Type D (M=5.06; SD=2.69) and non 
Type D participants on when I work I eat snacks (M=5.11; SD=2.59; F(1, 209)=.018, 
ns). In addition, there were no significant differences between Type D (M=4.84; 
SD=2.66) and non-Type D individuals (M=4.81; SD=2.96; F(1, 209)=.006, ns) on 
when I’m tired I eat sweet foods. There were also no significant differences between 
Type D (M=5.76; SD=2.77) and non-Type D individuals (M=5.0; SD=3.07; F(1, 
209)=3.25, ns)  on I have breaks from work by eating. Furthermore, there were no 
significant differences between Type D (M=3.69; SD=2.68) and non-Type D (M=3.32; 
SD=2.71; F(1, 209)=0.88, ns)  individuals on I have been eating all the time. In 
addition, there were no significant differences between Type D (M=3.69; SD=2.41) 
and non-Type D individuals (M=3.37; SD=2.53; F(1, 209)=0.835, ns) on I have been 
hungry all the time. There were also no significant differences between Type D 
(M=4.21; SD=2.94) and non-Type D individuals (M=3.67; SD=3.0; F(1, 209)=1.14, 
ns) on I have eaten a lot of chocolate. Finally, there were no significant differences 
between Type D (M=5.4; SD=3.07) and non-Type D individuals (M=5.86; SD=3.11; 
F(1, 209)=1.12, ns) on I have cooked myself a lot of meals. 
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6.7 Discussion 
The current study had four main aims. They were, (i) to further investigate the 
relationship between Type D personality and social support by using two measures of 
perceived social support; (ii) to investigate more comprehensively the relationship 
between Type D personality and health-related behaviour by utilising three measures 
of health-related behaviour, and (iii) to determine if these relationships remain 
significant after controlling for neuroticism. 
 
6.7.1 Type D Personality, Social Support and Neuroticism 
The current study has again identified a relationship between Type D personality and 
social support. Results from both measures of social support used in the current study 
demonstrate that Type D individuals have lower levels of perceived social support 
compared to non-Type D individuals. More specifically, findings from the MOS-SSS 
show that Type D individuals experience lower perceived social support across a 
variety of domains (emotional/informational, tangible and affectionate) compared to 
non-Type D individuals. Thus, these findings add important clarity regarding the 
nature of the relationship between Type D and social support. In addition, the current 
findings replicate those in Chapter 5 and Study 1 of the current chapter which also 
found evidence that Type D individuals report lower levels of social support. 
Furthermore, it was again found in the current study that the relationship between 
Type D and social support cannot be explained by the presence of neuroticism. 
 
6.7.2 Type D Personality, Health-Related Behaviour and Neuroticism 
The findings from the current study regarding the relationship between Type D and 
health-related behaviour are less consistent. Three measures of health-related 
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behaviour were used in order to establish the nature of the relationship between Type 
D and a wide range of specific health-related behaviours. Findings from Chapter 5 
(Section 5.3.3) and from Study 1 in the current chapter had identified that Type D 
individuals were less likely to perform a number of health-related behaviours, 
including, eating sensibly and engaging in regular exercise.  
 
However, the current study failed to replicate the majority of these findings. Indeed, 
very few relationships between Type D and health-related behaviour were established. 
On the GPHB, Type D individuals were found to be significantly more likely to be 
smokers and were significantly less likely to avoid letting things get them down. 
Using Weinman et al’s (2000) measure Type D individuals were found to be 
significantly less likely to get 7-8 hours sleep each night. Finally, using Ogden and 
Mtandabari’s measure, Type D individuals were found to get significantly fewer 
hours sleep each night compared to non-Type D individuals. In addition, neuroticism 
was found to fully mediate 2 out of 4 of these relationships. Again, these inconsistent 
findings suggest that the self-report measurement of health-related behaviour is 
problematic. For example, the GPHB found a significant relationship between Type D 
and smoking behaviour, but this was not replicated on either of the other measures 
which also assessed smoking behaviour. Problems surrounding assessment of health 
behaviour are described further in Section 6.8.2. 
 
6.7.3 Limitations 
Limitations of the current study are as follows. First, the study is limited by the use of 
health-related behaviours measures which provide disparate findings on the same 
behaviours; the validity of such questionnaires is therefore questionable. In addition, 
 128 
the generalisability of the findings to a cardiac population is limited by the fact that 
the sample consisted of healthy young adults. 
 
6.7.4 Conclusions and Future Research 
Existing evidence on Type D personality has been in extended in the current study. 
The Type D prevalence rate was established to be 39%, replicating the finding of the 
prevalence study reported in Chapter 5.The current study has also provided further 
evidence regarding possible mechanisms by which Type D may affect health. First, it 
has provided further confirmatory evidence on the relationship between Type D and 
social support, again suggesting that Type D individuals experience lower levels of 
social support compared to non-Type D individuals. The current study also identified 
significant relationships between Type D and several health-related behaviours, 
including smoking, sleeping and avoiding letting things get them down. However, the 
number of behaviours consistently emerging as significant is more limited that had 
been anticipated which may be due to problems with the assessment of health-related 
behaviour generally. In summary, the evidence suggests that social support may 
represent a potential mechanism by which Type D may affect health. However, the 
evidence regarding the role of health related behaviour as a mechanism is less 
consistent and robust. 
 
Future research should assess these relationships prospectively with cardiac patients. 
In addition, in order to overcome difficulties with the retrospective self-report 
assessment of health-related behaviour using questionnaire methods, it may be 
advantageous to use a diary measure of health behaviour, which requires participants 
to keep a daily record of the behaviours that they engage in. 
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6.8 General Discussion 
 
The results described in the current chapter make a substantial contribution to the 
understanding of the mechanisms by which Type D may affect health. In addition, the 
studies provide further evidence on the prevalence of Type D personality in the UK. 
With regards to Type D prevalence, when compared to studies carried out elsewhere 
in Europe (e.g. Denollet et al, 2005), the rates established here of 43.6% and 39.3% 
for study 1 and study 2 respectively, are significantly higher. In addition, these 
findings are in line with the prevalence rate of 39% that was established in the UK 
and Ireland prevalence study presented in Chapter 5. Thus, the evidence clearly points 
to a higher rate of Type D personality in the UK compared to other European 
countries. 
 
The current findings on potential mechanisms, taken together with Denollet and 
colleagues’ work, suggest that social support and health-related behaviour are two 
possible mechanisms by which Type D personality may lead to adverse prognosis in 
cardiac patients. Specifically, with regards to social support, Denollet et al (1996) 
found that Type D personality was associated with social inhibition in cardiac patients. 
The findings from the current study, taken in conjunction with the findings from 
Chapter 5 clearly support this earlier work by Denollet and colleagues by establishing 
an association with Type D and low levels of perceived social support. 
 
The current studies also add to the evidence for behavioural mechanisms linking Type 
D and adverse prognosis. Previous research by Pedersen et al (2004) found that Type 
D individuals were more likely to be smokers compared to non-Type D individuals, 
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therefore, the current finding that Type D individuals engage in fewer health-related 
behaviours adds further evidence for the role of health behaviour as a possible 
mechanism linking Type D and ill-health. Although the results observed in the current 
studies are less consistent than the findings of Chapter 5, they are suggestive of a 
relationship between Type D and health-related behaviour. 
 
6.8.1 Limitations 
It is important to acknowledge the limitations of the current studies. First, the 
generalisability of both studies to a cardiac population is limited as the current studies 
were carried out with healthy young adults. Second, the studies are limited by the 
measures of health-related behaviours that were used; these problems are particularly 
evident in the second study in which the validity of the measures is questionable due 
to differing results on the same behaviours. Third, although Study 1 has added 
important information concerning the consistency over time of the relationships 
between Type D and social support, and Type D and health-related behaviour, it is 
important to incorporate longer follow-up periods in future studies. 
 
6.8.2 Problems in Assessing Health Behaviour 
As mentioned earlier, the findings related to Type D and health-behaviour is limited 
by the measures of health behaviour that were used. Indeed, it is important to question 
whether retrospective self-report questionnaires are a reliable way to assess health 
behaviour. When selecting the measures for inclusion in these studies it proved 
extremely difficult to find a recognised measure of health behaviour. Remarkably, 
there exists little or no reliability and validity data on such measures. Furthermore, 
many of these questionnaires utilise a yes/no scoring response which may not be 
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suitable for assessing something as complex as behaviour. The lack of reliable, well-
validated measures of health behaviour represents a major problem for the field of 
Health Psychology as a whole. Future research is urgently required which investigates 
the reliability and validity of measures of health-behaviour, and different scoring 
systems that may be used. 
 
6.8.3 Conclusions 
To conclude, the results outlined in this chapter have provided strong evidence in 
support of social support and inconsistent evidence regarding health-related behaviour 
as two potential mechanisms by which Type D may affect health. In addition, the 
Type D prevalence rate was again found to be significantly higher than that observed 
in other countries. 
 
The following chapter again focuses on identifying potential mechanisms by which 
Type D may affect health. In addition to the psychosocial mechanisms described in 
the current chapter it is also possible that Type D may have a deleterious affect on 
health through psychophysiological mechanisms, specifically via cardiovascular 
reactivity. The study described in the following chapter will therefore investigate the 
relationship between Type D personality and cardiovascular reactivity to stress. 
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Chapter 7: Type D Personality and Cardiovascular Reactivity to 
Stress 
7.0 Abstract 
Objectives: The purpose of the current study is to examine one possible 
psychophysiological mechanism that may explain the link between Type D 
personality and adverse prognosis. It was predicted that, (a) Type D individuals may 
experience increased cardiovascular reactivity to stress, and (b) Type D individuals 
will experience higher subjective feelings of stress compared to non-Type D 
individuals  
 
Methods: Eighty four healthy young adults participated, (42 males, 42 females, mean 
age 22 years) who were either high or low Type D (screened from a larger sample of 
415 participants). Participants completed a number of psychological measures (Type 
D personality, health behaviour, social support, neuroticism and stress arousal) and a 
stress inducing procedure involving a demanding mental arithmetic task. Blood 
pressure, heart rate, cardiac output and peripheral resistance were recorded throughout 
the experiment.  
 
Results: Repeated measures ANOVA showed a significant group by time effect of 
Type D on cardiac output in male participants. Type D males exhibit significantly 
higher cardiac output during the stressor phase compared to non-Type D males. In 
addition, Type D individuals exhibited significantly higher feeling of subjective stress 
on the stress arousal checklist compared to non-Type D’s. 
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Conclusions: The findings suggest that one way in which Type D may affect health 
in males is through increased cardiac output during stress. However, future studies are 
required to investigate this and other potential mechanisms within cardiac patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
______________________________ 
A paper based on this chapter is in press in Psychology and Health: 
Williams, L., O’Carroll, R.E. & O’Connor, R.C. (in press). Type D Personality and cardiac output in 
response to stress. Psychology and Health. 
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7.1 Introduction 
As outlined in chapter 2, and shown in Figure 7.1 there are a number of possible 
mechanisms by which Type D may affect health. The studies described in chapters 5 
and 6 have demonstrated that Type D is associated with health-related behaviours and 
social support, thus suggesting possible psychosocial mechanisms by which Type D 
may lead to adverse clinical outcome in cardiac patients. The purpose of the current 
chapter is to present a study which aimed to investigate a possible 
psychophysiological mechanism by which Type D may affect health. Specifically, the 
study investigates the association between Type D personality and cardiovascular 
reactivity to stress.  
 
 
Figure 7.1 Potential mechanisms linking Type D personality with adverse clinical 
outcome, adapted from Pedersen & Denollet (2006). 
Type D 
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It has been repeatedly demonstrated that stress has a negative effect on the 
cardiovascular system (Brotman, Golden & Wittstein, 2007). Research has 
demonstrated that acute physical stressors, such as, surgery, trauma and intense 
physical exertion are triggers of cardiovascular events. In addition, the role of 
emotional stressors as precipitants to cardiovascular events is increasingly been 
recognised (Brotman, Golden & Wittstein, 2007). For example, the risk of having a 
myocardial infarction is two times higher in the short period after an anger outburst 
compared to other periods (Strike et al, 2006). Indeed, emotional stress has been 
identified as a more common precipitant of acute infarction than physical exertion 
(Tofler et al, 1990). 
 
Recent research on cardiovascular responses to stress has focussed on the reactivity 
hypothesis. The hypothesis suggests that exaggerated blood pressure and heart rate 
responses to stress can damage the cardiovascular system and may consequently lead 
these individuals to be at greater risk for the development of cardiovascular disease 
(Krantz & Manuck, 1984). Therefore, it is possible that Type D personality may have 
its effects on health through a direct psychophysiological mechanism. Specifically, 
the mechanism linking Type D to CHD may be that Type D individuals have a higher 
cardiovascular reactivity (CVR) in stressful situations compared to non-Type D 
individuals which in turn leads to the development of CHD.              
                                                                                                                                                                                                                     
7.1.1 Definition of Cardiovascular Reactivity 
CVR reflects the physiological changes from a resting or baseline state to some type 
of psychological or physical challenge or stressor (Manuck et al., 1989). It is widely 
thought that individuals showing exaggerated cardiovascular responses to these 
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stressful conditions may be more at risk for the development of cardiovascular 
syndromes such as hypertension or coronary heart disease than those exhibiting 
relatively smaller responses (Manuck & Krantz, 1986). 
 
Early theories concerning reactivity postulated that CVR was a risk factor for the 
development of future hypertension or CHD as opposed to being a direct causal factor 
in its development. However, more recently CVR has been identified as a causal 
factor in the development of both hypertension and CHD (Gerin et al, 2000). In 
hypertension, reactivity is thought to lead to increased peripheral resistance, which 
contributes to elevated blood pressure over time (Manuck, Kasprowicz & Muldoon, 
1990). Hyperreactivity could lead to heart disease by causing injury to the endothelial 
lining of the arteries, thereby promoting the accumulation of plaque, which, over time 
can lead to acute events such as thrombosis or ischemia (Manuck, 1994). 
 
7.1.2 Cardiovascular Reactivity and the Development of Cardiovascular Risk 
A number of studies have examined the link between cardiovascular reactivity and the 
development of CHD. A recent review carried out by Treiber and colleagues (2003) 
examined the evidence linking cardiovascular reactivity to preclinical and clinical 
disease states. They found that three large epidemiological studies with follow-up 
periods of 20 years or more reported that blood pressure responses to the cold pressor 
test (this task involves placing a hand or forearm in cold water) were predictive of 
subsequent essential hypertension in initially normotensive participants (Wood et al, 
1984; Menkes et al, 1989; Kasagi, 1995). In addition, a recent 9-12 year follow-up 
study by Tuomisto et al (2005) found that systolic blood pressure observed during 
psychological tasks predicted future systolic blood pressure level and that diastolic 
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blood pressure reactivity to active stressors improves the prediction of the need for 
antihypertensive medication. 
 
7.1.3 Experimental Stressors 
Research in the area of CVR has relied heavily on the use of laboratory stressors to 
invoke responses in individuals. Standardised mental stressors such as mental 
arithmetic tasks or public speaking provide a controlled way in which to examine the 
effect of mental stress on physiological variables. However, there are a number of 
problems associated with the use of such tasks which has resulted in the ecological 
validity of their use being questioned.  
 
It is argued that CVR results obtained in the laboratory may not be generalizable to 
stressful experiences in everyday life (Kamarck & Lovallo, 2003). Indeed, Schwartz 
et al. (2003) suggest that there is little evidence that cardiovascular responses 
observed in the laboratory predict heart rate and blood pressure responses occurring in 
the real world. Studies (e.g. Pickering & Gerin, 1990; Manuck, et al, 1990) which 
have investigated the issue of generalizability have assessed subjects undergoing 
reactivity testing in the laboratory and then monitored their ambulatory blood pressure 
and heart rate during their normal activities. These studies have found only small 
associations. However, the inclusion of recovery responses and appropriate task 
selection improves the generalizability of experimental stressors. Also, more recently, 
Johnston, Tuomisto & Patching (in press) have demonstrated that reactivity in the lab 
predicts reactivity to stressors in real life. 
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7.1.4 Consistency of Cardiovascular Reactivity 
An important aspect of the reactivity hypothesis is whether stress-related CVR 
exhibited by individuals is consistent across time. Indeed, reactivity has been 
described as a psychophysiological trait. In order for this to be the case, an 
individual’s reactivity should be consistent across time and under different stimulus 
conditions. However, responses are usually assessed with a single stimulus presented 
on one occasion (Manuck, 1994). Studies investigating inter-task correlations for 
common stressor tasks such as mental arithmetic or the cold pressor task average 
between .40 to .50. In addition, retest correlations for heart rate and blood pressure are 
moderate (Manuck et al, 1989).   
  
7.1.5 Cardiovascular Recovery 
The majority of research on CVR has examined acute cardiovascular responses during 
a stressor, however, more recently attention has also turned to examine the recovery 
period following the stressor, i.e. focussing on how long it takes for an individual to 
return to their baseline levels following a stressor. Several studies have suggested that 
the length of time blood pressure and heart rate is elevated in addition to the initial 
peak reaction to the stressor may contribute to cardiovascular illness (Gerin & 
Pickering, 1995). For example, it is expected that individuals who take longer to 
recover from a stressor would be more likely to develop hypertension or 
atherosclerosis. A study by Borghi et al. (1986) found blood pressure carry-over was a 
strong predictor of future stable hypertension in a sample of borderline hypertensives 
and that carryover was a more useful predictor than reactivity. Therefore this study 
will investigate both acute responses to the stressor and responses during a post-
stressor recovery time.  
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7.1.6 Type D Personality and Psychophysiological Mechanisms 
7.1.6.1 Type D Personality and Immune Activation 
Research that has sought to explain the link between Type D and ill-health through 
pathophysiological mechanisms has met with some success. In a preliminary study of 
42 men with chronic heart failure, Denollet et al (2003) identified that Type D was a 
significant predictor of increased circulating levels of pro-inflammatory cytokine 
tumour necrosis factor (TNF-α), a factor associated with the pathogenisis of chronic 
heart failure (CHF). Although these results are based on a small cross-sectional 
sample, they do provide suggestive evidence for a link between Type D and immune 
activation, suggesting that Type D personality may be linked to the 
psychoneuroimmunological aspects of heart failure. More recently, Conraads et al 
(2006) found an association between Type D and increased circulating levels of TNF-
α in a larger sample of CHF patients. These findings suggest that as well as 
attempting to uncover potential indirect mechanisms to explain the link between Type 
D and CHD (e.g. social support and health behaviours) it is also important to 
investigate further possible pathophysiological mechanisms such as CVR.  
 
7.1.6.2 Type D Personality and HPA Axis Function 
Recently, Whitehead et al (2007) investigated a further biological pathway by which 
Type D may affect prognosis. They assessed cortisol output in 72 patients who had 
recently suffered from acute coronary syndrome (ACS). Patients with Type D 
personality showed significantly higher cortisol awakening responses, independent of 
demographic and clinical factors and depression. This finding suggests that Type D 
may be associated with disruption of HPA axis function. Changes in HPA axis 
function may play a role in the pathogenesis of CHD (Girod & Brotman, 2004). 
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7.1.6.2 Type D Personality and Cardiovascular Reactivity 
Habra et al., (2003) sought to investigate, for the first time, if there was a link between 
Type D and cardiovascular or neuroendocrine reactivity. Their study involved a 
sample of students completing an experimental stressor task (mental arithmetic task 
with harassment) while having their blood pressure and heart rate measured 
throughout a baseline, stressor and recovery period. In addition, saliva samples were 
collected at the end of the baseline and task periods in order to assess salivary cortisol 
levels.  
 
Their results provide some limited support for the association between Type D and 
CVR. Although no associations were found between the global Type D construct and 
reactivity, the individual NA and SI components were significantly linked to blood 
pressure reactivity and cortisol reactivity. More specifically, SI was associated with 
heightened systolic and diastolic reactivity in the male participants. In addition, both 
NA and SI were found to be related to greater cortisol reactivity, again only in the 
male participants. The authors propose that their findings suggest a potential 
pathophysiological role for the Type D construct in the development of the disease, 
particularly in men.  
 
The aim of the current study is to extend the research on Type D and cardiovascular 
reactivity carried out by Habra and colleagues. First, it is important to further 
investigate whether the global Type D construct (in addition to the separate 
components as established by Habra et al.) is associated with cardiovascular reactivity. 
Previous research has identified that personality factors influence CVR in stressful 
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situations (Fichera & Andreassi, 2000). Second, this study will utilise more 
comprehensive measures of physiology, by measuring cardiac output and peripheral 
resistance in addition to blood pressure and heart rate, whereas Habra’s study only 
measured blood pressure and heart rate. Third, the current study will also include a 
recovery phase post-stressor in order to examine the role of Type D on recovery from 
stress, which also extends previous research which relied solely on responses during 
the stressor. 
 
7.1.6.3 Hypotheses 
The current study has four main hypotheses; 
 (i) Type D individuals will exhibit a differential cardiovascular response to stressful 
stimuli compared to non-Type D’s; 
(ii) The components of Type D (negative affectivity and social inhibition) will be 
related to cardiovascular responses to stress, in line with previous research carried out 
by Habra et al (2003) 
(iii) The cardiovascular response to stress will be more evident in Type D males, as 
reported by Habra et al (2003), and  
(iv) Type D individuals will demonstrate higher subjective feelings of stress following 
a stressor compared to non-Type D individuals. It is known that Type D individuals 
experience higher levels of distress than non-Type D individuals (Denollet, Sys & 
Brutsaert, 1995; Pedersen et al, 2004), this may be because they perceive situations as 
being more stressful than non-Type D’s. 
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7.2 Method 
7.2.1 Participants 
Four hundred and fifteen healthy young adults (339 females) completed a screening 
questionnaire. Following this, a 2-stage selection process was carried out. First, 
participants were classified as Type D and non-Type D using the established cut off 
scores (Denollet, 2005). Second, in order to maximise the chances of detecting 
significant effects (i.e. statistical power) in this exploratory experimental comparison, 
we selected those participants who scored in the upper and lower quartiles of the 
negative affectivity and social inhibition subscales of the Type D Scale, for the 
laboratory study  (i.e. for the top quartile scoring ≥ 13 on both the negative affectivity 
and social inhibition subscales, and for the lower quartile scoring ≤ 9 on both 
subscales). Through this process 166 participants (120 females) were identified and 
invited to take part in the experimental phase and from this 84 participants took part, 
representing a 50% recruitment rate. The respondents and non-respondents did not 
differ significantly in terms of age (t (1, 164) = 1.32, ns) or gender (χ² (1, N=166) = 
6.34, ns). All participants were university students who took part in the study for 
course credit. 
 
Participants in the experimental phase were 84 healthy young adults (42 females, age 
M=22.0 yrs, SD=6.8 yrs). The men (mean=21.0, SD=4.6) and women (mean=22.9, 
SD=8.5) did not differ significantly in terms of age, t (1, 82) = 1.26, ns. There were 24 
Type D females and 21 Type D males who scored ≥ 13 on both the negative 
affectivity and social inhibition subscales of the DS14 Type D scale (Denollet, 2005). 
In addition, there were 18 non-Type D females, and 21 non-Type D males who scored 
≤ 9 on both subscales. Traditionally, Type D personality is classified based on 
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Denollet’s (2005) cut-off points of ≥10. Of course, participants in our study would 
also be classified as Type D or non-Type D using Denollet’s recommended cut-off 
points.  No participants reported either being in poor health or taking any medication 
that might influence the cardiovascular measurements. 
 
7.2.2 Physiological Measures 
Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), 
cardiac output (CO), and total peripheral resistance (TPR) were recorded throughout 
the experiment. These measurements were recorded using the FMS Portapres blood 
pressure monitor and Beatscope 1.0 (TNO, Biomedical Instrumentation Research Unit, 
Amsterdam, The Netherlands) which takes non-invasive blood pressure measurement 
and beat to beat haemodynamic monitoring. The instrument has been used extensively 
in cardiovascular reactivity research (e.g. Chafin et al., 2004; Wright et al., 2007).  
This technique uses a finger cuff which the participant wears on the third finger of the 
left hand which monitors finger arterial pressure continuously throughout the 
experimental session. Beatscope is a software package used for the analysis of arterial 
pressure waveforms. It enables the application of filters that correct for pressure wave 
distortion when the arterial pressure is obtained from a peripheral site, such as a finger 
artery. 
 
7.2.3 Psychological Measures 
7.2.3.1 Type D personality 
This was assessed using the 14 item Type D personality scale (DS14; Denollet et al, 
2005) (Appendix 1). This comprises a 7-item subscale which measures negative 
affectivity (NA) and a 7-item subscale measuring social inhibition (SI). Cronbach’s α 
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was 0.91 and 0.90 respectively for NA and SI, demonstrating excellent internal 
consistency in the current study. 
 
7.2.4 Affect Measures 
7.2.4.1 Stress Arousal Checklist 
Participants subjective feelings of stress were measured by the Stress-Arousal 
Checklist (Mackay et al, 1978) (Appendix 11). For the purposes of this experiment 
only the stress items were selected. Participants are required to respond to 19 words 
such as ‘tense’, ‘worried’ and ‘jittery’ on the following response categories ‘definitely 
feel’, ‘slightly feel’, ‘cannot decide’ and ‘definitely do not feel’ based on how they 
feel at the present moment. This gives each participant a score of 0-19. Participants 
completed the checklist at three times during the experiment; baseline, stressor and 
recovery. 
 
Additional self-report measures of subjective feelings of stress were in the form of a 
visual analogue scale (VAS; 10cm) which were also administered at baseline, stressor 
and recovery. 
 
7.2.5 Stressor Task 
Paced Auditory Serial Addition Test (PASAT) 
The PASAT mental arithmetic task was used as the experimental stressor (Gronwall, 
1977). This task was selected as it has been shown in numerous studies to reliably 
perturb the cardiovascular system (Ring et al, 2002; Winzer et al, 1999). It also 
demonstrates good test-retest reliability (e.g. Willemson et al, 1998). In this task 
participants were required to add two sequentially presented single digit numbers 
 145 
together. In order to do this, the participant is required to retain the latter number and 
add it to the next number presented, and so on. Numbers were presented using a tape 
recorder and answers given orally. If participants faltered they were instructed to start 
again with the next numbered pair.  After completing a practice trial, the participants 
completed the first task phase in which 60 numbers were presented at a rate of one 
every 4 seconds, then the second sequence of 60 at one every 2 seconds. In total, the 
task lasted for 6 minutes, 4 minutes for the slower sequence and 2 minutes for the 
faster sequence. Participant performance was recorded by the experimenter.  
 
7.2.6 Procedure 
An outline of the experimental procedure is provided in Figure 7.1. Each participant 
arrived individually for the experiment. The experimenter explained that the 
participants’ heart rate and blood pressure would be monitored during a mental 
arithmetic task. After the participant consented to take part they were seated at a table 
and the finger cuff of the blood pressure monitor was attached to them. Participants 
were then given a questionnaire pack to complete consisting of the measures of Type 
D personality, the stress arousal checklist and visual analogue scale for the first time.  
Following this, recording began for the five minute baseline period, during this time 
participants were asked to sit quietly and read a textbook. 
 
After the five minute baseline period was completed, the experimenter began the 
PASAT mental arithmetic task (stressor), participants were given a practice trial to 
ensure that they understood the instructions of the task. Following this the stressor 
phase of the experiment began, starting with the presentation rate of one number 
every 4 seconds, immediately followed by a rate of one number every 2 seconds. 
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At the end of the mental arithmetic task, the experimenter turned off the Portapres, 
and removed the finger cuff from the participant, this was done to minimise 
discomfort for the participant in wearing the Portapres for a long period of time. At 
this point participants were asked to complete the stress arousal checklist and visual 
analogue scale for the second time. After this participants were instructed to sit 
quietly during a ten-minute rest period where they were again asked to read a 
textbook. Following this ten minute period, participants were re-attached to the 
Portapres for 5 minutes (recovery) where they were again asked to sit quietly and read 
a textbook. Upon completion of the recovery period, participants were asked to 
complete the stress arousal checklist and visual analogue scale for the final time. The 
participant was then debriefed before leaving the room. 
 
 
Figure 7.2 Outline of the Experimental Procedure 
 
 
 
10 min 
15 min 
0 min 
25 min 
35 min 
40 min 
 
Habituation to Portapres, Participant completes questionnaires          
(Type D Scale, Stress Arousal Checklist) while wearing the Portapres 
BASELINE Recording- Participant at rest, reading 
STRESSOR Mental Arithmetic Task 
RECOVERY recording- Participant at rest, reading 
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7.2.7 Statistical Analyses 
Four cardiovascular measures were examined: systolic blood pressure, diastolic blood 
pressure, heart rate and total peripheral resistance. These measures were assessed 
across three time periods: baseline, stressor and recovery. The stressor phase 
recordings were taken during the 2 second presentation rate of the PASAT. The 
average value for the cardiovascular measures at each time point is used as the 
dependent variable.  In order to investigate the effect of Type D on each of the 
physiological dependent variables a series of mixed measures ANCOVA were 
computed across the three time periods (baseline, stressor, recovery) while controlling 
for initial levels of the dependent variable in each case (in order to control for 
individual differences in baseline levels and their impact on subsequent magnitude of 
change). As the assumption of sphericity was violated in each case, the Greenhouse-
Geisser correction was used. It is this value that is reported in each of the analyses 
which follow. In addition, analyses were subsequently carried out separately for males 
and females, this was done because gender differences in reactivity studies are 
commonly observed (e.g. Habra et al, 2003). Furthermore, the effects of the 
components of Type D - negative affectivity and social inhibition - on each of the 
physiological measures was also investigated using mixed measures ANOVA. An 
alpha level of .05 was used throughout. 
 
7.3 Results 
 7.3.1 Stress Manipulation Check 
In order to establish that the mental arithmetic task was an effective stressor in 
producing physiological change, a series of repeated measures ANOVA were run on 
each of the dependent variables (heart rate, blood pressure, cardiac output and 
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peripheral resistance). For each outcome variable, a significant main effect of time 
was found. Mean scores for the baseline and stressor scores are presented in Table 7.1. 
 
Table 7.1: Mean baseline and stressor values for the physiological data 
 
Measurement Baseline  Stressor  Recovery F-value 
HR 79.46 (9.87) 85.55 (10.1) 76.03 (12.15) 4.66 (p<.001)  
SBP 122.83 (18.87) 142.34 (23.51) 117.99 (18.29) 5.23 (p<.01) 
DBP 70.14 (13.28) 81.92 (15.97) 66.48 (13.62) 3.51 (p<.05) 
CO 5.68 (1.26) 6.2 (1.26) 5.41 (1.32) 6.2  (p<.001) 
TPR 0.98 (0.3) 1.09 (0.59) 1.01 (0.48) 3.56 (p<.05) 
HR= heart rate (bmp), SBP= systolic blood pressure (mm HG), DBP= diastolic blood pressure (mm 
HG), CO= cardiac output (lpm), TPR= total peripheral resistance (dyn · s/cm
5
). 
 
 
7.3.2 Type D Personality and Physiological Data 
Analyses revealed that the separate components of Type D, i.e., negative affectivity 
and social inhibition, were unrelated to the physiological variables. Therefore, all 
further analyses were conducted using the global Type D construct. Mixed measures 
ANOVA revealed a significant effect of time across each of the physiological 
variables (see Table 7.1). However, there was no overall time x Type D interaction for 
any of the physiological variables [HR: F (2, 79) =0.01, ns; SBP: F (2, 79) = 0.14, ns; 
DBP: F (2, 79) = 0.04, ns; TPR: F (2, 79) = 0.093, ns; CO: F (2, 79) = 2.31, ns]. 
 
There was a significant group effect of Type D on cardiac output (F(3,79)=6.7, 
p<0.03), but not on any of the other physiological measures [HR: F (3,79) =0.004, ns; 
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SBP: F (3,79) =0.44, ns; DBP: F (3,79) =0.04, ns; TPR: F (3,79) =0.06, ns; CO:  
F(3,79)=6.7, p<.03]. Given this significant group effect of Type D on CO, it is 
important to carry out further analyses to investigate any gender differences. A 
significant group x time effect of Type D on CO was found for males [F (3, 37) = 3.4, 
p<.05] but not in the female participants [F (3, 37) = 0.78, ns] as demonstrated in 
Figure 7.3. ANCOVA (controlling for baseline cardiac output) revealed that the 
difference in cardiac output between Type D’s and non-Type D’s occurs during the 
stressor phase F (1, 82) = 4.91, p<0.05. In the interests of completeness it should be 
noted that no further gender differences were found on the remaining physiological 
measures. 
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Figure 7.3: The effect of Type D on Cardiac Output in the male participants across the 
baseline, stress and recovery phases. 
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7.3.3 Type D Personality and Subjective Stress 
It is also important to examine the effect of Type D personality on the participants’ 
self-ratings of stress on both the stress arousal checklist and the visual analogue scale. 
Mixed measures ANOVA were again calculated across the three time points; baseline, 
stressor and recovery while controlling for initial levels of the dependent variable. 
 
There was a significant effect of time on subjective stress arousal as measured by the 
stress arousal checklist F (2, 82) = 99.02, p<.001, and a significant group effect of 
Type D on stress arousal F (1, 83) = 6.43, p<.03, as shown in Figure 7.4, indicating 
that participants who were high on Type D personality reported significantly higher 
feelings of subjective stress compared to those low on Type D. In addition, a 
significant time x Type D interaction F (2, 79) = 3.38, p<.05 was established. 
ANCOVA (controlling for baseline subjective stress) showed that the difference in 
subjective stress between the Type D and non-Type D individuals occurred during the 
stressor phase, F (1, 82) = 5.32, p<.05. 
 
 For the ratings obtained from the visual analogue scale, there was a significant effect 
of time F (2, 82) = 47.5, p<0.001, but there was no group effect of Type D F (1, 83) = 
2.16, ns, and no time x Type D interaction F (2, 79) = 0.87, ns. Again, in the interests 
of completeness it should be noted that no gender differences were found on either of 
the subjective measures of stress. 
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Figure 7.4: The effect of Type D on subjective stress arousal across the baseline, 
stress and recovery phases. 
 
7.4 Discussion 
The study had two main aims: (i) to investigate the relationship between Type D 
personality and cardiovascular reactivity to stress and, (ii) to investigate the 
relationship between Type D and subjective feelings of stress.  
 
7.4.1 Type D Personality and Cardiovascular Reactivity 
The first aim of the study was to establish if Type D individuals exhibit a differential 
pattern of cardiovascular reactivity to stress compared to non-Type D’s. Type D’s 
were compared to non-Type D’s on several physiological measures; heart rate, blood 
pressure and cardiac output. Although no differences were found between Type D’s 
and non-Type D’s on measures of heart rate, blood pressure and peripheral resistance, 
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there was a significant effect of Type D on cardiac output in the male participants, 
with males high in Type D personality exhibiting significantly higher cardiac output 
during the stressor phase of the experiment compared to the non-Type D male 
participants. This is in line with previous research carried out by Habra et al (2003) 
who also identified differences in the reactivity of males who were high in the 
components of Type D – negative affectivity and social inhibition. However, their 
study failed to demonstrate any relationship between the global Type D construct and 
cardiovascular reactivity. The current study has therefore extended previous research 
by demonstrating, for the first time, a relationship between the Type D construct and 
cardiovascular reactivity. 
 
The relationship between Type D and increased cardiac output during stress is 
important for a number of reasons. By establishing that Type D is related to 
heightened physiological reactions to acute stress, a further mechanism by which 
Type D may potentially influence health has been found. Specifically, increased 
cardiac output means that the heart has to work at an increased level in order to pump 
blood to the rest of the body during stress. Importantly, increased cardiac output over 
time has been implicated early in the disease course of hypertension (Julius, 1998). 
 
7.4.2 Type D Personality and Subjective Stress 
The second aim of the current study was to examine the relationship between Type D 
and subjective stress. It was found that Type D individuals report higher feelings of 
subjective stress during stressor compared to non-Type D’s. Type D has previously 
been found to be related to a number of negative emotional states, such as anxiety and 
depression. Therefore, the association between Type D and heightened feeling of 
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stress provides further evidence for the link between Type D and psychological 
distress. Establishing a link between Type D and increased feelings of stress is 
particularly important given the potential role of stress in the aetiology of CHD.  
 
7.4.3 Limitations 
Several limitations of the present study should be noted. Firstly, the generalizability of 
the current findings to a more ‘at-risk’ population is limited by the fact that the 
sample consisted of healthy young adults. Secondly, as the experiment was conduced 
in the laboratory the findings may be limited to how Type D and physiology related to 
stress experienced in the lab, which may not be representative of stress experienced 
during daily life. However, a recent study by Johnston, Patching & Tuomisto (in press) 
has demonstrated that reactivity in the lab predicts reactivity to stressors in real life. 
Additionally, it would have been useful to include a prospective component to the 
study in order to test if the association between Type D and cardiac output is 
consistent across time. Finally, given the nature of Type D personality, it may have 
been better to use a social stressor task, such as the Trier Social Stress Task 
(Kirschbaum, Pirke & Hellhammer, 1993) rather than a cognitive stressor. However, 
my presence as experimenter during the PASAT may have acted as a possible 
inadvertent social stressor. 
 
7.4.4 Conclusions and Future Research 
The current study has extended the existing research on Type D in several important 
ways. First, it has identified for the first time that Type D is related to heightened 
physiology to acute stress in males. This may represent a direct physiological pathway 
by which Type D is associated with ill-health.  Second, it has established that Type D 
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is associated with increased subjective feelings of stress following acute stress. These 
findings suggest that Type D individuals may be at a particular risk for stress-related 
cardiac events. 
 
Future research is needed to test if these are robust and replicable findings, and to 
investigate if the relationship between Type D and cardiac output is also present in a 
cardiac population. Furthermore, in order to make the findings generalizable beyond 
laboratory stress ambulatory monitoring should be used to see if the relationships 
observed still hold as the individual faces daily hassles and stressors. 
 
The study described in this chapter and those in chapters 5 and 6 have identified both 
psychosocial and psychophysiological mechanisms by which Type D may affect 
health. The following chapter will extend this research by investigating further 
mechanisms by which Type D may affect recovery from myocardial infarction. 
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Chapter 8: Predictors of Psychological Outcome Post Myocardial 
Infarction: A Prospective Study 
 
8.0 Abstract 
 
Objectives: This study assessed predictors of psychological outcome (adherence, 
quality of life, functional outcome, distress, benefit finding) at 3-months post-MI. 
There were three main aims; (i) to investigate the prevalence of Type D personality in 
the current sample; (ii) to determine whether personality predicts outcome after 
controlling for mood, and clinical and demographic variables, and (iii) to identify the 
mechanisms by which personality is associated with adverse psychological outcome. 
Methods: In a prospective study, 191 MI patients completed a series of psychological 
measures (Type D personality, optimism, illness perceptions, locus of control, future 
thinking, beliefs about medicines, depression and anxiety) at Time 1, 3-7 days 
following MI. At Time 2, 3 months later, 131 of these MI patients completed 
measures of Type D personality, depression and anxiety, beliefs about medicines, 
quality of life, medication adherence, functional outcome, and benefit finding. 
Results: Type D was found to be a relatively stable construct, with a prevalence of 
33.9%. In addition, Type D was found to predict adherence, quality of life, functional 
outcome and benefit finding after controlling for demographics, MI severity and 
mood. The relationship between Type D and quality of life was mediated by illness 
perceptions. Findings also confirmed the importance of mood (depression and anxiety) 
in predicting quality of life and functional impairment post-MI, and the importance of 
illness perceptions in predicting quality of life post-MI. Finally, it was demonstrated 
for the first time that future thinking predicts quality of life, functional impairment 
and depression post-MI. 
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Conclusions: The current study found that Type D personality is a significant 
predictor of adherence, quality of life, functional outcome and benefit finding post-MI, 
independent of demographics, MI severity and mood. In addition, two further 
mechanisms (medication adherence and illness perceptions) to explain the association 
between Type D and adverse outcome were identified. It is, therefore, important to 
include personality factors in future research as they have been shown to predict 
short-term outcome in MI patients. In addition, the role of mood, illness perceptions 
and future thinking in predicting outcome post-MI requires further attention. 
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8.1 Introduction 
The study described in the current chapter investigates predictors of outcome post-MI. 
In order to do this, five key outcome variables were selected. These are psychological 
distress, quality of life, functional outcome, medication adherence, and benefit finding. 
More specifically, the study aimed to determine the role and relative importance of a 
number of predictor variables, including personality and patient cognitions (described 
previously in Chapter 2) in a prospective study of MI patients. Crucially, the present 
study investigated potential mechanisms through which personality (Type D 
personality and optimism) may affect outcome in MI patients. The psychosocial 
variables to be investigated have been outlined previously in Chapter 2. The following 
sections delineate the outcome measures that are assessed in the current study, and the 
key studies relating to each variable. 
 
8.1.1 Psychological Distress Post-MI 
Symptoms of psychological distress are prevalent in MI patients (Lane et al, 2002).  A 
number of studies have investigated the nature and duration of symptoms of anxiety 
and depression in patients in the years following an MI. These studies have found 
symptoms of depression and anxiety to be common problems in MI patients (e.g. 
Frasure-Smith, Lesperance & Talajic, 1995), and more prevalent than in the general 
population. Studies of MI patients report prevalence rates of depression ranging from 
17-37% (Frasure-Smith et al, 1995; Ladwig et al, 1994) and prevalence rates of 
anxiety between 24-31% (Frasure-Smith et al, 1995, 1999). In addition, Lane et al 
(2002) examined symptoms of depression and anxiety in a prospective sample of 
nearly 300 MI patients. They assessed the patients at 3 time points; 2-15 days 
following MI, and 4 and 12 months subsequently. Rates of depression and anxiety 
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were found to be high at follow-up, the prevalence rates were 37.7% and 37.2% for 
depressive symptoms, and 41.8% and 40.0% for anxious symptoms at the 4 and 12 
month follow-up periods, respectively.   
 
Not only does the high prevalence of symptoms of anxiety and depression have 
important implications for psychological well-being, they also have implications for 
morbidity and mortality in MI patients (the impact of depression on quality of life is 
discussed further in Section 8.1.2). Indeed, studies have shown that depression is 
associated with a 2-7 fold increased risk in mortality (e.g. Barefoot et al, 2000; 
Frasure-Smith et al, 1999). In addition, studies have also demonstrated that depression 
has an independent effect on morbidity and quality of life (Ladwig & Roll, 1994; 
Mayou et al, 2000; Beck et al, 2001; Lane et al, 2001; Fauerbach et al, 2005; Dickens 
et al, 2006). A recent review by Stafford et al (2007) examined studies which have 
investigated the relationship between depression and quality of life in cardiac patients. 
They concluded that; (i) the prevalence of depression is disproportionately high in 
patients with CAD; (ii) depression confers an increased risk of mortality, and (iii) 
depressive symptoms significantly undermine quality of life even after successful 
medical and surgical treatment. 
 
A recent large-scale prospective study undertaken by de Jonge et al (2006) provides 
further information relating to the effects of post-MI depressive disorder on health 
status, cardiac symptoms, disability, and quality of life. Their sample consisted of 
over 400 MI patients who were assessed at 3 and 12 months. Importantly, the authors 
were interested in determining whether the effects of depression on outcome are 
independent of baseline functioning and cardiovascular disease severity. They found 
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that patients with post-MI depressive disorder (as assessed by standardised psychiatric 
interview) were more likely to have poor quality of life, more health complaints, more 
cardiac complaints, and more disability at 12 months follow-up, compared to those 
not diagnosed with depressive disorder. Moreover, the association between post-MI 
depression and health status remained after controlling for cardiac condition and 
socio-demographic variables. 
 
However, despite the large body of evidence that suggests that depression is 
prospectively associated with cardiac prognosis, it is important to note that symptoms 
such as loss of energy, insomnia, and loss of interest may be a direct consequence of 
having an MI, rather than being related to depression per se (Strik et al, 2001). Indeed, 
several authors (e.g. de Jonge et al (2006)) have pointed out that the reporting of 
depressive symptoms following MI may be confounded by complaints originating 
from the MI itself, such as fatigue, sleeping problems or appetitive problems (Irvine et 
al, 1999; Mendes de Leon, 1999). If post-MI depressive complaints originate even 
partially from the MI, the relationship between post-MI depression and prognosis 
would be confounded, and depression would not be an independent risk factor for 
post-MI prognosis (de Jonge et al, 2006). Furthermore, a recent meta-analysis of 22 
studies suggested that the effects of depression post-MI were at least partly 
confounded by the size of the MI (van Melle et al, 2004). 
 
Importantly, within the context of the aims of this thesis, de Jonge et al (2007) 
investigated the extent to which the relationships between both depression and Type 
D personality with outcome may be confounded by somatic health. They investigated 
the association of depressive disorder and Type D with baseline somatic health in a 
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sample of over 1000 post-MI patients. It was found that post-MI depression is more 
related to somatic health than Type D, at 12 months post-MI. The authors therefore 
conclude that confounding of cardiovascular effects of psychological distress by poor 
somatic health is more likely to occur in post-MI depression than in Type D 
personality. 
 
Although the majority of research has focussed on the role of depressive symptoms 
when investigating psychological distress in MI patients, anxiety has also been 
identified as an important construct. Indeed, prevalence rates for anxiety have been 
found to be higher than those for depression (Havik & Maeland, 1990; Mayou et al, 
2000). Furthermore, there is evidence to suggest that a significant number of MI 
patients experience persistent and unremitting anxiety. For example, Mayou et al 
(2000) reported a decrease in mean anxiety scores between hospital admission and 3 
months but thereafter no changes were observed amongst the distressed patients. 
Furthermore, Lane et al (2002) also reported higher correlations between anxiety 
scores at 4 months and 1 year than those between baseline and 4 months. Moreover, 
approximately 40% of the MI patients were anxious at 4 months and 1 year post-MI. 
These findings suggest that anxiety is chronic problem in many post-MI patients. 
 
Anxiety has also been identified as a predictor of outcome post-MI. For example, 
Moser and Dracup (1996) found that patients experiencing higher levels of anxiety 
were more likely to suffer from ischemic and arrhythmic complications. In addition, 
studies conducted by Lane et al (2001) and Mayou et al (2000) found that anxiety (as 
well as depression) was predictive of post-MI quality of life. More recently, Moser et 
al (2007) again identified that patients with higher levels of anxiety experienced 
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significantly more in-hospital complications compared to less anxious patients 
independent of traditional sociodemographic and clinical risk factors. In addition, they 
found that this relationship is moderated by perceived control, with the combination 
of high anxiety and low perceived control being associated with the highest risk of 
complications. 
 
Given the important role of depression and anxiety as predictors of psychological 
outcome in MI patients, and the high prevalence of symptoms of depression and 
anxiety observed in MI patients, the current study will further investigate the role of 
depression and anxiety as both predictors of outcome, and as indicators of 
psychological distress post-MI. 
 
8.1.2 Quality of Life Post-MI 
As outlined in Chapter 1 (see section 1.4) the concept of quality of life has increased 
in importance as an outcome measure in clinical studies. Although there is no 
universally accepted definition of quality of life, the definition provided by the world 
health organisation (WHO) is adopted by the majority of studies. The WHO defines 
quality of life as a multidimensional concept in which ‘an individual’s perception of 
their position in life in the context of the culture and value systems in which they live 
in relation to their goals, expectations, standards and concerns’. More specifically, 
health-related quality of life has been defined as ‘the functional effect of an illness 
and its consequent therapy upon a patient, as perceived by the patient’ (Schipper, 
Clinch & Olweney, 1996). Although the concept of health-related quality of life has 
gained increased attention within the area of health care in recent years, relatively 
little research has been carried out on the quality of life of patients post-MI 
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specifically. It is important to investigate health related quality of life as it has been 
shown to influence morbidity and mortality in cardiac patients. Indeed, Rumsfeld et al 
(1999) reported that patients with poorer self-perceived physical health had a greater 
mortality rate at 6 months. In the present study, quality of life was assessed using the 
MacNew. This is a particularly useful measure for the current study as it is a heart 
disease specific instrument.  
 
A longitudinal study by Brink et al (2002) investigated quality of life in MI patients. 
They compared MI patients with normative data of people who had not had an MI. 
The MI patients reported poorer quality of life in both physical and mental health 
domains at 5 months. Deficits were particularly marked in areas of limitations due to 
physical problems, for example, work and other daily activities, and limitations due to 
emotional problems. In addition, women reported significantly poorer quality of life 
than men, experiencing significantly poorer physical health and more bodily pain. 
Gender differences were also reported in a study by Wiklund et al (1993) in which 
women reported greater problems in social functioning compared to men. 
 
Further evidence relating to the importance of the concept of quality of life comes 
from a qualitative study by Roebuck et al (2001) who interviewed patients following 
an MI. Patients reported that the area of life they were most concerned about was their 
physical symptoms and their effect on everyday life. They also reported that their 
inability to perform basic activities such as shopping, or gardening were as distressing 
as the symptoms themselves. 
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Much of the research which has sought to investigate predictors of quality of life in 
cardiac patients has focussed on the impact of depression and anxiety. For example, 
Lane et al (2001) sought to examine the impact of symptoms of depression and 
anxiety on mortality and quality of life in MI patients. Their findings demonstrated 
that poorer quality of life at 12 months was predicted by greater baseline levels of 
depression, greater severity of infarction, living alone, and state anxiety. An earlier 
study by Mayou et al (2000) also reported that greater baseline levels of anxiety and 
depression among MI patients assessed within the first 72 hours after hospital 
admission predicted poorer quality of life at 1 year. More recently, Dickens et al 
(2006) reported that depression and anxiety assessed 6 months after MI predicted 
subsequent impairment on physical aspects of quality of life. Further support for the 
role of depression in quality of life can be seen in a recent review by Stafford et al 
(2007). They reviewed studies relating to the impact of depression on quality of life in 
patients with CHD, and reported that depressive symptoms predict quality of life even 
after successful medical and surgical treatment. 
 
Further evidence on the importance of assessing quality of life in MI patients comes 
from a study undertaken by Brink, Karlson & Hallberg (2002). They reported that 
coping strategies, depression, and health complaints were associated with both 
physical and mental health 5 months post-MI. The relationship between illness 
perceptions and quality of life in MI patients has also been investigated. French et al 
(2005) reported that illness perceptions predicted emotional, physical and social 
quality of life, with beliefs about consequences being most strongly related. In 
addition, these relationships remained after controlling for anxiety and depression. 
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Further predictors of quality of life in cardiac patients have been identified by Joekes, 
Van Eldern & Schreurs (2007) who reported that both self-efficacy and perceived 
overprotection are associated with lowered quality of life in patients suffering from 
CHF or MI. In addition, Boersma et al (2006) found that self-efficacy with regards to 
goal attainment was an independent predictor of physical and social quality of life in 
MI patients. 
 
Type D personality has also been investigated as a predictor of quality of life in 
cardiac patients. Al Ruzzeh et al (2005) assessed quality of life at 1 year after CABG 
and found that Type D was the best predictor of quality of life, with Type D patients  
being more than twice as likely to have poor physical quality of life, and more than 5 
times as likely to have poor mental quality of life. 
 
As outlined above a number of predictors of quality of life have been identified, most 
noticeably anxiety and depression. However, it is important to further examine other 
predictors of quality of life in MI patients. The current study aims to extend the 
findings relating to illness perceptions, Type D personality, depression and anxiety 
and also aims to determine the utility of prospective thinking, locus of control and 
role and goal investment in predicting quality of life post-MI. 
 
8.1.3 Functional Outcome post-MI 
Related to the idea of quality of life is functional outcome. However, it is important to 
acknowledge that while quality of life refers to satisfaction, functional outcome refers 
to actual disability, i.e. what you can and cannot do. In the present study, the measure 
of functional outcome used in the current study is an abbreviated version of the 
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widely used Sickness Impact Profile (SIP; De Bruin et al, 1992). It has also been 
conceptualised in a number of studies as a measure of disability post-MI (e.g. Petrie et 
al, 1996). The difficulties patients face after leaving hospital in terms of changing 
their lifestyle and regaining their vocational, sexual, and other functioning may be 
considerable. Indeed, functional disability post-MI is generally associated with higher 
levels of reported symptoms and lower levels of well-being (Brown et al, 1999). 
 
As with the research carried out in the area of quality of life post-MI, most of the 
research to have focussed on functional limitations or disability post-MI has examined 
the role of depression and anxiety. For example, Mayou et al (2000) found that 
patients who were scored as probable cases of depression and anxiety exhibited 
significantly poorer functioning on specific measures of everyday activity compared 
to probable non-cases. In addition, a study by de Jonge et al (2006) also investigated 
predictors of disability post-MI. They found that patients with post-MI depressive 
disorder experienced more disability at 12 months post-MI. 
 
Petrie et al (1996) investigated the relationship between illness perceptions and 
disability in post-MI patients. They found that patients’ beliefs that their heart disease 
would have serious consequences were significantly related to later disability in work, 
around the house, recreational activities, and social interaction. In addition, a strong 
illness identity was significantly related to greater sexual dysfunction at both 3 and 6 
months post-MI. In addition, Petrie et al (2002) found that a randomised controlled 
trial designed to change patients’ illness perceptions was effective in increasing return 
to work. 
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Given the importance of patient functional outcome post-MI, the current study aims to 
determine the utility of personality and cognitive variables to predict functioning 
across four key areas; ambulation, mobility, recreation and social interaction. 
 
8.1.4 Adherence in MI Patients 
As outlined in Chapter 2 (see section 2.2.3), adherence to prescribed medication for 
patients diagnosed with an MI is crucial. Evidence from a number of drug trials has 
shown that medications such as beta-blockers, cholesterol lowering medication and 
aspirin significantly reduce mortality and morbidity rates (e.g. Chalmers et al, 2004; 
Sacks et al, 1996). Indeed, in a review from McDermott et al (1997), greater 
adherence to medication was found to be related to lower hospital readmission rates 
and improved outcomes in patients with or at risk for CHD. In addition, findings from 
the Beta-blocker Heart Attack trial demonstrated that poor adherers (who took 75% or 
less of prescribed medication) were 2.6 times more likely than good adherers to die 
within a year of follow-up (Horwitz et al, 1990).  
 
Although there has been relatively little research on medication adherence in MI 
patients specifically, research has examined other adherence-related behaviours in 
cardiac patients. For example, there has been considerable interest in predictors of 
attendance at cardiac rehabilitation, and modifying lifestyle to incorporate health 
related behaviours in line with medical advice. There is considerable evidence to 
suggest the beneficial effects for patients in attending a cardiac rehabilitation 
programme, with meta-analyses suggesting a reduction in total mortality of around 
20% among those who attend rehabilitation programmes (Thompson & Lewin, 2000). 
Indeed, one recent Cochrane review reported a 26% reduction in cardiac mortality as 
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a result of rehabilitation (Jolliffe et al, 2004). Despite this, only around one quarter to 
one third of MI patients attend rehabilitation classes (Jackson et al, 2005). 
 
Patients give various reasons for non-attendance, these include, not wishing to attend, 
returning to work, the presence of comorbid health problems, and living too far away 
(Lane et al, 2001). A study by Cooper et al (1999) also reported that non-attenders 
were likely to be older, have a lower level of income, less likely to be employed and 
more likely to deny the severity of their illness. A further study by Melville et al 
(1999) reported that predictors of non-attendance included greater social deprivation, 
and previous history of MI. In contrast, factors that predicted attendance included 
younger age, male gender, and admission to a coronary care unit. Social support has 
also been established as a predictor of adherence to medical advice and attendance at 
rehabilitation programmes in cardiac patients (Krantz & McCeney, 2002). More 
recently, Cooper et al (2007) sought to develop a measure of patients’ beliefs 
regarding cardiac rehabilitation. In doing so they identified four subscales which 
accounted for 65% of the variance in rehabilitation. They were; perceived necessity of 
rehabilitation, concerns about exercise, practical barriers, and perceived personal 
suitability. They also reported that patients were more likely to attend if they believed 
that rehabilitation was necessary and if they understood its role better, compared to 
non-attenders. 
 
Patients’ illness perceptions relating to their illness have also been examined 
extensively in relation to adherence behaviour, particularly with regards to attendance 
at rehabilitation. For example, Petrie et al (1996) examined the illness perceptions of a 
prospective study of MI patients. They reported that attendance at cardiac 
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rehabilitation was significantly related to a stronger belief at admission that the illness 
could be cured or controlled. Similarly, Cooper et al (1999) reported that patients who 
believed that their heart problems could be cured or controlled and patients who 
attributed the cause of their heart attack to lifestyle factors were more likely to attend 
rehabilitation. 
 
A further study by Whitmarsh et al (2003) reported that those attending rehabilitation 
perceived a greater number of symptoms and consequences than poor/non-attenders. 
In addition, patients who had stronger beliefs that the illness was controllable or 
curable were more likely to attend. Attenders also experienced significantly higher 
rates of distress compared to non-attenders. More recently, in the largest study 
published to date investigating illness perceptions and attendance, French et al (2005) 
also investigated the relationship between illness perceptions and attendance. 
However, in contrast to previous studies, they found no significant associations 
between illness perceptions and attendance.  
 
Prompted by the inconsistent findings relating to illness perceptions and attendance, 
French, Cooper & Weinman (2006) carried out a systematic review with meta-
analysis of the available literature. They identified that cardiac rehabilitation was 
predicted by four components of illness perceptions: patients with more positive 
identity, cure/control, consequences, and coherence. However, these effects all 
corresponded to small effect sizes. Therefore, this study does provide some support 
for the role of illness perceptions in predicting adherence. It also points to the fact that 
further research is needed to examine how illness perceptions develop from the point 
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of admittance as the time at which illness perceptions were measured was identified to 
be a key moderating factor.  
 
A further study from Cooper et al (2005), this time employing a qualitative approach, 
also found that patient beliefs may act as a barrier to attendance. They identified five 
key themes following interviews with thirteen MI patients. They were; content of the 
course, perceived benefits, explicit barriers to attendance, cardiac knowledge, and the 
nature of the patients’ CHD.  
 
With regards to lifestyle changes, Weinman et al (2000) investigated the effects of 
causal attributions and subsequent lifestyle changes in a prospective study of first time 
MI patients and their spouses. They reported that patients’ and their spouse’s beliefs 
about the cause of their MI affected adherence to healthy lifestyle changes. 
Specifically, patients who believed that their MI was caused by unhealthy lifestyle 
behaviours were more likely to have made dietary changes at 6 month follow-up. In 
addition, spouse attributions that poor health habits were associated with their 
partner’s MI were associated with improvement in the patients’ level of exercise. 
However, French et al (2005) carried out a re-analysis of the data, taking into account 
pre-MI behaviour. They found that once this was controlled for there was no 
relationship between causal attributions and subsequent behaviour change. 
 
Byrne, Walsh & Murphy (2005) investigated the relationship between illness 
perceptions and CHD patients’ secondary preventive behaviour. This is the one of few 
studies to-date which has investigated the relationship between illness perceptions and 
medication in cardiac patients specifically. They reported only a weak association 
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between illness perceptions and preventive behaviour, and a small-to-medium 
relationship between medication beliefs and adherence to medication. However, 
medication adherence were predicted more strongly by specific medication beliefs. A 
stronger belief in the necessity of medication and fewer concerns about medication 
was predictive of higher adherence to medication. 
 
Further research on medication adherence has investigated the role of depression. For 
example, Carney et al (1995) found that elderly patients suffering from depression 
and CHD were less likely to adhere to prescribed aspirin therapy when compared to 
non-depressed patients. Research has also been conducted to determine the 
relationship between quality of life, adherence and depression. Fogel et al (2004) 
examined whether quality of life predicted adherence, independent of depression after 
4 months post-MI. They reported that quality of life on the physical health domain 
was related to adherence, even after controlling for the effects of depression. 
 
Given the central role of medication adherence in the prognosis of MI patients, it is 
vital to identify robust predictors of adherence. In addition, little research has been 
carried out to investigate the role of illness perceptions and specific medication beliefs 
in MI patients. A similar approach has met with success in predicting nonadherence to 
preventer medication in asthma patients (Horne & Weinman, 2002). In this study, 
Leventhal’s self regulation model was extended to include medication beliefs (see 
section 2.2.3). Indeed, it has been suggested that the ability of the self-regulation 
model to explain treatment adherence may be improved by the inclusion of specific 
treatment or medication beliefs into the model (Horne, 1997).  
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Horne & Weinman (2002) reported that non-adherence was associated with doubts 
about the necessity for the medication to maintain health and with concerns about the 
potential adverse effects of the medication. In addition, illness perceptions were also 
found to be substantial independent predictors of adherence. These findings therefore 
lend support to an extended self-regulatory model of treatment adherence, which 
incorporates beliefs about treatment as well as illness perceptions. A previous study 
by Horne and Weinman (1999) had investigated medication beliefs in four different 
illness groups, including cardiac patients. They found that many patients engage in an 
implicit cost-benefit analysis in relation to medication adherence where beliefs about 
the necessity of medication are weighed against concerns about its potential adverse 
effects. 
 
The current study will, therefore, aim to identify further predictors of medication 
adherence in MI patients. In particular, the role of illness perceptions and medication 
beliefs will be investigated as no study has utilised this approach specifically with MI 
patients. In addition, the role of depression and anxiety in predicting adherence will 
be further examined. It is also important to determine if there is a relationship 
between personality and medication adherence, and if so, how this relationship 
manifests itself. Indeed, Type D’s toxic effect on outcome could be explained via 
poor adherence.                                                                                                                                                                                              
 
8.1.4 Benefit Finding post-MI 
Although the majority of research carried out on patient outcome following illness 
concentrates on negative consequences, such as a reduction in quality of life, more 
recently there has been increased interest in examining potential positive 
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consequences. For example, patients with a wide variety of medical problems report 
benefits or gains from their adversity, such as, the strengthening of relationships, and 
a change in life’s priorities and personal goals (e.g. Affleck et al, 1987; Pakenham, 
2005).  
 
The majority of research into benefit finding has been carried out with cancer patients. 
For example, Carver & Antoni (2004) investigated benefit finding in breast cancer 
patients in the year following surgery. These patients were then followed-up between 
5 and 8 years later, it was found that benefit finding reported initially, predicted more 
positive emotion and self-judged quality of life and lower distress and depression at 
follow-up. Furthermore, higher benefit finding predicted lower distress and 
depression even after controlling for initial levels of these variables. In addition, 
recent intervention programmes are now aiming to improve benefit finding among 
patients as an important factor in the psychological adjustment of cancer patients (e.g. 
Cameron et al, 2007). However, findings relating to benefit finding in cancer patients 
are not entirely consistent. Indeed, Tomich & Helgeson (2004) reported that benefit 
finding was associated with increased negative affect, and worse mental functioning 
in breast cancer patients at 4-6 months post diagnosis. The authors suggest that benefit 
finding may signal a reluctance to recognise the severity of one’s diagnosis, thus it 
may be one way to reduce the threat of negative information. If benefit finding signals 
denial then it may be maladaptive over time as it may interfere with coping strategies. 
 
Relatively little research has examined the role of benefit finding in cardiac patients. 
However, Petrie et al (1999) have carried out a study which examined the positive 
effects of illness in both MI and breast cancer patients. They assessed MI patients in 
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hospital and breast cancer patients on referral for radiotherapy, and again 3 months 
later. At 3-month follow-up, the patients were asked to report any positive changes 
that had taken place in their lives following their illness. Approximately 60% of each 
patient group reported positive changes from their illness, for MI patients the most 
common theme reported was healthy lifestyle change. In addition, the reporting of 
positive experiences was unrelated to illness severity.  
An earlier study by Laerum et al (1987) found that one third of MI patients reported 
positive changes in their lives at 4-months post-MI, the most common theme reported 
in this study was an improved feeling of closeness to their immediate family. Prior to 
this, Affleck et al (1987) interviewed nearly 300 MI patients at 7 weeks and 8 years 
post-MI. They found that patients who reported benefits relating to their MI at 7 
weeks were less likely to have had another infarction, and had lower levels of 
morbidity at 8 year follow-up. More recently, Sheikh (2004) investigated the 
relationship between personality, social support, and coping and posttraumatic growth 
in the context of heart disease. They found that extraversion was the most significant 
predictor of posttraumatic growth, and that problem-focused coping partially mediates 
this relationship. In addition, they found no relationship between social support and 
posttraumatic growth. 
Due to the lack of research that has examined the role of benefit finding in MI patients, 
and the promising findings in the three studies that have been carried out, the current 
study will examine further the role of benefit finding in MI patients. Specifically, it 
will test for predictors of benefit finding in post-MI patients. 
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8.1.5 Aims 
Within the broader context of identifying predictors of outcome post-MI, the current 
study primarily examines the role of personality, and mechanisms by which 
personality may lead to adverse psychological outcome. Personality in the current 
study is assessed by both Type D personality and optimism, two distal risk factors for 
adverse outcome in post-MI patients. It is important to identify; (i) if personality is 
predictive of outcome after controlling for clinical and sociodemographic variables; 
(ii) to determine if any relationship observed between personality and outcome can be 
explained by mood, and (ii) how the relationship between personality and outcome 
manifests itself, in other words, to determine the mechanisms by which personality 
may influence health. Proximal risk factors, such as, illness perceptions, future 
thinking and locus of control will be investigated as possible bridges between 
personality and adverse psychological outcome in post-MI patients. 
 
In summary, the current study has four key aims: 
(1) To investigate the prevalence of Type D personality in a clinical sample, and 
the relationship between Type D and each of the variables under investigation 
(illness perceptions, locus of control, future thinking, role and goal investment, 
optimism, mood, medication beliefs, adherence, quality of life, functional 
outcome, benefit finding). 
(2) To investigate if personality predicts outcome after controlling for clinical and 
demographic variables. 
(3) To determine if personality predicts outcome after controlling for mood. 
(4) To identify the mechanisms by which personality is associated with adverse 
psychological outcome. 
 175 
8.2 Method 
8.2.1 Participants and Procedure 
Patients were recruited from the Cardiology ward of the Royal Infirmary of 
Edinburgh following an MI. Their psychological wellbeing was assessed 3-7 days 
post-MI and again three months later. Two hundred and five patients were recruited to 
the study. Exclusions were limited to participants who were unfit for interview, 
unable to give informed consent or unable to understand English. It is not possible to 
determine if the sample recruited is representative of all MI patients being admitted to 
the ward as this information was not available from the hospital. Ninety-six percent of 
patients who were approached agreed to take part. Only 8 potential participants who 
were approached declined to take part. There were 59 females and 146 males with an 
overall mean age of 66.03 years (SD=10.7, range=40-88) in the sample at Time 1. 
The men (M=66.42; SD=10.83) and women (M=65.05; SD=10.78) did not differ 
significantly in terms of age (t (1, 203) =0.781, ns). Sixty-four of the participants 
(31%) had experienced an MI previously. 
 
Potential participants were approached in the cardiology ward and invited to 
participate in the study. A brief introduction outlining the nature of the study 
assessment was given, it was also highlighted that participation was voluntary, 
confidential and that refusal would not interfere with their treatment protocol. Ethical 
approval had been obtained from the Local Research Ethics Committee and the 
University Department of Psychology. At this stage, all patients invited to participate 
were given a patient information sheet (see Appendix 21), which explained the 
rationale for the study, implications of their participation and specified the main 
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investigators involved. Those who agreed to participate were then asked to give 
written consent (see Appendix 22). 
 
At Time 1, 3-7 days post-MI (M=4.32 days, SD=1.14) patients were interviewed in 
hospital. The future thinking task was always administered first to reduce 
contamination effects, followed by measures of Type D personality, optimism, locus 
of control, illness perceptions, mood (i.e., anxiety and depression), health-related 
behaviour and views on medicines, but the order of presentation of these measures 
was counterbalanced.  
 
Of the 205 patients recruited at time 1, 131 went on to complete the Time 2 measures, 
representing a 62.6% follow-up rate (which is comparable to other studies with this 
population, e.g. Mayou et al, 2000). A flow-chart of the sample size and retention rate 
at each stage of the study is given in Figure 8.1. Fourteen participants (6.8%) were 
excluded as they had missing data on an entire self-report measure, 3 participants 
(1.46%) died between Time 1 and Time 2, 19 participants (9.27%) could not be 
contacted at Time 2, and 38 participants (18.53%) declined to participate at Time 2. 
Those who completed the Time 2 measures, and those who did not, were not 
significantly different in terms of age (t (1, 203) =0.621, ns), gender (χ² (2, N=205) 
=6.59, ns), deprivation category (χ² (7, N=205) =5.34, ns) or MI severity as assessed 
by left ventricular functioning (χ² (4, N=205) =3.75, ns). 
 
At time 2, on average 3 months later (M=13.63 weeks, SD=2.86), patients were 
contacted again via telephone and asked to complete measures of quality of life, 
functional outcome, benefit finding, medication adherence, role and goal investment, 
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Type D personality, health-related behaviour, and views of medication. The order of 
presentation of the measures was counterbalanced to control for transfer effects. 
 
 
 
 
 
Total number of patients at Time 1 
 
Excluded due to missing  
data on self-report measures  
 
Died between hospitalisation 
and 3 months follow-up 
 
Could not be contacted at  
3 months follow-up 
 
Declined to participate at 
3 months follow-up 
 
Included patients at Time 2 
 
Figure 8.1: Flowchart of sample size and retention rate at each stage of the study 
 
n= 205 
n= 131 
n= 14 
n= 38 
n=3 
n= 19 
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8.2.2 Measures 
8.2.2.1 Demographic Information 
Socio-demographic variables included gender, age socioeconomic status, and 
smoking status. Socioeconomic status was measured by the deprivation scores 
attached to an individual’s postal code (Carstairs & Morris, 2001). This is a well-
established measure of socio-economic status in Scotland. It ranges from a 
deprivation category (DEPCAT) of 1=most affluent postcode sectors, to DEPCAT 
7=most deprived.  The Carstairs and Morris index was originally developed in the 
1980s using 1981 census data. It is composed of 4 indicators at postcode sector level 
that are judged to represent material disadvantage in the population (lack of car 
ownership, National Statistics Socio-economic Classification, overcrowded 
households and male unemployment). The index used in the current study is based on 
2001 census data.  
 
8.2.2.2 Clinical Variables 
Baseline clinical variables, including history of previous MI, creatine kinase level, 
troponin level, and left ventricular functioning (LVF) were obtained from patients’ 
hospital records. LVF was measured by means of echocardiography.  
 
8.2.2.2.1 Cardiac Enzymes 
Creatine kinase (CK) and troponin are cardiac enzymes that are measured through 
blood tests to determine if an MI has occurred, and the resulting damage to muscle 
and heart cells. During the process of muscle damage, muscle cells break open and 
their contents find their way into the bloodstream, because most of the CK in the body 
normally exists in muscle, a rise in the amount of CK in the blood indicates that 
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muscle damage has occurred, or is occurring. Higher amounts of serum CK indicate 
acute muscle injury. Cardiac troponin is the most specific and sensitive laboratory 
marker of myocardial cell injury. Certain subtypes of troponin (cardiac troponin I and 
T) are very sensitive and specific indicators of damage to the heart muscle. A patient 
who had suffered from a MI would have an area of damaged heart muscle and so 
would have elevated cardiac troponin levels in the blood. A meta-analysis carried out 
by Heidenreich et al (2001) demonstrated that troponin has good prognostic value in 
patients with acute coronary syndromes. 
 
8.2.2.2.2 Left Ventricular Functioning 
The main measure of MI severity used in the current study is LVF which assesses the 
functioning of the heart’s left ventricle. LVF measurements are taken during 
echocardiogram. The echocardiogram report then outlines whether LVF is normal, 
mildly impaired, moderately impaired, or severely impaired. Sixteen patients (8.3%) 
did not have an echocardiographic examination as they were assumed to have suffered 
a mild MI with no cardiac damage. This was confirmed by examining their cardiac 
enzyme scores. Low values of cardiac enzymes (troponin <5, CK<500) have been 
found to correlate with good LV function (Rao et al, 1998). All participants without 
an echo were found to be below these recommended cut-off points for both cardiac 
enzyme scores and so were deemed to have normal LVF. 
 
8.2.2.3 Baseline Measures 
As full details of each of the following measures have been provided in Chapter 4, the 
measures are described only briefly here. 
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8.2.2.3.1 Future Thinking 
The future thinking task (FTT; MacLeod et al, 1997) was used to assess prospective 
thinking (see Appendix 5). It requires participants to generate potential future 
experiences (both positive and negative) across three time periods in the future; the 
next week, the next year and the next five to ten years. 
 
8.2.2.3.2 Type D Personality 
The Type D Personality Scale (DS14; Denollet, 2005) is a 14-item scale comprising 
of 2 subscales (see Appendix 1). A 7-item subscale which measures negative 
affectivity and a 7-item subscale measuring social inhibition. Cronbach’s α=0.88 and 
0.86 respectively for NA and SI indicating excellent internal consistency in the 
current sample. 
 
8.2.2.3.3 Optimism 
Optimism/ Pessimism was assessed by the Life Orientation Task-Revised (LOT-R; 
Scheier, Carver & Bridges, 1994) (Appendix 6). This is a 10-item scale including 
three positively worded items, three negatively worded items, and four filler items. 
Participants are asked to indicate their agreement with these statements on a 5-point 
scale ranging from ‘I agree a lot’ to ‘I disagree a lot’. Cronbach’s α=0.88 
demonstrating good internal consistency in the current sample. 
 
8.2.2.3.4 Depression and Anxiety 
The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) is a 
14-item self-report measure designed to assess depression and anxiety (see Appendix 
12). It contains two subscales, one 7-item scale relating to depression, and one 7-item 
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subscale relating to anxiety. Items are rated on a 0-3 point scale indicating strength of 
agreement with each item. Internal consistency was good for both the depression and 
anxiety subscales with α=0.90 and α=0.91 respectively. 
 
8.2.2.3.5 Locus of Control 
The Recovery Locus of Control Scale (RLOC; Partridge & Johnson, 1989) is a 9-item 
scale developed to measure the internality/externality of an individual’s perceptions of 
control over their recovery (see Appendix 7). Five items reflect internal beliefs, and 
four items are worded to reflect external beliefs. Participants are asked to indicate 
their level of agreement with each item using a five-point Likert-type scale from 1 
(‘strongly agree’) to 5 (‘strongly disagree’). Internal consistency was good in the 
current study (Cronbach’s α=0.90). 
 
8.2.2.3.6 Health-Related Behaviour 
A brief version of the GPHB was employed; this was done in order to reduce response 
burden. The Brief GPHB is an 8-item measure (see Appendix 14). These items were 
selected as being the eight preventive health behaviours on which groups of 
respondents who were found to be in ‘very good’, ‘good’ and ‘average to very poor’ 
health following medical assessment significantly differed (Amir, 1987). Cronbach’s 
α is not calculated as the items are not intended to be a scale. 
 
8.2.2.3.7 Illness Perceptions 
The Brief Illness Perception Questionnaire (Brief IPQ; Broadbent et al, 2006) is a 9-
item scale designed to quickly assess the key cognitive and emotional representations 
of illness (see Appendix 9). Five of the items assess cognitive illness representations: 
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consequences, timeline, personal control, treatment control, and identity. Two of the 
items assess emotional representations: concern and emotions. One item assesses 
illness comprehensibility. All of these items are rated using a 0-10 response scale. No 
cronbach’s α is computed for this measure because each item corresponds to a 
different illness representation. 
 
8.2.2.3.8 Beliefs about Medicines – General 
The Beliefs about Medicines Questionnaire (BMQ; Horne, Weinman & Hankins, 
1999) assesses cognitive representations of medication (Appendix 8). The BMQ-
General assesses beliefs about medicines in general. It comprises two scales, 
consisting of 4-items each. The general-overuse scale assesses views about the way in 
which medicines are used by doctors and assesses personal beliefs about the extent to 
which doctors place too much trust in medicines. The general-harm scale assesses 
beliefs about the intrinsic properties of medicines and the degree to which they are 
perceived by the individual as being harmful. Respondents indicate their level of 
agreement with each statement on a 5-point Likert-type scale, ranging from 
1=strongly disagree to 5=strongly agree. Cronbach’s α= 0.83 and 0.64 for the overuse 
and harm scales respectively, demonstrating acceptable internal consistency. 
 
8.2.2.4 Follow-up Measures 
Participants again completed measures of Type D personality (NA-T2; α=0.73; SI-T2; 
α=0.78), health-related behaviour, depression and anxiety (Depression-T2; α=0.91, 
Anxiety-T2; α=0.83). In addition, participants completed the following measures: 
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8.2.2.4.1 Quality of Life 
Quality of life after myocardial infarction was assessed using the MacNew (Lim et al, 
1993; Valenti et al, 1996) (Appendix 18). This is a heart disease specific health-
related quality of life health-related quality of life instrument which assesses three 
major domains: emotional, physical, and social. The instrument consists of 27 items, 
each with a seven-point Likert-type response scale. Cronbach’s α=0.95 for the overall 
measure, indicating excellent internal consistency. In addition α=0.95, 0.94, and 0.94 
for the emotional, social, and physical domains, respectively. 
 
8.2.4.4.2 Functional Outcome 
The Functional Limitations Profile (FLP; Patrick & Peach, 1989) aims to assess 
changes in function due to ill-health (see Appendix 19). The scale consists of 136 
items within 12 categories of activity. Four categories were selected for use in the 
current study. These were ambulation, mobility, recreation and social interaction. 
Each category contains items which describe a restriction in activity and the 
respondents are required to indicate whether the item applied to the today and if it is 
due to their health. Administration of the FLP was modified for use in the current 
study.  Participants were asked whether they agreed or disagreed with each statement. 
If they agreed, they were asked; ‘Is this due to your health?’ If the participant 
answered yes then they moved on to the next category of items. Cronbach’s α=0.81 
for the composite score from the 4 abbreviated FLP scales indicating good internal 
consistency in the current sample. 
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8.2.4.4.3 Medication Adherence 
The Medication Adherence Report Scale (MARS; Horne, Weinamn & Hankins, 1999) 
was developed to measure adherence to a wide-range of medication regimes (see 
Appendix 20). It assesses how often patients have been non-adherent, by assessing 
various non-adherent behaviours. The 5-item scale asks respondents to rate the 
frequency with which they engage in each of five aspects of non-adherent behaviour, 
for example ‘I forget to take them’ on a five point scale (5=never; 4=rarely; 
3=sometimes; 2=often; 1=very often). Internal consistency for the MARS was 
excellent in the current study, α=0.92. 
 
8.2.4.4.4 Benefit Finding 
Benefit finding was measured using a 17-item measure developed by Urcuyo, Boyers, 
Carver & Antoni (2005) (Appendix 17). The measure used the stem ‘Having had a 
heart attack…’ and each item continued by mentioning a potential positive 
contribution to the respondent’s life that might plausibly follow from their experience 
of having a heart attack. Respondents rate their level of agreement with each item on a 
4-point scale ranging from ‘I disagree a lot’ to ‘I agree a lot’. Cronbach’s α=0.93 
indicating excellent internal consistency in the current sample. 
 
8.2.4.4.5 Role and Goal Investment 
The Roles and Goals Questionnaire (RAG; Lam & Power, 1991) assesses an 
individual’s roles and goals across four domains (see Appendix 10). (1) present work; 
(2) the most important interests and hobbies; (3) the most important personal 
relationships; and (4) health and independent living. Internal consistency of the 
measure was good in the present sample, with α=0.88. 
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8.2.4.4.6 Beliefs about Medicines – Specific 
The Beliefs about Medicines Questionnaire (BMQ; Horne, Weinman & Hankins, 
1999) assesses cognitive representations of medication (see Appendix 8). The BMQ 
comprises two sections. The BMQ-Specific comprises two scales, one 5-item scale 
which assesses personal beliefs about the necessity of prescribed medication for 
controlling their illness and another 5-item scale which assesses concerns about the 
potential adverse effects of taking the medication. Respondents indicate their level of 
agreement with each statement on a 5-point Likert-type scale, ranging from 
1=strongly disagree to 5=strongly agree. Internal consistency was good for both the 
concerns and necessity subscales, cronbach’s α=0.69 and 0.93 respectively. 
 
8.2.5 Statistical Analyses 
G-Power for multiple regression (Faul, Erdfelder, Lang & Buchner, 2007) was 
conducted prior to data collection in order to determine the sample size required at 
follow-up to be statistically significant. In order to detect a medium effect size of 0.15, 
with alpha at .05, power at .80, a sample size of 131 participants at time 2 allows us to 
use 13 predictors (the maximum number of predictors that will be used in a single 
regression analysis). 
 
First, the baseline demographic and clinical characteristics of the sample are described. 
Then correlations, means and standard deviations (SD’s) are presented for each of the 
outcome and predictor variables from T1 and T2. A series of hierarchical multiple 
regression analyses are then presented in order to identify the best predictors of each 
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outcome variable: quality of life (emotional, physical and social), functional outcome, 
medication adherence, benefit finding, T2 depression, and T2 anxiety.  
 
The order by which variables were entered into the regression analyses was 
determined as follows. Sociodemographic variables were entered in the first step as 
these are fixed entities. Clinical variables were entered next as it is important to 
determine of any of the psychological variables that are entered subsequently explain 
outcome over and above clinical variables. The personality variables (i.e. Type D and 
optimism) were entered next as they are relatively stable trait-like factors while all of 
the remaining factors are states. In addition, as it is of primary interest to investigate 
possible mediators of the relationship between personality and outcome, the 
remaining variables were entered after personality. At the next step illness perceptions 
are entered as we are testing the utility of the SRM. The remaining variables were 
selected if they were significantly correlated with the outcome variable in question. 
The order in which these remaining variables were entered was determined based on 
the strength of their relationship with the outcome variable as demonstrated by 
previous research. Variables that are known to be stronger predictors were entered 
higher up the equation. 
 
If the regression analyses suggest that mediation has taken place then formal tests of 
mediation were conducted following the procedure outlined by Baron and Kenny 
(1986). According to Kenny et al. (1998), mediation is demonstrated when the 
following conditions are met:  (1) the independent variable (e.g., Type D) affects the 
mediator (e.g., illness perceptions); (2) the independent variable affects the dependent 
variable (e.g., quality of life); (3) the mediator affects the dependent variable when the 
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independent variable is controlled for and; (4) full mediation is confirmed when the 
association between the independent variable and dependent variable is reduced to 
non-significance after the effect of the mediator is controlled for.  If conditions 1-3 
are met partial mediation is indicated.  Sobel tests were also conducted in each case in 
order to determine if there had been a significant reduction in the relationship between 
the dependent and independent variables. 
 
8.3 Results 
8.3.1 Baseline Characteristics of Patients 
The baseline characteristics for the 192 participants (the 14 participants with missing 
data had been excluded at this stage) are as follows: The mean age of the participants 
was 66.0 (10.8) years (range 40-88 years). Women comprised 28.1% of the sample 
(n=54). The mode for deprivation category for the sample was 4. With regards to the 
baseline clinical data, 52 patients (27%) had experienced an MI previously, 58.9% of 
patients (n=113) had normal left ventricle functioning, 24.5% (n=47) had mild 
impairment, 11.5% (n=22) had moderate impairment, and 5.2% (n=10) had severe 
impairment. Sixty-two patients (32%) were currently smokers.  
 
In order to determine probable clinical caseness of anxiety and depression in the 
current sample, the following recommended cut-off points were used (Zigmond & 
Snaith, 1983). On the HADS subscales, individuals are classified as normal if they 
score 0-7, borderline if they score 8-10, with scores of 11-21 representing ‘caseness’. 
Therefore, in the current sample 39 (20.3%) patients scored in the ‘caseness’ range of 
anxiety, and another 12 (6.2%) scored as borderline cases of anxiety. For depression, 
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31 (16.1%) scored in the range of ‘caseness’, while 13 (6.8%) scored as borderline 
cases.  
 
8.3.2 Type D Personality Analysis 
From the sample of 192 participants, 65 (18 females and 47 males) were classified as 
Type D (33.9%) by using the recommended cut off point of ≥ 10 on both NA 
(M=11.43; SD=5.87) and SI (M=10.85; SD=5.73) sub-scales. This corresponds to 
33.3% of females and 36.1% of males being categorised as having a Type D 
personality. There was no effect of gender on Type D status, χ² (1, N=192)=0.009, ns. 
Z-tests for the equality between two proportions revealed that the prevalence rate 
observed in the current sample is not significantly higher (z=1.4, ns) than that found 
in the Dutch sample that was used to validate the DS14 (Denollet, 2005). In addition, 
the rate established in the current study is not significantly different to that found in  
the non-clinical sample in Chapter 4 (z=-1.57, ns). The stability of the Type D 
construct was found to be good (k=0.69), with 86.4% classified in the same way on 
both occasions. 
 
A MANOVA was carried out to examine differences between Type D and non-Type 
D individuals in each of the variables under investigation (see Table 8.1), gender was 
also entered as a factor. It was found that Type D individuals experience significantly 
higher levels of depression and anxiety compared to non-Type D individuals, Type D 
individuals have significantly lower levels of optimism compared to non-Type D’s. In 
addition, Type D’s also scored significantly lower on the measure of locus of control, 
indicating that they believe their recovery is less controllable by them, compared to 
non-Type D’s.  
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With regards to illness perceptions, Type D individuals believe that their illness has 
significantly more serious consequences, will last significantly longer, will be 
significantly less controllable by them or through treatment compared to non-Type D 
patients, and experience significantly more symptoms that they attribute to their 
illness. In addition, they are significantly more concerned about their illness, 
experience significantly more emotions as a result, and find their illness to be 
significantly less comprehensible compared to non-Type D individuals. Importantly, 
this demonstrates that all illness perceptions are different in Type D individuals.  
 
When looking at views on medications, Type D individuals believe their medication 
to be significantly less necessary compared to non-Type D individuals. However, 
there were no differences between Type D and non-Type D individuals in how 
concerned they were about their medication.  
 
For future thinking, Type D individuals generated significantly fewer positive future 
events compared to non-Type D’s. In addition, they generated significantly more 
negative future events compared to the non-Type D patients. However, there were no 
significant differences on role and goal investment between the two groups. 
 
Type D and non-Type D individuals were also compared across each of the main 
outcome measures. It was found that Type D individuals had significantly lower 
levels of quality of life, were significantly more functionally impaired, and were 
significantly less adherent to medication compared to non-Type D individuals. There 
were no differences between Type D and non-Type D individuals on benefit finding. 
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In the interest of completeness it should be noted that there was no significant effect 
of gender on any of these variables. In addition, there were no Type D x gender 
interations. Therefore, for ease of presentation Table 8.1 only shows the analysis for 
Type D and non-Type D individuals. 
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Table 8.1 Patient characteristics as a function of Type D personality 
Variable Type D Non-Type D F p 
Depression 10.93 (5.87) 4.83 (3.7) 51.16 p<.001 
Anxiety 10.32 (5.21) 5.22 (3.11) 56.85 p<.001 
Optimism 16.11 (4.18) 23.5 (3.03) 57.42 p<.001 
Recovery Locus of 
Control 
33.48 (6.68) 38.53 (3.88) 54.76 p<.001 
Consequences 8.03 (0.9) 6.07 (1.11) 50.64 p<.001 
Timeline 7.92 (1.17) 6.43 (1.45) 50.97 p<.001 
Personal Control 5.67 (0.92) 6.39 (1.97) 7.71 p<.05 
Treatment Control 6.43 (1.49) 7.79 (1.58) 33.31 p<.001 
Identity 6.6 (1.15) 4.89 (1.88) 45.42 p<.001 
Concern 7.77 (1.22) 7.04 (1.51) 11.11 p<.05 
Emotions 7.58 (1.22) 5.64 (1.88) 57.1 p<.001 
Comprehensibility 6.72 (0.65) 7.35 (1.21) 15.21 p<.001 
Medication 
Necessity 
14.37 (3.93) 16.84 (4.84) 8.86 p<.05 
Medication Concerns 13.87 (3.05) 13.55 (2.71) 0.37 ns 
Positive Future 
Thinking 
10.92 (4.12) 13.44 (3.22) 20.95 p<.001 
Negative Future 
Thinking 
9.07 (2.11) 7.86 (2.5) 11.17  p<.05 
Roles and Goals 2.95 (2.45) 2.99 (2.28) 0.1 ns 
Quality of Life 86.41 (18.84) 122.16 (25.52) 69.61 p<.001 
Functional Outcome 111.86 (29.01) 69.75 (29.49) 61.54 p<.001 
Adherence 18.72 (5.12) 23.06 (1.94) 48.38 p<.001 
Benefit Finding 36.78 (8.78) 40.23 (12.67) 2.7  ns 
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Chi-square analyses were then carried out in order to examine the differences between 
Type D and non-Type D individuals (see Table 8.2) on each of the health-related 
behaviours. It was found that Type D individuals are significantly less likely to eat 
sensibly or get enough sleep compared to non-Type D patients. In addition, Type D 
patients were found to be significantly more likely to be smokers compared to their 
non-Type D counterparts. However, no significant differences were found between 
Type D and non-Type D individuals on the following behaviours; spending time 
outdoors everyday, getting enough exercise, avoid letting things get me down, and get 
a regular medical check-up. 
 
Table 8.2 Chi-square Analysis for Type D and Health-related Behaviour 
 
 Type D  Non-Type D    
Health 
Behaviour 
Do not do or 
sometimes do 
Always Do not do or 
sometimes do 
Always χ² p 
Eat Sensibly 27 38 25 102 10.4 p<.01 
Get enough 
sleep 
46 19 56 71 12.29 p<.001 
Spend time 
outdoors 
everyday 
26 39 44 83 0.53 ns 
Do not smoke 
 
45 20 20 107 54.92 p<.001 
Get enough 
exercise 
45 20 83 44 0.29 ns 
Avoid letting 
things get me 
down 
38 27 81 46 0.52 ns 
Get a regular 
medical check-
up 
34 31 83 44 3.07 ns 
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8.3.3 Correlation Analysis 
Correlations, means, and SD’s were calculated for the outcomes and predictors. This 
was done in order to investigate the relationships between each of the variables.  The 
following sections outline which variables were significantly associated with each of 
the outcome variables. Three separate correlation matrices are presented (due to space 
constraints). The first (Table 8.3) gives the correlations between the demographic and 
clinical data with each of the outcome variables. The second (Table 8.4) presents the 
correlations between the outcome variables and illness perceptions, and the third 
(Table 8.5) presents the correlations between the remaining predictor variables and 
outcomes.  
 
8.3.3.1 Correlations between Demographic and Clinical Factors 
From Table 8.3 it can be seen that age was positively correlated with deprivation, 
depression at time 2, and anxiety at time 2. Age was also associated with lower levels 
of adherence and quality of life. Gender was not found to be correlated with any of 
the outcome measures, while deprivation was negatively correlated with quality of life. 
Having a previous MI was also negatively correlated with quality of life, and benefit 
finding, and was associated with more functional impairment and anxiety at time 2. 
Greater left ventricular impairment was associated with lower quality of life. 
 
8.3.3.2 Correlations between Illness Perceptions 
Table 8.4 presents the correlations between the illness perceptions and the outcome 
variables. The belief that your illness would have more serious consequences was 
associated with poorer quality of life, and adherence. It was associated with greater 
functional impairment, and depression and anxiety at time 2. The perception that your 
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illness would last for longer was associated with lower quality of life and benefit 
finding, and was associated with greater functional impairment and symptoms of 
depression and anxiety at time 2. The belief that your illness is personally controllable 
was not significantly correlated with any of the outcome variables. Believing that 
your illness could be controlled by treatment was associated with higher quality of life 
and adherence. It was related to greater functional impairment, and depression and 
anxiety at time 2. The perception of experiencing a greater number of symptoms from 
your illness was associated with greater functional impairment, and depression and 
anxiety at time 2. Being more concerned about your illness was not significantly 
associated with any of the outcome variables. Experiencing more negative emotions 
as a result of your illness was associated with poorer quality of life, and adherence. In 
addition, it was associated with higher depression and anxiety at time 2. Finally, 
understanding more about your illness was associated with lower depression at time 2. 
 
8.3.3.3 Correlations between Remaining Predictor Variables 
As shown in Table 8.5 all of the outcome variables (depression T2, anxiety T2, 
quality of life, adherence, functional outcome, benefit finding) were strongly 
intercorrelated. With regards to the predictor variables, depression and anxiety at time 
1 were associated with lower adherence, quality of life, and benefit finding, and with 
greater depression and anxiety at time 2. Overinvestment in roles and goals was not 
associated with any of the outcome measures. Recovery locus of control was 
associated with greater adherence and quality of life. It was associated with lower 
functional impairment, and depression and anxiety at time 2. Optimism was 
associated with greater adherence, quality of life, and benefit finding. It was 
associated with lower functional impairment, and depression and anxiety at time 2. 
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Type D personality was associated with poorer adherence and quality of life. In 
addition, it was associated with greater functional impairment, and depression and 
anxiety at time 2. Positive future thinking was associated with higher adherence, 
quality of life, and benefit finding, and was associated with lower functional 
impairment, and depression and anxiety at time 2. Conversely, negative future 
thinking was associated with lower adherence and quality of life, and associated with 
higher depression and anxiety at time 2. A stronger belief in the necessity of 
medication was correlated with higher adherence, quality of life and benefit finding. It 
was associated with lower functional impairment, and depression and anxiety at time 
2. Being more concerned about taking your medicines was associated with lower 
quality of life, and depression and anxiety at time 2. 
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8.3.4 Hierarchical Multiple Regression Analysis 
A series of hierarchical multiple regression analyses was conducted to determine what 
factors were predictive of each outcome variable: (1) adherence, (2) quality of life, (3) 
functional outcome, (4) distress, and (5) benefit finding. As described in Section 8.2.5, 
the order in which variables were entered into the equation was determined 
theoretically. Variables were selected for inclusion if they correlated significantly 
with the outcome variable as described in Section 8.3.3. Finally, if the regression 
analyses suggested that mediation had occurred between personality and outcome, 
formal mediation analyses were conducted using Baron and Kenny’s (1986) 
conditions for mediation, as described in Section 8.2.5. 
 
8.3.4.1 Adherence 
As demonstrated in Table 8.6, a multivariate hierarchical regression analysis with 
adherence at 3 months post-MI as the outcome variable was conducted. The variables 
were entered into the regression model in a series of steps as follows: the 
demographic (age, sex, deprivation) and clinical variables (LVF, previous MI) were 
entered in the first steps. Taken together, these variables accounted for a significant 
8.6% of the variance in adherence (R² = .086). Next, Type D personality was entered 
at Step 3, and significantly increased the variance explained by 20.9% (R²=.209). 
Optimism was then entered but it did not significantly increase the amount of variance 
explained. Depression and anxiety were then entered at Step 5, and significantly 
increased the variance explained by 6% to 37.7% (R²= .377). None of the remaining 
predictors (illness perceptions, medication beliefs, locus of control) added 
significantly to the amount of variance explained. The final model explained 41.5% of 
 203 
the variance in adherence (R² = .451), with high anxiety (β = -0.534, p<.05) being the 
only significant predictor of adherence in the final model.  
 
The regression model suggests that illness perceptions may mediate the relationship 
between Type D and adherence. However, as illness perceptions do not predict 
adherence when Type D is controlled for (as shown in Table 8.7), condition 3 for 
mediation is not met (Baron and Kenny, 1986).  Therefore, there is no evidence for 
mediation in this case. 
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8.3.4.2 Quality of Life 
Table 8.7 presents the hierarchical regression analysis of quality of life (overall score). 
Demographic and clinical factors were again entered in the first steps, taken together 
these variables accounted for a significant 17% (R² = .170) of the variance in quality 
of life. Type D was then entered at Step 3, significantly increasing the variance 
explained by 24.7% (R² = .247). The addition of optimism at Step 4 did not increase 
the amount of variance explained. Depression and anxiety were then entered at Step 5, 
their inclusion significantly increased the amount of variance explained by 5.9% (R² 
= .059), with anxiety (β = -0.531, p< .01) being responsible for the increase in 
variance explained. Illness perceptions were then entered at Step 6, but they did not 
significantly increase the amount of variance explained. Finally, future thinking 
(positive and negative) was entered at Step 7, significantly increasing the amount of 
variance explained by 4.8%. The final model accounted for 54.3% (R² = .543) of the 
variance in quality of life. Higher impairment of LVF (β = -0.146, p<.05), low 
positive future thinking (β = 0.248, p<.01), and high anxiety (β = -0.462, p<.05) 
remained significant predictors of quality of life in the final model. 
 
The regression model suggests that illness perceptions may mediate the effect of Type 
D on quality of life. However, again, illness perceptions do not predict quality of life 
when Type D is controlled for (as shown in Table 8.8), condition 3 for mediation is 
not met (Baron and Kenny, 1986).   
 
8.3.4.2.1 Emotional Quality of Life 
The hierarchical regression analysis of emotional quality of life is shown in Table 8.8. 
Again, demographic and clinical factors were entered in the first steps. Taken 
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together, these variables accounted for a significant 14.3% (R² = 0.143) of the 
variance in emotional quality of life. Type D then entered the equation at Step 3, and 
significantly explained an additional 27.4% of the variance (R² = 0.274). The addition 
of optimism at Step 4 did not significantly increase the variance explained. 
Depression and anxiety were then entered at Step 5, their inclusion significantly 
increased the variance explained by 4.4% (R² = 0.044). Illness perceptions (timeline 
and consequences) were then entered at Step 6, however, their inclusion did not 
significantly increase the amount of variance explained. In Step 7, future thinking 
(positive and negative) was added, and significantly explained an additional 5% of the 
variance. The final model accounted for 52.1% of the variance (Total R² = 0.521) in 
emotional quality of life. Higher impairment of LVF (β = -0.161, p<.05), low positive 
future thinking (β = 0.248, p<.01), and having a Type D personality (β = -0.439, 
p<.01), all remained significant predictors of emotional quality of life in the final 
model. As Type D remained significant at this stage it is not necessary to test for 
mediation. 
 
8.3.4.2.2 Social Quality of Life 
Table 8.9 presents the analysis for social quality of life. Demographic and clinical 
factors were again entered first. Taken together, their inclusion explains a significant 
16.5% of the variance in social quality of life (Total R² = 0.165). Type D was then 
entered at Step 3, significantly explaining an additional 21.5% of the variance (R² = 
0.215). Optimism was entered at Step 4, but it did not add significantly to the model. 
In Step 5, depression and anxiety were entered. Their inclusion accounted for a 
significantly additional 3.9% of the variance (R² = 0.039). Illness perceptions 
(timeline and consequences) then entered the equation at Step 6, and significantly 
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explained an additional 4.4% of the variance (R² = 0.044). Finally, future thinking 
(positive and negative) was entered at Step 7, and explained an additional 4.7% of the 
variance (R² = 0.047). The final model accounted for 51% of the variance in social 
quality of life. In the final model, low positive future thinking (β = 0.228, p<.01), high 
anxiety (β = -0.531, p<.05), and the belief that your illness has more serious 
consequences (β = -0.258, p<.05), remained significant predictors of social quality of 
life. 
 
The regression model suggests that illness perceptions (consequences) may mediate 
the relationship between Type D and social quality of life. Conditions 1-3 for 
mediation were met as Type D significantly affects the mediator (i.e., illness 
perceptions); (2) the independent variable affects the dependent variable (i.e., social 
quality of life); (3) illness perceptions affects social quality of life after controlling for 
Type D (as shown in Table 8.10). Furthermore, condition 4 was met as the addition of 
illness perceptions (consequences) reduced the beta coefficient of Type D from β=-
0.357 (p<0.01) to non-significance, β=0.036. The Sobel test confirmed that the 
relationship between Type D and social quality of life had been significantly reduced, 
z=-2.45, p<.05.  
 
8.3.4.2.2 Physical Quality of Life 
Table 8.10 presents the regression analysis of physical quality of life. Demographic 
and clinical factors were entered first, and significantly explained 18.8% of the 
variance (R² = 0.188). Next, Type D was entered at Step 3, it increased the variance 
explained by 22.6% (R² = 0.226). Optimism was entered next but it did not add 
significantly to the model. Depression and anxiety were then entered at Step 5, their 
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inclusion increased the variance explained by 7.8% (R² = 0.078). Illness perceptions 
(timeline and consequences) were then entered, they explained an additional 3.2% of 
the variance (R² = 0.032). Future thinking (positive and negative) was then entered in 
the final step and increased the variance explained by 4.2% (R² = 0.042). Overall, the 
final model accounted for 57.3% of the variance in physical quality of life (R² = 
0.573). Higher impairment of LVF(β = -0.132, p<.05), having experienced a previous 
MI (β = -0.144, p<.05), high anxiety (β = -0.581, p<.05), low positive future thinking 
(β = 0.236, p<.01) , and the belief that your illness would last for longer (β = -0.182, 
p<.05), remained significant predictors of physical quality of life in the final model. 
 
The model suggests illness perceptions (consequences) may mediate the relationship 
between Type D and physical quality of life. Conditions 1-3 for mediation were met 
as Type D significantly affects the mediator (e.g., illness perceptions); (2) the 
independent variable affects the dependent variable (e.g., quality of life); (3) the 
mediator affects the dependent variable when the independent variable is controlled. 
In addition condition 4 was met as the addition of illness perceptions (consequences) 
reduced the beta coefficient of Type D from β=-0.273 (p<0.01) to non-significance, 
β=0.031. The Sobel test confirmed that the relationship between Type D and physical 
quality of life had been significantly reduced, z=-4.19, p<.01.  
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8.3.2.3 Functional Outcome 
Table 8.11 presents the regression model for functional outcome. The demographic 
and clinical factors were entered in the first steps, and explained a significant 9.4% of 
the variance (R² = 0.094). Type D was then entered at Step 3 and significantly 
increased the amount of variance explained by 25.3% (R² = 0.253). Optimism was 
then entered but it did not add significantly to the amount of variance explained. 
Depression and anxiety were then entered at Step 5; their inclusion significantly 
increased the variance explained by 8.7% (R² =0.087). Illness perceptions and 
medication beliefs, and future thinking were then entered, but their inclusion did not 
add significantly to the model. The final model accounted for 48.2% of the variance in 
functional outcome (R²=0.482). Higher levels of depression (β = 0.645, p<.05) and 
anxiety (β = 0.872, p<.01) at time 1 remained significant predictors of functional 
outcome in the final model. 
 
The regression model suggests that illness perceptions may mediate the relationship 
between Type D and functional outcome. However, as illness perceptions do not 
predict functional outcome when Type D is controlled for (as shown in Table 8.12), 
condition 3 for mediation is not met (Baron and Kenny, 1986).   
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8.3.2.4 Psychological Distress 
8.3.2.4.1 Hierarchical Regression of Depression 
Table 8.12 presents the regression model for depression at time 2. Distress 
(depression and anxiety) at time 1 entered the equation at the first step, and explained 
a significant 73.1% of the variance (R² = 0.731). Demographics, MI severity, Type D, 
optimism and illness perceptions were then entered into the model, but their inclusion 
did not increase the amount of variance explained significantly. Finally, future 
thinking (positive and negative) was entered at Step 7, and significantly explained an 
additional 2.1% of the variance (R² = 0.021). The final model accounted for 77.9% of 
the variance in depression at time 2 (R² = 0.779). Higher levels of depression at time 1 
(β = 0.839, p<.01), a lower number of positive thoughts (β = -0.102, p<.05) , and a 
higher number of negative thoughts (β = 0.157, p<.01) remained significant predictors 
in the final model. 
 
8.3.2.4.2 Hierarchical Regression of Anxiety 
The regression model for anxiety at time 2 is presented in Table 8.13. Distress 
(depression and anxiety) at time 1 was again entered in the first step, and significantly 
explained 64.9% of the variance (R² = 0.649). Demographics, MI severity, Type D, 
and optimism were then entered, but their inclusion did not add significantly to the 
amount of variance explained. Illness perceptions (timeline, consequences, identity, 
treatment control) were then entered at Step 6, and significantly explained an 
additional 5.4% of the variance (R² = 0.054). Finally, future thinking (positive and 
negative) was entered at Step 7, but it did not add significantly to the model. The final 
model accounted for 73.8% of the variance in anxiety at time 2 (R² = 0.738). 
Treatment control (β = -0.256, p<.05), previous MI (β = 0.122, p<.05), and anxiety at 
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time 1 (β = 0.735, p<.01), remained significant predictors in the final model. Anxiety 
at time 2 was therefore predicted by higher anxiety at time 1, a lower perception of 
treatment control, and whether patients had experienced a previous MI. 
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8.3.2.5 Benefit Finding 
Table 8.14 presents the regression model for benefit finding. Demographic and 
clinical factors were entered in the first steps, their inclusion explained a non-
significant 5.5% of the variance. Next, Type D entered at Step 3, but it did not 
significantly increase the amount of variance explained. Optimism was entered at Step 
4, significantly explaining an additional 4.9% of the variance (R² = 0.049). Depression 
and anxiety were then entered at Step 5, their inclusion significantly explained an 
additional 13.3% of variance (R² = 0.133). Next, illness perceptions (timeline and 
comprehensibility) were entered, and significantly explained an extra 16.7% of the 
variance (R² = 0.167). Finally, future thinking (positive and negative) was entered at 
Step 7, but their inclusion failed to add significantly to the variance explained. Overall, 
the model accounted for 41.6% of the variance in benefit finding (R² = 0.416). 
Optimism (β = 0.279, p<.05) and comprehensibility (β = -0.562, p<.05) remained 
significant predictors in the final model. Thus, in the final model, higher levels of 
optimism and lower levels of comprehensibility predicted benefit finding. 
 
Table 8.15 provides a summary a summary table relating to the significant predictors 
of each outcome variable 
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8.4 Discussion 
The broad aim of the current study was to identify predictors of psychosocial and 
psychological outcome post-MI. Specifically, the study had four key aims; (i) To 
investigate the prevalence of Type D personality in the current sample, and the 
relationship between Type D and each of the variables under investigation; (ii) to 
investigate if personality predicts outcome after controlling for clinical and 
demographic variables; (iii) to determine if personality predicts outcome after 
controlling for mood, and (iv) to identify the mechanisms by which personality is 
associated with adverse psychological outcome. 
 
8.4.1 The Role of Type D Personality 
8.4.1.1 Prevalence of Type D Personality 
The prevalence of Type D personality in the current sample was found to be 33.9%. 
To our knowledge, this is the first time that the prevalence of Type D personality has 
been investigated in a sample of cardiac patients in the UK. Previous studies, in other 
European cardiac populations have found prevalence rates of between 25-28% 
(Denollet, 2005; Grande et al, 2004; Gremigni et al, 2005). Although the prevalence 
found in the current sample is higher, it was not found to be significantly higher than 
that found in other countries. The rate found in the present sample is also similar to 
that found in the general population in the studies reported in Chapter 5 (section 5.3.1) 
and 6 (section 6.6.1) which found rates of 39%. 
 
8.4.1.2 Stability of Type D Personality 
The stability of Type D personality was also assessed in the current study. It was 
found that 86.4% of the sample was consistently classified as Type D or non-Type D 
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at time 1, and 3 months later at time 2. The first study presented in Chapter 6 found 
the stability of the Type D construct to be lower in a healthy population, at 76.7%. 
However, Pelle et al (in press) report similar findings to the present study, with 81% 
of their cardiac sample being classified in the same way across two time points, also 
three months apart. These findings, therefore, suggest that Type D is a relatively 
stable construct over time. As Type D is intended to represent a personality trait then 
it would be necessary for the measure to show good stability over time.  
 
However, it should be noted that despite the high percentage of those individuals 
being classified the same at both time points, approximately 1 in 5 were not classified 
consistently as Type D or non-Type D over a relatively short period of 3 months. 
Indeed, as Type D personality delineates a stable personality trait it is important to 
question whether classifying 13.6% of the sample differently on 2 occasions, 
separated by only 3 months, is satisfactory. Therefore, future research is required to 
investigate the stability of Type D over longer periods of time. 
 
8.4.1.3 The Relationship between Type D and the Outcome and Predictor Variables 
It was also important to determine the relationship between Type D and each of the 
variables under investigation. With regards to the outcome measures, Type D 
individuals reported lower quality of life and medication adherence. They also 
reported higher levels of functional impairment and a greater number of symptoms of 
depression and anxiety. Previous research has also found Type D to be related to 
outcome in cardiac patients. For example, Al-Ruzzeh et al (2005) found an 
association between Type D and poor quality of life. In addition, Denollet et al (1995) 
and Schiffer et al (2005) also found Type D to be related to symptoms of depression 
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and anxiety. However, the current study is the first to suggest a relationship between 
Type D and medication adherence. If Type D individuals are less likely to take their 
medication as directed then this could help to explain why Type D patients have poor 
clinical outcome relative to non-Type D patients. 
 
The relationship between Type D and each of the predictor variables was also 
examined. It was found that Type D individuals were less optimistic than their non-
Type D counterparts. Denollet (1998) had also identified a relationship between Type 
D and optimism. The current study also identified a relationship between Type D and 
locus of control for the first time, with Type D individuals believing that they had less 
control over their recovery than non-Type D’s. The current study is also the first to 
establish a relationship between Type D and all illness perceptions. Specifically, Type 
D’s believed their illness to be less controllable by themselves or by treatment. In 
addition, they understood their illness less, believed it would last for longer, and 
experienced more emotions and symptoms as a result of their illness. Importantly, 
Type D individuals can therefore be seen to be different to non-Type D individuals on 
all illness perceptions. These findings suggest that one way that Type D leads to poor 
cardiac outcome is through illness perceptions. 
 
Furthermore, the current study also identified a relationship between future thinking 
and Type D for the first time. Type D’s produced fewer positive thoughts and more 
negative future thoughts. All of these relationships suggest possible mechanisms by 
which Type D may affect health. Sections 8.4.2 – 8.4.6 outline which of these 
possible mechanisms were found to be important in relation to the outcome measures. 
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As in the studies described in Chapter 5 (section 5.3.3) and 6 (section 6.6.4), the 
current study also found a relationship between Type D and health-related behaviours. 
Type D’s were less likely to eat sensibly or get enough sleep compared to non-Type D 
participants. In addition, Type D patients were found to be significantly more likely to 
be smokers compared to their non-Type D counterparts.  
 
8.4.1.4 Does Type D Personality Predict Outcome After Controlling for Demographic 
and Clinical Factors? 
A further aim of the study was to determine if Type D predicts outcome after 
controlling for clinical and demographic factors. As demonstrated by the hierarchical 
multiple regression analyses, Type D was a significant predictor of adherence, quality 
of life, and functional outcome, after controlling for demographic and clinical factors. 
Indeed, Type D consistently predicted an additional 20-25% of the variance of each 
variable. Previous research (e.g. Denollet et al, 1996) has also found that Type D is 
predictive of both mortality and morbidity after controlling for biomedical factors. In 
the current study Type D is a stable predictor of psychological morbidity post-MI, 
increasing the variance explained by traditional demographic and clinical factors by 
20-25%. 
 
8.4.1.5 Does Type D Personality Predict Outcome After Controlling for Mood? 
Given that some theorists (e.g. Lesperance & Frasure-Smith, 1996) have criticised 
Type D as just being another measure of negative affect, it is important to ascertain 
whether Type D will remain a significant predictor of outcome in the current study 
once depression and anxiety are added to the equation. For adherence, quality of life, 
and functional outcome Type D remained a significant predictor, even after 
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depression and anxiety were controlled for.  In addition, Denollet et al (2006) found 
that it was the interaction of social inhibition and negative emotions, rather than 
negative emotions per se, which predicted poor clinical outcome. Taken together, the 
findings from the current study and the study by Denollet et al (2006) demonstrate 
that Type D is not simply a measure of negative affectivity. 
 
The following sections outline which factors were the best predictors of each of the 
outcome variables (adherence, quality of life, functional outcome, depression, anxiety, 
benefit finding).  
 
8.4.2 Predictors of Medication Adherence Post-MI 
Results from the regression analyses (section 8.3.4.1) demonstrate that Type D 
personality and psychological distress were significant predictors of adherence post-
MI. Type D patients, and those experiencing a greater number of symptoms of anxiety 
reporting lower levels of medication adherence. This is the first study to identify a 
relationship between Type D and adherence, and suggests one possible way in which 
Type D may be associated with poor outcome. However, anxiety was found to be the 
best predictor of adherence. Previous research has also identified that psychological 
distress is associated with adherence (e.g. Carney et al, 1995). However, surprisingly 
illness perceptions and medication beliefs were not found to be predictive of 
adherence. Previous research, for example, Byrne, Walsh & Murphy (2005) found an 
association between illness perceptions and preventive behaviour, and a relationship 
between medication beliefs and adherence to medication. 
 
 
 227 
8.4.3 Predictors of Quality of Life Post-MI 
For overall quality of life, demographics, MI severity, Type D, distress, and future 
thinking were found to be significant predictors. Similar findings regarding the 
predictive utility of Type D (Al-Ruzzeh et al, 2005), and psychological distress in 
relation to quality of life have been reported previously. For example, Lane et al 
(2001) found that poorer quality of life at 12 months was predicted by greater baseline 
level of depression, greater severity of infarction, living alone, and state anxiety. 
However, the current study is the first to identify a relationship between future 
thinking and outcome in MI patients. Previous research has found that future thinking 
is an important risk factor for depression and suicide risk. However, relatively little 
research has examined the predictive utility of future thinking in patients with 
physical health problems. Recently, Moore et al (2006) found that depressed multiple 
sclerosis patients had a lack of positive thoughts about the future. Similarly, results in 
the current study found that patients with lower quality of life also had a lack of 
positive future thoughts. The best predictors of quality of life were found to be LVF, 
anxiety and positive future thinking. Thus, patients with poorer LVF, greater 
symptoms of anxiety, and those who had a lack of positive future thoughts had poorer 
quality of life. 
 
A similar pattern of results was found for emotional quality of life, with MI severity, 
Type D, distress and future thinking being significant predictors. LVF, Type D, and 
positive future thinking remained significant predictors in the final model. For social 
quality of life, demographics, MI severity, Type D, distress, illness perceptions and 
future thinking were all significant predictors. However, in the final model only 
anxiety, consequences, and positive future thinking remained significant predictors. 
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Social quality of life is therefore predicted by high levels of anxiety, believing that 
your illness will have more serious consequences, and a lack of positive future 
thoughts. The role of illness perceptions in predicting quality of life of MI patients 
was also identified by Petrie et al (1996). They also found that patients who believed 
their MI would have more serious long-lasting consequences had higher levels of 
illness-related disability and were slower to return to work. Results from the current 
therefore add further evidence relating to the importance of illness perceptions in the 
recovery of MI patients.  
 
For physical quality of life, demographics, MI severity, Type D, distress, illness 
perceptions, and future thinking all significantly increased the amount of variance 
explained. However, in the final model, MI severity, anxiety, timeline and positive 
future thinking remained significant. Physical quality of life was therefore best 
predicted by increased severity of MI, greater symptoms of anxiety, the belief that 
your illness would last for a longer period of time, and a lack of positive future 
thoughts. Again, these results highlight the importance of illness perceptions in 
predicting outcome post-MI. Importantly, Petrie et al (2002) have demonstrated that it 
is possible to change patients’ illness perceptions, and in turn improve their outcome.  
 
Overall, when considering the subscales and the total score, these findings suggest 
that there are several key predictors of quality of life post-MI. First, demographics 
and MI severity are important determinants. However, the psychological variables do 
predict quality of life even after controlling for these factors. Second, Type D is an 
important predictor in the early steps of the model but its effect seems to be mediated 
by illness perceptions (see Section 8.4.7). Third, psychological distress is also an 
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important predictor. Specifically, symptoms of anxiety are associated with poorer 
quality of life. Fourth, the current study adds further evidence to support the role of 
illness perceptions in predicting the outcome of post-MI patients. Patients’ beliefs 
regarding consequences and timeline of their MI were particularly important. Finally, 
the current study has identified for the first time the importance of future thinking in 
predicting quality of life post-MI, specifically, a lack of positive future thoughts is 
related to poorer quality of life. 
 
8.4.4 Predictors of Functional Outcome Post-MI 
The predictors of functional outcome were also identified. MI severity, Type D, and 
distress were all significant predictors. However, only psychological distress 
remained a significant predictor in the final model. In line with previous research (e.g. 
Mayou et al, 2000) symptoms of both depression and anxiety predicted functional 
outcome. Similarly, de Jonge et al (2006) found that patients with post-MI depression 
had more disability at 12 months post-MI. 
 
8.4.5 Predictors of Distress Post-MI 
In the current sample, 20.3% of patients scored as possible cases of anxiety, and 
16.1% scored as possible cases of depression. These findings demonstrate that 
symptoms of depression and anxiety are prevalent in post-MI patients. Previous 
studies have also reported symptoms of depression and anxiety to be common 
problems in MI patients. Indeed, previous studies report prevalence rates of 
depression ranging from 17-37% in terms of probably caseness (Frasure-Smith et al, 
1995; Ladwig et al, 1994), and prevalence rates of anxiety between 24-31% (Frasure-
Smith et al, 1995; 1999). 
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It is also of importance to determine predictors of psychological distress post-MI. As 
expected, the best predictor of depression at time 2 was depression at time 1. However, 
future thinking also emerged as a significant predictor. A lack of positive future 
thoughts and a higher number of positive negative thoughts were both found to 
predict depression at 3 months post-MI. As mentioned previously, the current study is 
the first to examine the predictive utility of future thinking in MI patients. Findings 
from the current study suggest that future thinking is therefore predictive of both 
quality of life and depression post-MI. Previous research on future thinking has found 
that depressed individuals have difficulties thinking about the future. Indeed, earlier 
research has found future thinking to be related to depression in a number of patient 
groups, including those with multiple sclerosis (Moore et al, 2006),and tinnitus 
(Andersson et al, 2007). The current findings therefore extend the available evidence 
on future thinking, by identifying for the first time that future thinking is predictive of 
post-MI depressive symptoms. 
 
For anxiety at time 2, three factors emerged as significant predictors. They were 
anxiety at time 1, previous MI, and treatment control. Therefore, patients who 
experienced a greater number of symptoms of anxiety at time 1, those who had 
experienced an MI previously, and those who believed their illness was less 
controllable by treatment had a greater number of anxiety symptoms at time 2. These 
findings again suggest the importance of illness perceptions in predicting outcome 
post-MI.  
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8.4.6 Predictors of Benefit Finding Post-MI 
Benefit finding was investigated as a possible positive outcome in MI patients. It was 
found that being more optimistic and understanding less about your illness were 
predictive of benefit finding post-MI. The relationship between optimism and benefit 
finding is unsurprising as these are largely similar constructs. However, of greater 
interest is the finding that understanding less about your illness is predictive of 
experiencing more benefits or gains from their illness. In this case it seems that 
understanding less about your illness may have a beneficial effect. This finding ties in 
with recent some recent research on benefit finding, which questions whether benefit 
finding is actually beneficial for the individual (e.g. Tomich & Helgeson, 2004). They 
believe that benefit finding may reflect a reluctance to concede the severity of one’s 
diagnosis. The findings of the current study could therefore be understood as an 
individual’s avoidance to understand more about their illness in order to protect 
themselves from painful or frightening information. It is possible that benefit finding 
reflects the denial and avoidance of illness related information. Benefit finding may 
therefore become maladaptive over time because it may interfere with effective 
coping strategies. 
 
8.4.7 Type D Mechanisms of Effect 
A further aim of the current study was to identify the mechanisms through which 
personality (Type D and optimism) may affect outcome. As optimism was only found 
to be predictive of benefit finding, and remained significant in the final model it is not 
possible to investigate any potential mediators of the optimism – outcome relationship. 
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Several possible cases of mediation relating to Type D personality were established, 
in each case it appears as though the relationship between Type D and outcome is 
being mediated by illness perceptions. It was found that patients’ illness perceptions 
relating to consequences mediated the relationship between Type D and social quality 
of life, and Type D and physical quality of life.  
 
Illness perceptions may, therefore, reflect one way in which Type D personality 
causes poor outcome in cardiac patients. In the current study, Type D affected social 
and physical quality of life because Type D individuals believed that their illness 
would have more serious long-lasting consequences than non-Type D individuals. 
This may be a particularly important finding in relation to developing interventions 
for Type D patients. Previous research by Petrie et al (2002) has identified that it is 
possible to modify patients’ illness perceptions through intervention, and improve 
their outcome as a result. Thus, if the illness perceptions of Type D patients are 
modified it may be possible to improve their quality of life. 
 
Moreover, linked to the association between Type D and health-related behaviour, 
Type D individuals were found to be less adherent to medication than non-Type D 
individuals. Clearly, if Type D individuals are not taking their medication as directed 
this will have a substantial impact on their outcome. Medication adherence therefore 
represents one very powerful mechanism to explain the link between Type D and 
adverse clinical outcome in cardiac disease. 
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Taken together with the findings from the other studies in this thesis, several possible 
mechanisms through which Type D may lead to adverse outcome have been identified. 
It has been found that Type D may affect health through health-related behaviour, 
adherence, social support, cardiovascular reactivity, and illness perceptions. 
 
8.4.8 Limitations 
It is important to acknowledge limitations of the current study. First, the study may be 
limited by the representativeness of the sample.  The patient sample recruited for this 
study may have been affected by selection bias in the following way. Only patients 
who were well enough to be interviewed were recruited. These findings may, 
therefore, reflect patients who experienced a less serious MI than those who were too 
ill to participate. The sample may therefore not be representative of MI patients in 
general, but rather of those that had experienced a less serious MI, or those that had 
made a good recovery while hospitalised following MI. In addition, the considerable 
proportion of excluded patients during the different phases of the study should be 
considered. The number of patients who had incomplete assessments, or were lost to 
follow-up may have resulted in an under representation of patients with poor health 
status. 
 
The study may also have been limited by the timing of when the Time 1 and Time 2 
assessments took place. Patients’ beliefs and illness perceptions were assessed within 
the first few days following admission, and may therefore have been influenced by the 
information given to them by nursing and medical staff. Patients are often given a lot 
of information whilst on the coronary care unit, including information about the 
causes of MI. In addition, all patients are also given a copy of the Heart Manual 
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(Lewin et al, 1992) in the first few days following admission which gives the patients 
advice on rehabilitation and secondary prevention of CHD. Therefore, although 
efforts were made to interview patients early in their treatment in order to elicit their 
own beliefs and illness perceptions, it is possible that they had already been 
influenced by information given to them during the initial stages of their hospital 
admission. More generally, the follow-up period of three months is relatively short, 
and can only allow conclusions to be drawn regarding the short-term recovery of MI 
patients. For example, it may be that the duration of follow-up was insufficient to 
detect effects which may be present at longer follow-up periods. However, timescale 
of the PhD made a short follow-up the only option. 
 
The current study relied on self-report measures, and may therefore be subject to self 
presentation and recall biases which are common problems faced when using self-
report measures. Specifically, the assessment of medication adherence is known to be 
affected by recall bias, indeed it has been estimated that self reports may 
underestimate the true extent of non-adherence by approximately 20% (Horne, 2000). 
In order to encourage patients to be as honest as possible without concern that their 
answers might influence their treatment, patients were assured that the information 
they gave would not be entered into their medical notes and that their doctor would 
not see their responses. Even so, this study was subject to the risk of interviewer bias 
whereby patients seek to offer answers they believe will please the interviewer, and 
recall bias involving over or underestimation of behaviours, such as medication 
adherence. In addition, the reliance on a self-report questionnaire rather than formal 
diagnostic criteria when assessing anxiety and depression may be a further limitation. 
As a result, the possibility of a self report bias, which may be present both in the self 
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reported depressive symptoms and the outcome measures, such as quality of life, 
cannot be ruled out. In addition, it would also have been beneficial to include a 
measure of social support in the current study in order to determine if it had a 
mediating role on the relationship between personality and outcome. 
 
It is possible that the inconsistent pattern of results found in the current study is due to 
the relatively small sample size. Our sample only had the power to detect medium 
effect sizes and so may consequently have missed other smaller effects that may have 
been detected with more participants.   
 
8.4.9 Conclusions and Future Research 
Future research is required to determine if these are robust and replicable findings. In 
addition, it is important to determine if the relationships observed will remain 
significant in the longer term outcome of these patients. Furthermore, future research 
is required to identify further possible mediators of the personality – outcome 
relationship. It is important for both psychosocial and psychophysiological 
mechanisms to be investigated in cardiac patients in order to identify the proximal 
risk factors which explain the link between personality and outcome. 
 
The current study has extended the existing research on personality and psychological 
outcome post-MI in several key ways. First, the Type D construct has been assessed 
in a British cardiac population for the first time. The Type D prevalence rate was 
found to be 33.9% in the current sample. In addition the stability of the measure was 
found to be good. Second, it was found that Type D predicted adherence, quality of 
life and functional impairment after controlling for demographic factors, clinical 
 236 
factors and mood. Indeed, Type D exerted a consistent effect of outcome, explaining 
20-25% of the variance of each outcome measure. Third, illness perceptions and 
adherence have been identified as a possible mechanism by which Type D may affect 
health. 
 
The current findings have also extended the existing research on predictors of 
psychological outcome post-MI in a number of ways. First, the current study 
identified for the first time that future thinking may play an important role in 
predicting quality of life, functional impairment and depression post-MI. Second, the 
importance of depression and anxiety in predicting quality of life and functional 
impairment post-MI has again been highlighted. Third, the findings relating to illness 
perceptions have been extended, and confirm an important role for illness perceptions 
in predicting quality of life and benefit finding in MI patients. 
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Chapter 9: General Discussion 
 
9.0 Overview 
This final chapter offers a broad discussion of the key findings and whether the 
specific aims of the study have been met. It will discuss how the findings fit with 
previous research, outline the limitations of the thesis, and suggest areas where this 
research may be developed further. In addition, this chapter places the major findings 
within the theoretical context of Leventhal’s CSM (Leventhal et al, 1980). 
 
9.1 Introduction 
Due to advancements in the treatment of CHD more people are now surviving cardiac 
events (Fox et al, 2007), meaning that there are large numbers of people in the UK 
who have experienced an MI, estimated at around 1.3 million people (British Heart 
Foundation, 2006). This represents a new problem as experiencing an MI can have a 
long lasting impact on an individual in terms of both physical and psychological 
adjustment and quality of life (Frasure-Smith & Lesperance, 2003). Therefore, in 
order to address the problem of psychological outcome post-MI this thesis sought to 
investigate which factors predict outcome, including quality of life, mood, functional 
impairment, adherence, and benefit finding in a prospective cohort of MI patients. 
Within this, a particular focus was placed on the role of personality. The concept of 
Type D personality was investigated, as it appears to be an emerging risk factor in 
CHD (Pedersen & Denollet, 2006).To this end, five studies were conducted which 
investigated the concept of Type D personality, and predictors of outcome post-MI 
within a self-regulatory framework.  The thesis had four main aims: 
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(i) To investigate predictors of psychological outcome post-MI. 
(ii) To determine the prevalence and stability of Type D Personality in the UK. 
(iii) To determine if personality is predictive of psychological outcome after 
controlling for mood, and demographic and clinical factors. 
(iv) To investigate potential mechanisms which may explain the link between 
personality and adverse outcome in cardiac patients, specifically, (a) health-related 
behaviours, and (b) cardiovascular reactivity. 
 
9.2 Findings on Type D Personality 
This thesis aimed to extend the available evidence relating to Type D personality. 
Specifically, to investigate potential ways in which Type D may be associated with 
adverse prognosis in cardiac patients. Denollet and Pedersen have repeatedly 
demonstrated that the Type D construct is a predictor of adverse prognosis in cardiac 
patients (Pedersen & Denollet, 2006). The study had several key aims in relation to 
Type D personality. They were, (i) to investigate the prevalence and stability of Type 
D personality in the UK; (ii) to determine if Type D is predictive of psychological 
outcome in MI patients after controlling for demographics, clinical factors and mood, 
and (iii) to investigate potential psychosocial and psychophysiological mechanisms 
which may explain the link between Type D and adverse outcome in cardiac patients. 
 
9.2.1 Prevalence and Stability of Type D Personality 
The first aim of this thesis was to establish the prevalence of Type D personality in 
the UK. This is the first study to have examined Type D prevalence in either a healthy 
or cardiac population from the UK. The standard Type D classification of ≥ 10 on 
both NA and SI subscales was used (Denollet, 2005). The prevalence of Type D 
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personality was found to be 38.5% in the healthy population (Chapter 5, section 5.3.1), 
and 33.9% in the cardiac population (Chapter 8, section 8.3.2). From this it is 
apparent that the prevalence of Type D is higher in the healthy population, compared 
to the MI patients. If Type D is an etiological risk factor for CHD (something that has 
not yet been established), then it would be expected that the cardiac population would 
contain a higher number of Type D cases, but this was not the case. 
  
There are several possible explanations as to why the prevalence of Type D was 
higher in the healthy samples. First, the healthy sample is younger than the MI sample, 
and consists of university students who are known to suffer from high rates of 
psychological distress (Furr et al, 2001). This could have led to elevated scores on the 
SI and NA subscales, and consequently an increased Type D prevalence rate. Second, 
the healthy sample is predominantly female, while the MI sample is predominantly 
male. Although no gender differences in terms of prevalence were observed in any of 
the studies conducted within this thesis, a previous study by Pedersen and Middel 
(2001) found higher rates of Type D among female participants (41%) compared to 
males (26%). 
 
The prevalence rates in the current studies are higher than the rates of between 21% 
and 32.5% that have been found elsewhere in Europe (Grande et al, 2004; Gremigni 
& Sommaruga, 2005; Denollet et al, 2005). It is important to consider why the Type 
D rate is higher within the UK. One possibility is that it could represent a cultural 
difference between the UK and the rest of Europe. People from the UK are commonly 
thought to be more socially inhibited and less likely to show emotion than people 
from other cultures (Todd & Shapiro, 1974). This so-called ‘British stiff upper lip’ 
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could lead to increased scores on social inhibition, one of the components of Type D. 
Although Type D is more than just social inhibition, it is important to note that an 
increase in social inhibition by a even a couple of points may be enough to classify an 
individual as Type D, if they have the required level of negative affectivity. 
 
A further reason could be that the prevalence of Type D is higher because the 
prevalence of CHD is higher in the UK (Allender et al, 2006). At the moment it is 
unclear if Type D is a predictor of CHD incidence or only a predictor of recovery in 
patients with already established CHD. If Type D is established as a predictor of CHD 
then it would be expected for the Type D prevalence rate to be higher in the UK than 
in other countries. Indeed, one important way in which the research on Type D needs 
to develop is by the identification of the direction of causality by which Type D 
affects health. This is needed in order to determine if Type D is an etiological risk 
factor, as well as a prognostic risk factor for CHD.  
 
An important consideration is the arbitrary nature of the recommended cut-off points 
which are used to classify Type D. Denollet (2005) has suggested using a cut-off of 
≥10 on both the SI and NA subscales of the DS14. This recommendation was based 
on a median split of the NA and SI scores among the cardiac patients used in the 
study which validated the DS14 scale (Denollet, 2005). Prior to this there had been no 
standard way of assessing Type D. It may be important for future research to consider 
alternative ways of classifying Type D, for example by using more stringent cut-off 
points (similar to those used in Chapter 7, Section 7.2.1).  
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 The stability of the construct was also investigated. It was found that 76.7% of the 
healthy population, and 86.4% of the cardiac population were classified in the same 
way at two time points, three months apart. Pelle et al (in press) report similar 
findings, with 81% of their cardiac sample being classified in the same way across 
two time points, also three months apart. These findings therefore suggest that Type D 
is a relatively stable construct over time. As Type D is intended to represent a 
personality trait then it would be necessary for the measure to show good stability. 
However, it is important to note that the classification of approximately 1 in 5 
participants has changed over a relatively short period of time (3 months). Indeed, if 
Type D is intended to represent a stable personality trait then perhaps the stability of 
the measure should be better. Further research is required to determine the stability of 
Type D over longer periods of time. 
 
9.2.2 Type D Personality as a Predictor of Outcome in MI Patients 
The utility of the Type D construct in predicting psychological outcome in MI 
patients was investigated in Chapter 8. It was found that Type D was a significant 
predictor of poor adherence, poor quality of life, and poor functional outcome, after 
controlling for demographic and clinical factors. Previous research (e.g. Denollet et al, 
1996) has also found that Type D is predictive of both mortality and morbidity after 
controlling for biomedical factors. In the current study, Type D is a stable predictor of 
psychological morbidity post-MI, increasing the variance explained by traditional 
demographic and clinical factors by 20-25%. Furthermore, Type D remained a 
significant predictor after controlling for mood. This is a particularly important 
finding as some theorists (e.g. Lesperance & Frasure-Smith, 1996) have criticised 
Type D as being just another measure of negative affect. Similarly, the studies 
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described in Chapter 5 (section 5.3.2) and 6 (section 6.3.4) also demonstrated that the 
relationships between Type D and social support, and Type D and health-related 
behaviour remained significant after controlling for neuroticism.  In addition, Denollet 
et al (2006) found that it was the interaction of social inhibition and negative emotions, 
rather than negative emotions per se, which predicted poor clinical outcome. Taken 
together, the findings from the current study, those from Chapter 5 and 6, and the 
study by Denollet et al (2006) suggest that Type D is not simply another measure of 
negative affectivity. 
 
9.2.3 Type D Personality Mechanisms of Effect 
The studies described in Chapters 5-7 investigated both potential psychosocial (health 
behaviour, adherence, social support) and psychophysiological (cardiovascular 
reactivity) mechanisms in populations of healthy young adults. In addition, the 
clinical study described in Chapter 8 investigated potential mechanisms within a 
population of MI patients. The findings from these chapters suggest a role for social 
support, health-related behaviour, cardiovascular reactivity, and illness perceptions in 
explaining the relationship between Type D and adverse outcome in cardiac patients. 
 
Results from the studies presented in Chapter 5 (section 5.4.2) and 6 (section 6.6.2) 
demonstrated that Type D personality is associated with low social support. 
Specifically, Type D individuals were found to experience significantly lower levels 
of perceived social support (an established risk factor for ill health and cardiac death) 
compared with non-Type D individuals. Previous research by Denollet et al (1996) 
demonstrated that people with Type D personality experience higher levels of 
perceived social alienation and are more socially withdrawn than non-Type D 
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individuals. The association between Type D and low social support is important as 
an inverse association has been demonstrated between social support and mortality 
(Berkman & Syme, 1979), demonstrating that individuals with higher levels of social 
support have better health outcomes. For example, Type D may limit an individual’s 
access to coping resources, such as supportive social networks. Therefore, Type D 
individuals may have a poorer outcome due to lower levels of social support. Indeed, 
the importance of social support has been further demonstrated in a recent study by 
van den Broek et al (2007) who found that Type D patients without a partner reported 
more symptoms of anxiety and depression compared to Type D patients with a partner. 
 
The studies described in Chapters 5 (section 5.4.3), 6 (section 6.6.4), and 8 (section 
8.3.2) demonstrate that Type D personality is associated with health-related behaviour. 
Specifically, Type D individuals perform significantly fewer health-related 
behaviours compared to non-Type D individuals. Findings from a previous study by 
Pedersen et al (2004) also demonstrated that Type D individuals were more likely to 
be smokers compared to non-Type D individuals. In addition, evidence for a further 
behavioural mechanism was recently demonstrated by Schiffer and Denollet (2007) 
who found that Type D patients were less likely to report their cardiac symptoms 
compared to non-Type D individuals. Indeed, targeting the maladaptive health 
behaviour of Type D individuals may be the most obvious and effective way of aiding 
secondary prevention within this group. 
 
Moreover, linked to the above findings on health-related behaviour, Type D 
individuals were found to be less adherent to medication than non-Type D individuals. 
Clearly, if Type D individuals are not taking their medication as directed this will 
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have a substantial impact on their outcome. Medication adherence therefore 
represents one very powerful mechanism to explain the link between Type D and 
adverse clinical outcome in cardiac disease. 
 
The results from the study described in Chapter 7 (section 7.3.2) demonstrated that 
Type D personality is also related to cardiovascular reactivity to stress. Specifically, 
male Type D individuals were found to exhibit increased cardiac output during stress 
compared to non-Type D individuals. Previous research from Habra et al (2001) had 
demonstrated that the separate components of Type D (social inhibition and negative 
affectivity) were related to reactivity, but they failed to find an association with the 
global Type D construct. The results from Chapter 7 therefore demonstrate for the 
first time that Type D personality is related to heightened cardiac output during acute 
stress, importantly increased cardiac output has been implicated early in the disease 
course of hypertension. 
 
Findings from Chapter 8 (section 8.3.4.2.2) demonstrate that Type D may have an 
affect on outcome through illness perceptions. Indeed, when comparing Type D and 
non-Type D individuals it was shown that Type D’s are significantly different on all 
illness perceptions. In addition, the hierarchical multiple regression analysis 
demonstrated a possible mediating role of illness perceptions on the relationship 
between Type D and quality of life, specifically relating to patients’ beliefs about the 
consequences of illness. It was found that Type D affected social and physical quality 
of life because Type D individuals believed that their illness would have more serious 
long-lasting consequences than non-Type D individuals. This may be a particularly 
important finding in relation to developing interventions for Type D patients. Previous 
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research by Petrie et al (2002) has identified that it is possible to modify patients’ 
illness perceptions through intervention, and improve their outcome as a result. Thus, 
if the illness perceptions of Type D patients are modified early in the course of their 
illness it may be possible to improve their quality of life. 
 
9.3 Mood, Illness Perceptions, and Future-Thinking as Predictors of 
Psychological Outcome Post-MI 
In addition to Type D personality, three other variables emerged as consistent 
predictors of outcome. These were; mood, illness perceptions, and future thinking. 
 
As in previous studies, symptoms of anxiety and depression were found to be 
important predictors of adherence, quality of life, and functional impairment post-MI. 
Earlier work by Lane et al (2000), and Mayou et al (2000), found that both anxiety 
and depression predicted quality of life in post-MI patients. The findings from 
Chapter 8 (section 8.3.4.4) also demonstrated that symptoms of depression and 
anxiety are prevalent in MI patients with 20.3% scoring as possible cases of anxiety, 
and 16.1% as possible cases of depression. The current findings therefore highlight 
the importance of identifying those patients with symptoms of depression and anxiety, 
so that their symptoms can be reduced through therapeutic interventions. Reducing 
symptoms of psychological distress is an important way of improving outcome in 
post-MI patients. 
 
The findings from Chapter 8 have extended the finding relating to the role of illness 
perceptions in post-MI patients. Specifically, perceptions of consequences and 
timeline were found to be related to quality of life, psychological distress, and benefit 
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finding in MI patients. The role of illness perceptions in predicting quality of life of 
MI patients was also identified by Petrie et al (1996). They also found that patients 
who believed their MI would have more serious long-lasting consequences had higher 
levels of illness-related disability and were slower to return to work. Results from 
Chapter 8 therefore add further evidence relating to the importance of illness 
perceptions in the recovery of MI patients.  
 
The study described in Chapter 8 is the first to investigate the role of future thinking 
in a sample of MI patients. The results on the utility of future thinking in predicting 
quality of life and psychological distress post-MI are promising. Indeed, the findings 
suggest that a lack of positive future cognitions, and not simply more negative 
thinking that is predictive of both quality of life and depression post-MI. Previous 
research on future thinking has found that depressed individuals have difficulties 
thinking about the future (MacLeod et al, 1997). Indeed, earlier research has found 
future thinking to be related to depression in a number of patient groups, including 
those with multiple sclerosis (Moore et al, 2006), and tinnitus (Andersson et al, 2007). 
The current findings therefore extend the available evidence on future thinking, by 
identifying for the first time that future thinking is predictive of post-MI depressive 
symptoms and quality of life. Future research is required to determine if the role of 
future thinking in predicting outcome post-MI is a robust and replicable finding. 
 
It is important to consider possible reasons as to why future thinking is predictive of 
quality of life and depression post-MI. For example, should future thinking be viewed 
as a further cognitive processing mechanism which is associated with adverse or 
outcome or does it reflect a more of a coping mechanism? The later possibility is 
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particularly interesting. It could be that future thinking reflects a coping mechanism 
whereby individuals actively focus on future positive events or things they are looking 
forward to, such as spending time with family and friends, as a way of getting them 
through the difficult emotional period that they face post-MI. It appears as though 
individuals who are able to focus on these positive events, adjust better to their illness, 
and have improved quality of life, and lower psychological distress post-MI. It is 
possible that possessing a positive future thinking style may help a person to cope 
more effectively with stress. 
 
9.4 Theoretical Implications 
This section considers the extent to which the above findings are consistent within the 
self-regulatory framework of Leventhal’s CSM (Leventhal et al, 1980). Therefore, the 
aim of this section is discuss the findings of previous chapters by placing them within 
a theoretical construct. It is of particular interest to examine the extent to which 
personality (as assessed by Type D), fits within self-regulatory theory to enhance our 
understanding of patient recovery. A speculative diagram of Leventhal’s CSM with 
the inclusion of Type D is shown below in Figure 9.1. 
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Figure 9.1: Adaptation of Leventhal’s common sense model to include Type D 
personality  
 
According to the CSM, patients’ beliefs and perceptions of their illness are important 
predictors of behaviour and recovery in MI patients (e.g. Byrne, 1982). Petrie et al 
(1996) found that patients’ perceptions of their MI assessed at the time of 
hospitalisation predicted subsequent attendance at cardiac rehabilitation, return to 
work, disability, and sexual dysfunction at three and six months later. Similarly, 
findings from the MI study in the current thesis also found that patients’ illness 
perceptions assessed during hospitalisation predicted quality of life three months post-
MI. These findings are, therefore, supportive of the CSM, as they again point to the 
key role that cognitive processing (patients’ beliefs and perceptions of their illness) 
plays in recovery. Further evidence for the important role of cognitive processing can 
be seen from the findings relating to future thinking. Future thinking has been 
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identified as an important cognitive pathogen in other health contexts. The findings 
reported in Chapter 8 have extended this evidence by identifying that future thinking 
predicts outcome in MI patients. Future thinking could therefore be incorporated into 
the cognitive processing dimension of the CSM, as a further cognitive pathogen, 
enhancing the ability of the CSM to predict outcome post-MI. 
 
The CSM also describes an important role for emotional processing. A health threat, 
such as an MI, is thought to change the emotional state of the individual, leading to 
feelings of fear, anxiety and depression which then drive coping behaviours. Results 
from the MI study in this thesis also demonstrate the importance of depression and 
anxiety in predicting recovery post-MI. This lends further support for the parallel 
processing approach of the CSM which emphasises the importance of both cognitive 
and emotional factors. 
 
It is of particular interest to examine how Type D personality fits within the CSM. As 
shown in Figure 9.1 personality (including Type D) may play an important role early 
on in the CSM. Within the context of this thesis, Type D was related to both cognitive 
and emotional processing. Type D could therefore be seen as a dispositional factor 
that will influence the cognitive and emotional processing responses of an individual 
following a health threat. For example, after an MI (health threat) a Type D individual 
experiences a greater number of symptoms of depression and anxiety, and has more 
negative perceptions of their illness. These negative perceptions then influence 
behaviour and recovery post-MI. 
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The findings of this thesis demonstrate the utility of the CSM model in investigating 
the role of personality and illness-related cognitions in predicting outcome post-MI. 
Further evidence was found for the original CSM by identifying the importance of 
patients’ perceptions of their illness in predicting outcome. The findings also suggest 
that future thinking may be incorporated into model, as a further example of the 
importance of cognitive processing in predicting outcome. The results also suggest 
that the addition of personality to the CSM may enhance its ability to predict outcome 
post-MI. Specifically, Type D was found to be related to patients’ perceptions of their 
MI, and may therefore represent an important distal factor which could be 
incorporated into the CSM after the initial health threat. Personality will then play an 
important role in determining how an individual processes the health threat in both a 
cognitive and emotional way.  
 
It is also important to consider these findings in light of other self-regulation models. 
For example, Carver and Scheier’s (1998) model which was described in detail in 
Chapter 3 (section 3.2.1) may also provide a useful theoretical context by which to 
interpret the results of this thesis. For example, the role of future thinking in 
predicting outcome may be better understood from this view point. Individuals who 
possess positive future thinking compared to those who possess negative future 
thinking may have greater confidence in their ability to attain goals, and avoid anti-
goals. In addition, they may be better at identifying suitable goals and more persistent 
in pursuing these goals. Indeed, the future thinking task itself can be conceptualised in 
terms of Carver and Scheier’s model. Participants are asked to generate potential 
future events, essentially these can be viewed as goals, and anti-goals that they are 
either looking forward to, or are worried about (O’Connor & Cassidy, 2007). In 
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addition, Carver and Scheier’s model suggests that those individuals who are high on 
hopelessness have difficulty identifying goals in the form of specific, future positive 
expectations. This may be because they have repeatedly failed to meet previous goals 
and have learned that there is no relationship between their behaviour and outcomes. 
As a result, their generalised motivation and expectancies are much reduced. This 
may lead to possible depression and poor quality of life. 
 
9.5 Therapeutic Implications 
This section highlights the ways in which the findings relating to predictors of 
outcome post-MI may be used to aid the secondary prevention of CHD. Specifically, 
the current section concentrates on how the findings related to patients’ personality, 
mood, and cognition could aid treatment. 
 
This thesis has highlighted the importance of patients’ mood and cognitions in 
predicting their psychological outcome post-MI. In terms of secondary prevention of 
CHD, interventions could be developed to target cognitions and mood. An assessment 
of patients’ levels of anxiety and depression could be done as part of their routine care 
in hospital using simple questionnaires such as HADS or the Beck Depression 
Inventory. This might draw attention to patients in need of particular help and allow 
early treatment or counselling referral in order to avoid later problems. Similarly, 
assessing patients for Type D personality could help to identify patients who are at 
high risk of mortality and morbidity. The DS14 is easy and quick to administer, and 
could be performed alongside an assessment of mood as part of early routine care in 
hospital for cardiac patients. 
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Research has shown that reducing emotional distress in patients with CHD improves 
prognosis. For example, Denollet and Brutsaert (2001) investigated whether cardiac 
rehabilitation reduces emotional distress in the short-term and mortality in the long-
term. They compared 150 men with CHD, who either received rehabilitation or 
standard medical care. At the end of the 3-month trial, rehabilitation patients reported 
significantly more improvement in negative affect, and significantly less deterioration 
in negative affect. It was also found that those patients who had experienced a 
reduction in negative affect were significantly less likely to have died at 9 year 
follow-up. Therefore, it can be seen that reducing the negative affect of CHD patients 
is effective in improving their prognosis.  
 
Further research investigating patients’ perceptions might focus on developing an 
intervention to change patients’ maladaptive beliefs about the effects of their illness. 
For example, Petrie et al (2002) demonstrated that it is possible to alter the illness 
perceptions of MI patients, thus offering a potential route for interventions. They 
carried out a randomised control and found that a brief hospital intervention with 
patients aimed at altering their perceptions about their MI was successful in changing 
patients’ view of their MI. This change meant that these patients returned to work 
more quickly and experienced fewer angina symptoms compared to those patients in 
the control condition. Cognitive behaviour therapy has proved useful in treating a 
variety of conditions including anxiety and depression. This might provide a useful 
approach to help to change patients’ maladaptive perceptions about their heart disease. 
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9.6 Directions for Future Research 
This section outlines directions for future research in light of the main findings of this 
thesis. The association between Type D and outcome has been established previously 
by Denollet and colleagues, and warrants further investigation in the future. The 
research described above has demonstrated that Type D is associated with health-
related behaviour, social support, cardiovascular reactivity, and illness perceptions. 
By identifying the possible mechanisms which may be responsible for the link 
between Type D and poor prognosis it may be possible to identify how this risk factor 
can be modified, in order to enhance secondary prevention in these high-risk patients. 
For example, in light of the findings of this thesis it may be possible for interventions 
to target patients’ illness perceptions and health-related behaviour as one way of 
improving Type D patient outcome. Indeed, the Type D construct has been previously 
criticised as not providing an obvious route for intervention (Lesperance & Frasure-
Smith, 1999). It is therefore important that future research aims to develop 
interventions that either improves the outcome of Type D patients, or interventions 
that detect the presence of Type D at an early stage and attempt to modify either the 
social inhibition and/or negative affectivity components.  
 
Specifically, there is a need to conduct intervention trials that target Type D in order 
to enhance secondary prevention in this subset of CHD patients. Recent research has 
demonstrated that a reduction in negative emotions can lead to improved prognosis 
(e.g. Denollet & Brutsaert, 2001). Although social inhibition may be less amenable to 
change, it is important to note that a reduction in negative affectivity (below the 
standardised cut-off of ≤10) would make the difference between whether a patient is 
classified as Type D or not. Therefore, the risk profile of the patient would change, 
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hence leading to a reduced risk of adverse clinical outcome. As outlined by Ketterer et 
al (2000) if a risk factor cannot be modified, it has no clinical utility. It is therefore 
crucial for interventions to be developed. 
 
It will also be important to identify in the context of epidemiological studies whether 
Type D is not only a prognostic but also an etiological risk factor leading to the 
development of CHD in previously healthy individuals. In order to do this, it will be 
necessary to follow a healthy cohort over time. It is also important to determine 
further mechanisms (both psychosocial and psychophysiological) which may explain 
the link between Type D and adverse clinical outcome in cardiac patients. 
Furthermore, it is important to determine if Type D has an important role in other 
non-cardiac conditions. To-date, only one study has demonstrated an association 
between Type D and another illness. Denollet (1998) demonstrated that Type D was 
an independent predictor of the development of cancer in patients with established 
CHD. Therefore, it is important to further examine the role of Type D in the 
development of cancer, and other non-cardiac conditions. There is no reason to 
believe that Type D would be a cardiac specific pathogen.  
 
Further research is also required to determine if future thinking is a reliable prognostic 
risk factor in cardiac disease. If it is, then future thinking could represent a possible 
target for interventions and also for risk assessment, by identifying the types of 
cognitions (i.e. goals) that should be targeted clinically. Interventions aimed at 
helping individuals to generate plans, hopes, and goals for the future may lead to 
improvements in future thinking and outcome. 
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9.7 Limitations  
Several limitations specific to the measures and procedure used in each study have 
already been noted in the Discussion sections of Chapters 5-8. The following section 
outlines some broader limitations of the work. 
 
Each of the studies described in this thesis has relied on the use of self-report 
measures, and may therefore be subject to self presentation and recall biases which 
are common problems faced when using self-report measures. For example, the 
assessment of medication adherence is known to be affected by recall bias, indeed it 
has been estimated that self reports may underestimate the true extent of non-
adherence by approximately 20% (Horne, 2000). In order to encourage patients to be 
as honest as possible without concern that their answers might influence their 
treatment, patients were assured that the information they gave would not be entered 
into their medical notes and that their doctor would not see their responses. Even so, 
this study (and those undertaken with the young healthy populations) were subject to 
the risk of interviewer bias whereby patients seek to offer answers they believe will 
please the interviewer, and recall bias involving over or underestimation of 
behaviours, such as medication adherence. 
 
The length of follow-up used in the study described in Chapter 8, and Study 6.1 was 
three months (however, this was dictated by demands of the PhD timescale). This is a 
relatively short time period, and can only allow conclusions to be drawn regarding the 
short-term recovery of MI patients. For example, it may be that the duration of 
follow-up was insufficient to detect effects which may be present at longer follow-up 
periods. Furthermore, the use of a three month follow-up in Study 6.1 only allows for 
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the stability of Type D to be assessed over a relatively short period of time. If Type D 
is a stable personality trait then it is important to determine stability over a longer 
period of time. 
 
The measurement of health-related behaviour represents a further weakness of this 
thesis. Indeed, the findings related to Type D and health behaviour are limited by the 
measures of health-related behaviours that were available in the Health Psychology 
literature. It is important to question whether retrospective self-report questionnaires 
are a reliable way to assess health behaviour. When selecting the measures for 
inclusion in these studies it was difficult to find a recognised measure of health 
behaviour as little or no reliability and validity data exists on such measures. 
Furthermore, many of these questionnaires utilise a yes/no scoring response which 
may not be suitable for assessing something as complex as behaviour. The lack of 
reliable, well-validated measures of health behaviour represents a problem for the 
field of Health Psychology as a whole. Future research is required which investigates 
the reliability and validity of measures of health-behaviour. 
 
It is also important to consider the response rates of the samples in which a follow-up 
phase was used. For Study 6.1 (section 6.2.1) the response rate was 50.9%. Similarly, 
in Chapter 7 (section 7.2.1) only 50% of those invited to take part in the experimental 
phase did so. In addition, the response rate in the MI study was 63% (section 8.2.1). 
These response rates indicate that a significant number of participants did not 
participate in the follow-up phases of these studies. This may have led to the under-
representation of certain groups of participants in the analysis. For example, in the MI 
study may have resulted in an under representation of patients with poor health status. 
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The MI study (Chapter 8), and the study on Type D personality and cardiovascular 
reactivity (Chapter 7) represent studies in which sample size may be a possible 
limitations. Eighty-four participants took part in the reactivity study which represents 
a good sample size. However, the analyses were then conducted separately for males 
and females, giving two samples of 42 participants, which represents a relatively 
small sample size for these two groups. Furthermore, 131 participants took part in the 
follow-up stage of the MI study. Although this is a reasonable number, a larger 
number would have allowed for the inclusion of more variables in the regression 
analyses. This would have been an advantage as possible interaction effects could 
have then been explored. 
 
9.8 Conclusion: What Did This Thesis Add? 
The studies described within this thesis have extended the evidence relating to 
predictors of psychological outcome in several key ways: 
 
- The prevalence of Type D personality in healthy individuals from the UK and 
Ireland (38.5%) has been established for the first time. 
 
- Type D individuals were found to experience significantly lower levels of perceived 
social support compared to non-Type D individuals, even after controlling for 
neuroticism 
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- For the first time a relationship between Type D and health-related behaviour was 
established. Specifically, Type D individuals perform significantly fewer health-
related behaviours than non-Type D’s, even after controlling for neuroticism. 
 
- Type D was found to be a relatively stable construct in healthy individuals with 
76.7% of individuals being consistently classified as Type D or non-Type D over 3 
months. 
 
- Type D individuals experience significantly higher feelings of stress during acute 
stress compared to non-Type D individuals.  
 
- A relationship between Type D and cardiovascular reactivity to stress was 
established for the first time. Type D males have significantly higher cardiac output 
during stress compared to non-Type D individuals. 
 
- The prevalence rate of Type D (33.9%) in a Scottish cardiac population has been 
identified for the first time.  
 
- For the first time a relationship between Type D and illness perceptions has been 
identified, with Type D individuals having significantly different illness perceptions 
on all measures of the Illness Perceptions Questionnaire compared to non-Type D 
individuals. 
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- Chapter 8 identified a relationship between Type D and medication adherence for 
the first time. Type D individuals are less adherent to medication compared to non-
Type D individuals.  
 
- Type D is predictive of poor adherence, poor quality of life, and poor functional 
outcome after controlling for mood, and demographic and clinical factors. 
 
- The relationship between Type D and quality of life is mediated by illness 
perceptions. 
 
- Future thinking has been found to predict quality of life and mood in cardiac patients 
for this first time. 
 
- The role of illness perceptions in predicting outcome post-MI has been confirmed; 
with illness perceptions predicting quality of life, mood and benefit finding. 
 
- The importance of mood in predicting outcome post-MI has been confirmed with 
depression and anxiety predicting adherence, quality of life and functional outcome 
post-MI. 
 
Overall, the thesis has (i) established the prevalence of Type D personality in the UK 
to be 38.5% in the healthy population, and 33.9% in the cardiac population; (ii) found 
that Type D is predictive of adherence, quality of life, and functional impairment in 
post-MI patients after controlling for mood, demographics, and clinical factors; (iii) 
established five possible mechanisms (health-related behaviour, adherence, social 
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support, cardiovascular reactivity, and illness perceptions) by which Type D may lead 
to adverse outcome in cardiac patients; (iv) confirmed the importance of mood 
(depression and anxiety) in predicting quality of life and functional impairment post-
MI; (v) confirmed the importance of illness perceptions in predicting quality of life 
post-MI; and (vi) demonstrated for the first time that future thinking predicts quality 
of life, functional impairment and depression post-MI. 
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Appendix 1: Type D Personality Scale 
 
 
Below are a number of statements that people often use to describe themselves. Please 
read each statement and then circle the appropriate number next to the statement to 
indicate your answer. There are no right or wrong answers. Your own impression is 
the only thing that matters 
 
0=FALSE     1=RATHER FALSE     2=NEUTRAL     3=RATHER TRUE    4=TRUE 
 
1. I make contact easily when I meet people  0 1 2 3 4 
2. I often make a fuss about unimportant things 0 1 2 3 4 
3. I often talk to strangers    0 1 2 3 4 
4. I often feel unhappy    0 1 2 3 4 
5. I am often irritated     0 1 2 3 4 
6. I often feel inhibited in social interactions  0 1 2 3 4 
7. I take a gloomy view of things   0 1 2 3 4 
8. I find it hard to start a conversation  0 1 2 3 4 
9. I am often in a bad mood    0 1 2 3 4 
10. I am a closed kind of person   0 1 2 3 4 
11. I would rather keep other people at a distance 0 1 2 3 4 
12. I often find myself worrying about something 0 1 2 3 4 
13. I am often down in the dumps   0 1 2 3 4 
14. When socializing, I don’t find the right things 
 to talk about      0 1 2 3 4 
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Appendix 2: Quality of Social Network and Social Support Scale 
 
 
Please answer each question by circling the response that most closely 
applies to you 
 
1. How strongly do you feel attached to your close family? 
Very Strongly  Quite Strongly Quite loosely  Not at all 
 
2. Do you find it difficult to know where you are with your close family, with 
respect to their points of view and opinions? 
Often  Sometimes  Never 
 
3. Do you feel that you, by and large, can be yourself in relation to your close 
family? 
Always Usually  Seldom or never 
 
4. Do you feel that your close family puts reasonable weight upon your opinions? 
Always Usually  Seldom or never 
 
5. Do you feel that you can count on your friends in the future? 
Very sure Quite sure  Not sure 
 
6. Do you think you would be disappointed if you knew what your friends really 
thought about you? 
Yes  Maybe   No 
 
7. Do you feel closely attached to your friends? 
Always Usually  Seldom or never 
 
8. Do you feel that your friends put reasonable weight upon your opinions? 
Always Usually  Seldom or never 
 
9. Do you feel apart even among friends? 
Often  Sometimes  Never 
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Appendix 3: Social Support Survey- Medical Outcomes Study 
 
People sometimes look to others for companionship, assistance, or other types of 
support. How often is each of the following kinds of support available to you if you 
need it? Circle one number on each line.  
 None 
of the 
time  
A little 
of the 
time  
Some 
of the 
time  
Most 
of the 
time  
All of 
the 
time  
Emotional/informational support       
Someone you can count on to listen 
to you when you need to talk  
1  2  3  4  5  
Someone to give you information to 
help you understand a situation  
1  2  3  4  5  
Someone to give you good advice 
about a crisis  
1  2  3  4  5  
Someone to confide in or talk to 
about yourself or your problems  
1  2  3  4  5  
Someone whose advice you really 
want  
1  2  3  4  5  
Someone to share your most private 
worries and fears with  
1  2  3  4  5  
Someone to turn to for suggestions 
about how to deal with a personal 
problem  
1  2  3  4  5  
Someone who understands your 
problems  
1  2  3  4  5  
Tangible support       
Someone to help you if you were 
confined to bed  
1  2  3  4  5  
Someone to take you to the doctor if 
you needed it  
1  2  3  4  5  
Someone to prepare your meals if 
you were unable to do it yourself  
1  2  3  4  5  
Someone to help with daily chores if 
you were sick  
1  2  3  4  5  
Affectionate support       
Someone who shows you love and 
affection  
1  2  3  4  5  
Someone to love and make you feel 
wanted  
1  2  3  4  5  
Someone who hugs you  1  2  3  4  5  
Positive social interaction       
Someone to have a good time with  1  2  3  4  5  
Someone to get together with for 
relaxation  
1  2  3  4  5  
Someone to do something enjoyable 
with  
1  2  3  4  5  
Additional item       
Someone to do things with to help 
you get your mind off things  
1  2  3  4  5  
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Appendix 4: Neuroticism Scale 
 
 
Please answer each question by putting a circle around the Yes or 
No. There are no right or wrong answers. Work quickly and do not 
think too long about the exact meaning of the questions. 
 
1) Does your mood go up and down?    No  Yes 
2) Do you ever feel ‘just miserable’ for no reason  No  Yes 
3) Are you an irritable person?    No  Yes 
4) Are your feelings easily hurt    No  Yes 
5) Do you often feel ‘fed up’?    No  Yes 
6) Would you call yourself a nervous person?  No  Yes 
7) Are you a worrier      No  Yes 
8) Would you call yourself tense or ‘highly-strung’  No  Yes 
9) Do you worry too long after an embarrassing incident? No  Yes 
10) Do you suffer from nerves?    No  Yes 
11) Do you often feel lonely?     No  Yes 
12) Are you often troubled by feelings of guilt?  No  Yes 
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Appendix 5: Future Thinking Task 
 
Instructions for FAS: 
 
‘First I would like you to think of as many words beginning with a certain letter of the 
alphabet. I will ask you to do this for 3 different letters. You will have a minute in 
each case to think of as many words as you can beginning with that letter. Please say 
the words and I will write them down. That words can be anything that comes to mind 
except that they shouldn’t be proper names, that is names of people or places, or 
sequences involving the same basic word, for example, run, runner, running, and so 
on. I want you to give me as many words as you can beginning with the letter F.’ 
 
(participants are asked to do this for the letters F, A and S in that fixed order and 
given one minute to think of words for each of the letters). The researcher writes 
down the words, or if the participant is going to fast for this, just indicates on the 
scoring sheet that a valid response was given. 
 
Instructions for FTT: 
 
‘Now I’d like you to think about the things that might happen in the future. I will give 
you 3 different time points in the future, one at a time, and I’d like you to try to think 
of as many things as you can. It doesn’t matter whether the things are trivial or 
important, just say what comes to mind. But, they should be things that you think will 
definitely happen or are at least quite likely to happen. If you can’t think of anything 
or if you can’t think of many things, that’s fine, but just keep trying until the time 
limit is up.’ 
 
‘First I’m going to ask you to think of positive things in the future. So I’d like you to 
try to think of things that you are looking forward to, in other words things that you 
enjoy. So, I want you to give me as many things as you can that you’re looking 
forward to over the next week including today.’ 
 
(R gives one minute and writes down as close to verbatim as time allows what the 
participant says) 
 
‘Now I’d like you to do the same but this time I want you to give me things that 
you’re looking forward to over the next year’ 
 
(R does the same as for one week) 
 
‘Now I’d like you to do the same but this time I want you to give me things that 
you’re looking forward to over the next five to ten years’ 
 
(R does the same as previous) 
 
‘Now I’d like you to think of the things that you’re worried about or not looking 
forward to, in other words, things that you would rather not be the case or rather not 
happen. So, I want you to think of as many things as you can that you’re worried 
about or not looking forward to over the next week including today’ 
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(R does the same as previous) 
 
‘Now I want you to give me things that you’re worried about or not looking forward 
to over the next year’ 
 
(R does the same as previous) 
 
‘Finally, I want you to give me as many things as you can that you’re worried about 
or not looking forward to in the next five to ten years’ 
 
(R does the same as previous) 
 
The order of presentation of negative and positive conditions should be 
counterbalanced across participants, although within each condition the time periods 
are always presented in the same order (week, year, 5-10 years). 
 
If participant says during the thinking time that they can’t think of anything or, for 
example that there is nothing that they are looking forward to over the next week, say 
‘that’s ok, but just keep trying to think until I tell you to stop.’ 
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Appendix 6: Life Orientation Task Revised 
 
Please be as honest and accurate as you can throughout. Try not to let your response 
to one statement influence your responses to other statements. There are no ‘correct’ 
or ‘incorrect’ answers. Answer according to your own feelings, rather than how you 
think ‘most people’ would answer. 
 
A=I agree a lot 
B=I agree a little 
C=I neither agree nor disagree 
D=I disagree a little 
E=I disagree a lot 
 
1. In uncertain times, I usually expect the best A B C D E 
2. It’s easy for me to relax    A B C D E 
3. If something can go wrong for me it will  A B C D E 
4. I’m always optimistic about my future  A B C D E 
5. I enjoy my friends a lot    A B C D E 
6. It’s important for me to keep busy   A B C D E 
7. I hardly ever expect things to go my way  A B C D E 
8. I don’t get upset too easily    A B C D E 
9. I rarely count on good things happening to me A B C D E 
10. Overall, I expect more good things to happen  
to me than bad     A B C D E 
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Appendix 7: The Recovery Locus of Control Scale 
 
These are statements other people have made about their recovery. Please indicate the 
extent to which you agree or disagree with them 
 
 
 Strongly 
Agree 
Agree Uncertain Disagree Strongly 
disagree 
How I manage in the future depends 
on me, not on what other people can 
do for me 
     
It’s often best just to wait and see 
what happens 
     
It’s what I do to help myself that’s 
really going to make all the difference 
     
My own efforts are not very 
important, my recovery really 
depends on others 
     
It’s up to me to make sure that I 
makes the best recovery possible 
under the circumstances 
     
My own contribution to my recovery 
doesn’t amount to much 
     
Getting better now is a matter of my 
own determination rather than 
anything else 
     
I have little or no control over my 
progress from now on 
     
It doesn’t matter how much help you 
get, in the end it’s your own efforts 
that count 
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Appendix 8: The Beliefs about Medicines Questionnaire 
 
YOUR VIEWS ABOUT 
MEDICINES IN GENERAL 
 
 These are statements that other people have made about medicines in general 
 Please show how much you agree or disagree with them by ticking the 
appropriate box. 
 
 Views about MEDICINES 
IN GENERAL 
Strongly 
agree 
Agree Uncertain Disagree Strongly 
Disagree 
BG1 Doctors use too many 
medicines 
     
BG2 People who take medicines 
should stop their treatment 
for a while every now and 
again 
     
BG3 Most medicines are 
addictive 
     
BG4 Natural remedies are safer 
than medicines 
     
BG5 Medicines do more harm 
than good 
     
BG6 All medicines are 
poisonous 
     
BG7 Doctors place too much 
trust on medicines 
     
BG8 If doctors had more time 
with patients they would 
prescribe fewer medicines 
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YOUR VIEWS ABOUT 
MEDICINES PRESCRIBED FOR YOU 
 
 We would like to ask you about your personal views about medicines 
prescribed for you 
 These are statements other people have made about their medicines 
 Please show how much you agree or disagree with them by ticking the 
appropriate box 
 
There are no right or wrong answers. 
We are interested in your personal views 
 
 Views about 
MEDICINES 
PRESCRIBED FOR 
YOU 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
BS1 My health, at present depends 
on my medicines 
     
BS2 Having to take my medicines 
worries me 
     
BS3 My life would be impossible 
without my medicines 
     
BS4 I sometimes worry about the 
long-term effects of my 
medicines 
     
BS5 Without my medicines I would 
be very ill 
     
BS6 My medicines are a mystery to 
me 
     
BS7 My health in the future will 
depend on my medicines 
     
BS8 My medicines disrupt my life      
BS9 I sometimes worry about 
becoming too dependent on my 
medicines 
     
BS10 My medicines protect me from 
becoming worse 
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Appendix 9: The Brief Illness Perception Questionnaire 
 
How much does your heart condition affect your life? 
0 1 2 3 4 5 6 7 8 9 10 
no affect                Severely affects 
at all                   my life  
 
How long do you think your heart condition will continue?    
    
0 1 2 3 4 5 6 7 8 9 10 
a very short          forever 
time                  
 
How much control do you feel you have over your heart condition? 
0 1 2 3 4 5 6 7 8 9 10 
absolutely          extreme amount 
no control          of control 
 
How much do you think your treatment can help your heart condition? 
0 1 2 3 4 5 6 7 8 9 10 
not at all          extremely  
           helpful 
How much do you experience symptoms from your heart condition? 
0 1 2 3 4 5 6 7 8 9 10 
no symptoms          many severe 
at all           symptoms 
 
How concerned are you about your heart condition? 
0 1 2 3 4 5 6 7 8 9 10 
not at all          extremely 
concerned          concerned 
 
How well do you feel you understand your heart condition? 
0 1 2 3 4 5 6 7 8 9 10 
don’t understand        understand 
at all          very clearly 
 
How much does your heart condition affect you emotionally? (e.g. does it make you 
angry, scared, upset or depressed?) 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all                   extremely affected  
affected emotionally                                                                                         emotionally  
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Please list in rank-order the three most important factors that you believe caused your illness 
 
1. 
 
2. 
 
3. 
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Appendix 10: Roles and Goals Questionnaire 
 
In this questionnaire, we are interested in finding out your attitudes towards various 
aspects of your life.  For example, whether you have any current interests and hobbies, 
relationships that mean a lot to you, and so on. 
 
Please go through each page and make sure that you fill in every area accordingly.  For 
each question, please circle the appropriate number. 
 
 
A. PRESENT EMPLOYMENT (include part-time or voluntary work.) 
 
Please state what this is (if applicable).................................... 
 
                                        very      moderate     quite   a great 
                                       little      amount         a lot    deal 
a. How much does this work make 
   you feel good as a person?              1            2              3          4 
 
b. How much energy and effort 
   do you put into this work?                                 1           2                3         4 
 
c. How successful will you be 
   in this work?                           1            2                3          4 
 
d. To what extent does being 
   successful in other areas 
   of your life depend on your 
   being successful at work?              1            2                3          4 
 
e. To what extent would life 
   feel meaningless or unhappy 
   without it?                             1           2                 3           4 
 
 
 
B. YOUR MOST IMPORTANT CURRENT HOBBY OR INTEREST (for example, 
reading, knitting, sports, DIY etc.) 
 
Please state what this is (if applicable).................................... 
 
                                      very       moderate      quite     a great 
                                     little       amount       a lot      deal 
a. How much does this hobby 
   make you feel good as a 
   person?                             1              2             3              4 
 
b. How much energy and effort 
   do you put into this hobby?          1              2               3              4 
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c. How successful do you think 
   you will be in this hobby?           1               2                3               4 
 
d. To what extent does being 
   successful in other areas 
   in your life depend on your 
   doing well in this hobby?                                  1               2                3               4 
 
e. To what extent would life 
   feel meaningless or 
   unhappy without it?                                           1               2                3               4 
 
 
 
C. YOUR MOST IMPORTANT CURRENT RELATIONSHIP 
 
Please state who this is with (e.g. spouse, son or daughter, close friend, 
 
etc.)........................................................................ 
 
                                   very         moderate      quite      a great 
                                  little         amount       a lot       deal 
a. How much does this 
   relationship make you 
   feel good as a person?             1                 2              3              4 
 
b. How much energy and 
   effort do you put into  
   this relationship?              1                  2              3              4 
 
c. How successful do you 
   think this relationships 
   will be?                          1                   2             3              4 
 
d. To what extent does being 
   successful in other areas 
   of your life depend on 
   your doing well in this 
   relationship?                     1                   2             3              4 
  
e. To what extent would life 
   feel meaningless or 
   unhappy without it?            1                 2             3              4 
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D. INDEPENDENT LIVING AND HEALTH 
 
1. Has there been any significant deterioration  
   in your physical or mental health? (please circle)      YES       NO 
 
If applicable, please state what this is and write down the name of the 
 
illness (if known)........................................................... 
 
                                     very       moderate      quite     a great 
                                    little       amount       a lot      deal 
a. How much does being in 
   good health make you feel 
   as a person?                      1                 2              3             4 
 
b. How much energy and effort 
   do you put into keeping 
   good health?                      1                 2              3             4 
 
c. What is the probability of 
   your being in reasonable 
   health in the future?                1                 2              3            4 
 
d. To what extent does being 
   successful in other areas of 
   your life depend on you being 
   in reasonable health?                 1                 2              3            4 
 
e. To what extent would life 
   feel meaningless or unhappy 
   without it?                             1                 2              3            4 
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E. OTHER GOALS 
 
Is there another important goal or relationship 
in your life in addition to those mentioned above? 
(please circle)                                             YES       NO 
 
Please state what this is (if applicable).................................... 
 
                                     very        moderate     quite    a great 
                                    little        amount        a lot     deal 
a. How much does this goal 
   make you feel good as a 
   person?                           1                2                3           4 
 
 
b. How much energy and effort 
   do you put into it?                 1                2                3           4 
 
c. What is the probability 
   of your being successful 
   in this goal?                                                     1                2                3            4 
 
d. To what extent does being 
   successful in other areas of 
   your life depend on you being       
   in this goal?                    1                 2                3           4 
 
e. To what extent would life 
   feel meaningless or unhappy 
   without it?                                                      1                  2                3           4 
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Appendix 11: Stress Arousal Checklist 
 
Please read the following words and for each, tick the box that best describes how you 
feel at the moment 
 
 Definitely Feel Slightly Feel Cannot Decide Definitely Do 
Not Feel 
Tense     
Worried     
Apprehensive     
Bothered     
Unease     
Dejected     
Up-tight     
Jittery     
Nervous     
Distressed     
Fearful     
Peaceful     
Relaxed     
Cheerful     
Contented     
Pleasant     
Comfortable     
Calm     
Rested     
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Appendix 12: The Hospital Anxiety and Depression Scale 
 
Read the following items and place a CROSS in the box opposite the reply which 
comes closest to how you have been feeling of late, ONLY ONE CROSS PER 
QUESTION. 
 
a. I feel tense or wound up:   g. I can sit at ease and feel relaxed: 
Most of the time……………     Definitely……………… 
       
A lot of the time……………   Usually………………… 
       
Time to time, occasionally…   Not often………………. 
 
Not at all……………………   Not at all………………. 
 
 
b. I enjoy the things I used to   h. I feel as if I am lacking in energy: 
Definitely as much…………   Nearly all of the time….. 
 
Not quite so much…………   Very often…………….. 
 
Only a little………………..   Sometimes 
 
Not at all…………………….  Not at all 
 
 
c. I get a sort of frightened feeling as if i. I get a sort of frightened feeling like 
something awful is about to happen:  butterflies in the stomach: 
Most of the time……………   Not at all………………. 
 
A lot of the time…………….   Not often………………. 
 
Time to time, occasionally…   Sometimes…………….. 
 
Not at all…………………….  Most of the time………. 
 
 
d. I can laugh and see the funny  j. I have lost interest in my appearance: 
side of things 
As much as I always could…   Definitely……………….. 
 
Not quite so much…………   I don’t take as much   
      care as I should………. 
Definitely not so much……. 
      I may not take quite as 
Not at all……………………   much care……………… 
 
      I take just as much care  
      as ever…………………. 
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e. Worrying thoughts go through my mind  k. I feel restless as if I have to be 
       on the move 
A great deal of the time………….   Very much indeed…………… 
 
A lot of the time………………….   Quite a lot…………………… 
 
From time to time, not too often…   Not very often……………….. 
 
Only occasionally………………..   Not at all…………………….. 
 
 
f. I feel cheerful:     l. I look forward with enjoyment 
       to things 
Not at all………………………….   As much as I ever did………. 
 
Not often…………………………   Rather less than I used to……. 
 
Sometimes……………………….   Definitely less than I used to… 
 
Most of the time………………….   Hardly at all………………… 
 
 
m. I get sudden feelings of panic:   n. I can enjoy a good book or  
       radio or TV programme 
Very often indeed………………..   Often…………………………. 
 
Quite often……………………….   Sometimes…………………….. 
 
Not very often……………………..   Not often……………………. 
 
Not at all…………………………   Very seldom…………………… 
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Appendix 13: General Preventive Health Behaviours Checklist 
 
Which of the following activities do you generally undertake or engage in? Please 
respond by underlining the number which best represents the extent to which 
you undertake or engage in each activity. 
 
0= No, do not do  1= Sometimes  2= Yes, always or almost always 
 
1.  Avoid drinking and driving    0 1 2 
 
2. Wear a seat belt when in the car    0 1 2 
  
3. Do things in moderation     0 1 2 
 
4. Get enough relaxation     0 1 2 
 
5. Check safety of electrical appliances   0 1 2 
 
6. Avoid overworking      0 1 2 
 
7. Fix broken things around the home   0 1 2 
 
8. Eat sensibly       0 1 2 
 
9. Maintain contact with friends and relatives  0 1 2 
 
10. Destroy old or unused medicines    0 1 2 
 
11. Regularly eat breakfast     0 1 2 
 
12. Practice safe sex      0 1 2 
 
13. Avoid crossing the street against the traffic lights 0 1 2 
 
14. Keep a first-aid kit in the home    0 1 2 
 
15. Get enough sleep      0 1 2 
 
16. Keep emergency phone numbers    0 1 2 
 
17. Avoid over-the-counter medicines   0 1 2 
 
18.  Spend time out of doors everyday   0 1 2 
 
19. Do not smoke      0 1 2 
 
20. Get enough exercise     0 1 2 
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21.Pray or live by the principles of religion   0 1 2 
 
22. Avoid letting things get me down   0 1 2 
 
23. Avoid eating snacks     0 1 2 
 
24. Limit alcohol intake     0 1 2 
 
25. Limit certain foods, e.g. fat, sugar   0 1 2 
 
26. Control my weight     0 1 2 
 
27. Get a regular medical check-up    0 1 2 
 
28. Get a regular dental check-up    0 1 2 
 
29. Take dietary supplements or vitamins   0 1 2 
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Appendix 14: General Preventive Health Behaviours Checklist (Brief) 
 
 
Which of the following activities do you generally undertake or engage in? Please 
respond by circling the number which best represents the extent to which you 
undertake or engage in each activity: 
 
0=Do not do  1=Sometimes  2= Yes, always or almost always 
1. Eat sensibly       0 1 2 
 
2. Avoid crossing the street against the traffic lights  0 1 2 
 
3. Get enough sleep      0 1 2 
 
4.  Spend time out of doors everyday    0 1 2 
 
5. Do not smoke      0 1 2 
 
6. Get enough exercise     0 1 2 
 
7. Avoid letting things get me down    0 1 2 
 
8. Get a regular medical check-up    0 1 2 
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Appendix 15: Health Behaviour Scale 
 
 
Looking back on an average week, please indicate how often you did each of the 
following behaviours: (Please tick the appropriate box) 
 
 Never Once 
a 
month 
Once 
a 
week 
2-3 
times 
a week 
4-5 
times 
per 
week 
Every 
day 
Strenuous or 
moderately strenuous 
physical exercise (e.g. 
brisk walking) 
      
Take vitamins       
Take alternative or 
complementary 
remedies 
      
Eat the recommended 
5+ portions of fruit 
and vegetables each 
day 
      
Eat breakfast       
Eat fried food       
Drink alcohol       
Get 7-8 hours sleep       
       
 
 
 
 
 
In an average week, how many minutes would you 
spend doing strenuous or moderately strenuous 
exercise (so you sweat)? 
minutes per week 
Do you usually use fat-reduced milk (e.g. trim milk )? Yes No 
What do you normally use as a choice of spread? Butter Margarine 
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Appendix 16: Health Related Behaviours Scale 
 
 
 
 
Smoking Behaviour 
 
1. Do you ever smoke?  Yes  No 
2. Over the last week, on average how many cigarettes have you smoked? _______ 
3. On average how many cigarettes have you smoked each day? _______ 
4. Over the last week, how much have you been craving cigarettes? 
 1 2 3 4 5 
Not at all    Extremely 
 
 
Sleeping Behaviour 
 
1. On average how many hours have you slept per night? _______ (hours) 
2. How does this amount related to your usual sleeping pattern? (Please circle) 
Much less than usual 
Less than usual 
Same as usual 
More than usual 
Much more than usual 
 
Alcohol Consumption 
 
1. Do you ever drink alcohol?  Yes  No 
2. Over the last week, on average how much have you drunk? ________ 
3. On average how many alcoholic drinks have you had each day? _______ 
4. Over the last week, how much have you been craving alcohol? 
 1 2 3 4 5 
Not at all    Extremely 
 
 
Exercise Behaviour (over the last week) 
 
1. How many hours have you spent exercising? (e.g. aerobics, walking, 
running) ______ (hours) 
2. How does this amount relate to your usual exercise behaviour? (Please 
circle) 
Much less than usual 
Less than usual 
Same as usual 
More than usual 
Much more than usual 
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Appendix 17: Benefit Finding 
 
Having a heart attack…. 
 
1. Has led me to be more accepting of things 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
2. Has taught me how to adjust to things I cannot change 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
3. Has helped me take things as they come 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
4. Has brought my family closer together 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
5. Has made me more sensitive to family issues 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
6. Has taught me that everybody has a purpose in life 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
7. Has shown me that all people need to be loved 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
8. Has made me realise the importance of planning for my family’s future 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
9. Has made me more aware and concerned for the future of all human 
beings 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
10. Has taught me to be patient 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
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11. Has led me to deal better with stress and problems 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
12. Has led me to meet people who have become some of my best friends 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
13. Has contributed to my overall emotional and spiritual growth 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
14. Has helped me become more aware of the love and support available from 
other people 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
15. Has helped me realise who my friends are 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
16. Has helped me become more focused on priorities, with a deeper sense of 
purpose in life 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
 
17. Has helped me become a stronger person, more able to cope effectively 
with future life challenges 
 
I disagree a lot I disagree a little I agree a little  I agree a lot 
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Appendix 18: MacNew Quality of Life Scale 
 
We would now like to ask you some questions about how you have been feeling 
DURING THE LAST 2 WEEKS 
 
Please circle your answer 
 
1. In general, how much of the time during the last 2   2. How often during the last 2 weeks have 
weeks have you felt frustrated, impatient or angry?  you felt worthless or inadequate? 
All of the time       All of the time 
Most of the time       Most of the time 
A good bit of the time      A good bit of the time 
Some of the time       Some of the time 
A little of the time      A little of the time 
Hardly any of the time      Hardly any of the time 
None of the time        None of the time 
 
3. In the last 2 weeks, how much of your time did you  4. In general how much of the time did  
feel very confident and sure that you could deal with  you feel discouraged or down in the  
your heart problem?      dumps during the last 2 weeks? 
None of the time       All of the time 
A little of the time      Most of the time 
Some of the time       A good bit of the time 
A good bit of the time      Some of the time 
Most of the time       A little of the time 
Almost all of the time      Hardly any of the time 
All of the time       None of the time 
 
5. How much of the time during the last 2 weeks did  6. How often during the last 2 weeks have  
you feel relaxed and free of tension?    You felt worn out or low in energy? 
None of the time       All of the time 
A little of the time      Most of the time 
Some of the time       A good bit of the time 
A good bit of the time      Some of the time 
Most of the time       A little of the time 
Almost all of the time      Hardly any of the time 
All of the time       None of the time 
 
7. How happy, satisfied, or pleased have you been with  8.In general, how often during the last 2  
your personal life during the last 2 weeks?   Weeks have you felt restless, or as if you  
Very dissatisfied, unhappy most of the time   were having difficulty trying to calm down 
Generally dissatisfies, unhappy     All of the time 
Somewhat dissatisfied, unhappy    Most of the time 
Generally satisfied, pleased     A good bit of the time 
Happy most of the time      Some of the time 
Very happy most of the time     A little of the time 
Extremely happy, could not have been more satisfied  Hardly any of the time 
or pleased        None of the time 
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9. How much shortness of breath have you experienced  10. How often during the last 2 weeks 
during the last 2 weeks while you were doing your  have you felt tearful, or like crying? 
day-to-day physical activities? 
Extreme shortness of breath     All of the time 
Very short of breath      Most of the time 
Quite a bit of shortness of breath    A good bit of the time 
Moderate shortness of breath     Some of the time 
Some shortness of breath     A little of the time 
A little shortness of breath     Hardly any of the time 
No shortness of breath      None of the time 
 
11. How often during the last 2 weeks have you felt as if  12. How often during the last 2 weeks have  
you are more dependent than you were before your heart you felt you were unable to do your usual  
problem?        social activities, or social activities with your 
All of the time       family? 
Most of the time       All of the time 
A good bit of the time      Most of the time 
Some of the time       A good bit of the time 
A little of the time      Some of the time 
Hardly any of the time      A little of the time 
None of the time       Hardly any of the time 
        None of the time 
 
13. How often during the last 2 weeks have you felt as if 14.How often during the last 2 weeks have 
others no longer have the same confidence in you as they you experienced chest pain while doing 
did before your heart problem?     your day-to-day activities? 
All of the time       All of the time 
Most of the time       Most of the time 
A good bit of the time      A good bit of the time 
Some of the time       Some of the time 
A little of the time      A little of the time 
Hardly any of the time      Hardly any of the time 
None of the time       None of the time 
 
15. How often during the last 2 weeks have you felt  16.How often during the last 2 weeks have 
unsure of yourself or lacking self-confidence?   you been bothered by aching or tired legs? 
All of the time       All of the time 
Most of the time       Most of the time 
A good bit of the time      A good bit of the time 
Some of the time       Some of the time 
A little of the time      A little of the time 
Hardly any of the time      Hardly any of the time 
None of the time       None of the time 
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17. During the last 2 weeks, how much have you been  18. How often during the last 2 weeks  
limited in doing sports or exercise as a result of your  have you felt apprehensive or frightened? 
heart problem? 
Extremely limited      All of the time 
Very limited       Most of the time 
Limited quite a bit      A good bit of the time 
Moderately limited      Some of the time 
Somewhat limited      A little of the time 
Limited a little       Hardly any of the time 
Not limited at all       None of the time 
 
19. How often during the last 2 weeks have you felt  20. In general during the last 2 weeks, how 
dizzy or lightheaded?      Much have you been restricted or limited  
All of the time       as a result of your heart problem? 
Most of the time       Extremely limited 
A good bit of the time      Very limited 
Some of the time       Limited quite a bit 
A little of the time      Moderately limited 
Hardly any of the time      Somewhat limited 
None of the time       Limited a little 
        Not limited at all 
 
21. How often during the last 2 weeks have you felt   22.How often during the last 2 weeks have 
unsure as to how much exercise or physical activity  you felt as if your family is being over- 
you should be doing?      Protective toward you? 
All of the time       All of the time 
Most of the time       Most of the time 
A good bit of the time      A good bit of the time 
Some of the time       Some of the time 
A little of the time      A little of the time 
Hardly any of the time      Hardly any of the time 
None of the time       None of the time 
 
23. How often during the past 2 weeks have you   24.How often during the past 2 weeks have 
felt as if you were a burden on others?    you felt excluded from doing things with 
All of the time       other people because of your heart problem? 
Most of the time       All of the time 
A good bit of the time      Most of the time 
Some of the time       A good bit of the time 
A little of the time      Some of the time 
Hardly any of the time      A little of the time 
None of the time       Hardly any of the time 
        None of the time 
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25. How often during the past 2 weeks have you felt  26. In general, during the last 2 weeks how  
unable to socialise because of your heart problem?  much have you been physically restricted   
All of the time       or limited as a result of your heart problem? 
Most of the time       Extremely limited 
A good bit of the time      Very limited 
Some of the time       Limited quite a bit 
A little of the time      Moderately limited 
Hardly any of the time      Somewhat limited 
None of the time       Limited a little 
        Not limited at all 
 
27. How often during the last 2 weeks have you felt 
your heart problem limited or interfered with sexual intercourse 
All of the time 
Most of the time 
A good bit of the time 
Some of the time 
A little of the time 
Hardly any of the time 
None of the time 
Not applicable 
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The following statements are about your current health and how your heart problems may have 
influenced your everyday life. Listen to each statement, think of yourself today and tell me if it 
describes you or not. If you agree or disagree you should tell me. I will then ask ‘Is this due to 
your health’ – Please answer yes or no. Ask me to repeat a statement or slow down if you do not 
understand. (Read down the list of items in each category. As soon as the patient agrees with a 
statement you must ask whether it is due to their health, if the answer to this is yes, tick the 
statement and move to the next category of items) 
 
Ambulation (126) – The following statements describe walking and use of stairs. Please think of yourself 
today and tell me if you agree or disagree with the statement, and if this is due to the state of your health 
 
1. I do not walk at all         ….. (126) 
2. I get about in a wheelchair         ….. (121) 
3. I do not use stairs at all         ….. (106) 
4. I only walk with help from somebody else       ….. (98) 
5. I get about only by using a walking frame, crutches, stick, walls, or hold onto furniture  ….. (96) 
6. I only go up and down stairs with assistance from somebody else    ….. (87) 
7. I only use stairs with a physical aid: for example, special rail, stick or crutches   ….. (82) 
8. I walk by myself but with some difficulty, for example, I limp, wobble, stumble or I have a stiff leg ….(71) 
9. I do not walk up or down hills        ….. (64) 
10. I go up and down stairs more slowly, for example, one step at a time or I often have to stop ….. (62) 
11. I walk shorter distances or often stop for a rest      ….. (54) 
12. I walk more slowly          ….. (39) 
 
 
 
Mobility (114) – These next statements describe how you get about the house and outside. Please tell me if you 
agree or disagree with the statement, and if it is due to the state of your health 
 
13. I stay in bed most of the time        ….. (114) 
14. I stay in one room         ….. (101) 
15. I stay in bed          ….. (91) 
16. I stay at home most of the time        ….. (79) 
17. I only get about in one building        ….. (76) 
18. I only go out if there is a lavatory nearby       ….. (64) 
19. I do not get about in the dark or in places that are not lit unless I have someone to help  ….. (57) 
20. I do not use public transport now        ….. (52) 
21. I do not go into town         ….. (47) 
22. I only stay away from home for short periods      ….. (46) 
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Recreation - The following statements describe the activities you usually do in your spare time, for relaxation, 
entertainment or just to pass the time. Again, think of yourself today. Please tell me if you agree or disagree 
with the statement, and if it is due to the state of your health. 
 
23. I am not doing any of my usual inactive pastimes; for example, I do not watch TV, play cards, 
     or read           ….. (91) 
24. I am not doing any of my usual physical recreation or more active pastimes   ….. (81) 
25. I am cutting down on some of my usual inactive pastimes; for example I watch TV less, play cards 
     less, or read less          ….. (50) 
26. I am doing more inactive pastimes instead of my other usual activities    ….. (43) 
27. I am cutting down on some of my usual physical recreation or more active pastimes  ….. (34) 
28. I spend shorter periods of time on my hobbies and recreation     ….. (32) 
29. I go out less often to enjoy myself        ….. (27) 
30. I take part in fewer community activities       ….. (25) 
 
 
Social Interaction – These statements describe your contact with family and friends today. Please tell me if 
you agree or disagree with the statement, and if it is due to the state of you health. 
 
64. I go out less often to visit people        ….. (31) 
65. I do not go out at all to visit people        ….. (91) 
66. I show less interest in other people’s problems; for example, I don’t listen when people tell me 
     about their problems; I don’t offer to help       ….. (50) 
67. I am often irritable with those around me; for example, I snap at people or criticize easily  ….. (64) 
68. I show less affection         ….. (44) 
69.  I take part in fewer social activities than I used to; for example, I go to fewer parties 
      or social events          ….. (25) 
70. I am cutting down the length of visits with friends      ….. (31) 
71. I avoid having visitors         ….. (73) 
72. My sexual activity is decreased        ….. (64) 
73. I often express concern over what might be happening to my health    ….. (44) 
74. I talk less with other people        ….. (44) 
75. I make many demands on other people; for example, I insist that they do things for me or tell 
     them how to do things         ….. (76) 
76. I stay alone much of the time        ….. (91) 
77. I am disagreeable with my family; for example, I act spitefully or stubbornly   ….. (86) 
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78. I frequently get angry with my family; for example, I hit them, scream or throw things at them ….. (103) 
79. I isolate myself as much as I can from the rest of my family     ….. (100) 
80. I pay less attention to the children        ….. (59) 
81. I refuse contact with my family; for example, I turn away from them    …..  (109) 
82. I do not look after my children or family as well as I usually do     ….. (66) 
83. I do not joke with members of my family as much as I usually do    ….. (66) 
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Appendix 20: Medication Adherence Report Scale 
 
QUESTIONS ABOUT USING YOUR  
MEDICINES 
 
 Many people find a way of using their medicines which suits them 
 This may differ from the instructions on the label or from what the doctor has 
said 
 We would like to ask you a few questions about how you use your medicines 
 
Here are some ways in which people have said that they use their 
medicines 
 
 
For each of the statements below, please tick the box which best applies to you 
 
 
 Your own way 
of using your 
medicines 
Always Often Sometimes Rarely Never 
M1 I forget to take 
them 
     
M2 I alter the dose 
 
     
M3 I stop taking 
them for a while 
     
M4 I decide to miss 
a dose 
     
M5 I take less than 
instructed 
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Appendix 21: Patient Information Sheet 
 
Study Title: The Role of Psychological Variables in Predicting Outcome 
Following Myocardial Infarction 
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part. 
Thank you for reading this. 
 
What is the purpose of the study? 
The aim of this study is to investigate some of the psychological factors which are 
thought to be associated with cardiac disease. With information gained from this 
study, we hope to have a better understanding of the factors associated with good 
recovery, and therefore be in a better position to plan interventions. 
 
Why have I been chosen? 
All patients who have been admitted to Edinburgh Royal Infirmary after experiencing 
a heart attack are being asked to participate. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part you will be given this information 
sheet to keep and be asked to sign a consent form. If you decide to take part you are 
still free to with draw at any time and without giving a reason. A decision to with 
draw at any time, or a decision not to take part, will not affect the standard of care you 
receive. We will also ask for your permission to inform your GP of your participation. 
 
What will happen to me if I take part? 
If you agree to participate, I will then ask you a series of questions which should take 
about 30 minutes. The questions will relate to how you are feeling, what your mood is, 
your feelings about your illness, what beliefs you have about medicines and what you 
are looking forward to and are worried about. You can write the answers to any of the 
questions down yourself or I can write them down for you; it is entirely up to you. 
When I have finished asking you these questions, I will ask you whether I can contact 
you again in 3 months, to answer some further questions over the phone. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be 
kept strictly confidential 
 
What will happen to the results of the research study? 
The results will be analysed and published in scientific journals. 
 
Who is organising and funding the research? 
The research is organised by Department of Psychology, University of Stirling and is 
funded by the Chief Scientist Office in Scotland. 
 
Contact for further information: If you require any further information about this 
study please contact Lynn Williams, telephone number 01786466853.  
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Appendix 22: Patient Consent Form 
 
CONSENT FORM 
(Version 1 16/12/2004) 
 
Title of Project: The Role of Psychological Variables in Predicting Outcome 
Following Myocardial Infarction 
 
Name of Researcher:  
 
 
 
 
Please tick box 
 
1. I confirm that I have read and understand the information sheet for the above 
study and have had the opportunity to ask questions     
 
2. I understand that my participation is voluntary and that I am free to with draw 
at any time, without giving any reason, without my medical care or legal rights 
being affected. 
 
3. I understand that sections of my medical notes may be looked at by 
responsible individuals from Stirling University. I give permission for these 
individuals to have access to my records. 
 
4. I agree to take part in the above study 
 
 
____________________  ___________  __________________ 
Name of Volunteer  Date   Signature 
 
 
____________________  ___________  __________________ 
Name of Investigator  Date   Signature 
 
 
Thank you for your help with this research project 
 
 
 
 
 
 
 
